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Abstract 
Pre-mRNA splicing involves the removal of non-coding sequences (introns) 
that intervene between the coding regions (exons) of pre-mRNA. This involves two 
transesterification reactions and occurs within a large, highly dynamic 
ribonucleoprotein complex termed the spliceosome. The spliceosome consists of 
over fifty known proteins as well as five different small nuclear RNAs (snRNAs); 
Ui, U2, U4, U5 and U6, which are associated with proteins to form small nuclear 
ribonucleoproteins (snRNPs). The assembly of these snRNPs onto the pre-mRNA is 
a complex highly regulated procedure. 
To enter the spliceosome, U6 snRNP must associate with the U4 snRNP to 
form a U4/U6 di-snRNP. This involves RNA-RNA interactions between U4 and U6 
RNAs, as the two have extensive sequence complementarity and form Watson-Crick 
base-pair interactions over their length. During splicing, the U4 snRNP dissociates 
from the U6 snRNP and U6 snRNA undergoes several structural rearrangements. 
Therefore, U4 and U6 snRNA must be reannealed following spliceosome 
dissasembly in order to recycle the factors back into the splicing pathway. 
A group of seven proteins, Lsm2-Lsm8p, has previously been identified that 
interact with U6 snRNA and are essential for U6 snRNA stability and pre-mRNA 
splicing in the yeast Saccharomyces cerevisiae. In this thesis the Lsm (like-) 
proteins have been produced either as recombinant protein in E. coil or as the product 
of a coupled in vitro transcription/translation reaction. Using these proteins it has 
been demonstrated that the Lsm proteins can facilitate U4/1J6 RNA duplex 
formation. Another U6-associated protein, Prp24p, did not facilitate U4/U6 duplex 
formation in the absence of the Lsm proteins. This was in contrast to previous reports 
suggesting a role for Prp24p in U4/1J6 annealing. Prp24p is, however, required when 
the 3' terminal Lsm binding site is deleted from U6 snRNA. Evidence is presented 
suggesting that the Lsm8 complex can facilitate U4/U6 duplex formation in vivo as 
well as in vitro. In particular, Lsm6p appears to be essential for stable U4/U6 duplex 
formation, whereas Lsm7p does not. The data presented, therefore, suggest a model 
where the Lsm8 complex, in particular Lsm6p, is sufficient and necessary for U4/U6 
duplex formation. Other factors such as Prp24p may facilitate this process, but are 
not essential for it to occur. 
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CHAPTER 1 
Introduction 
1.1 Pre-mRNA Splicing 
Nuclear pre-mRNA splicing involves the removal of non-coding sequences 
(introns) from the coding regions (exons) of mRNA. This was first discovered in the 
late 1970s when it was noticed that there is a large amount of sequence present in the 
DNA template and the newly transcribed pre-mRNA which is absent in the mature 
mRNA (Berget et al., 1977; Chow ci al., 1977; Sharp, PA, 1994; Figure 1.1). 
Gene 	 1 	DNA 
Transcription 
5jExoni 	 3' 	Pre-mRNA 
Pre-mRNA Splicing 
Exoni 	Exon2 3' 	 mRNA 
Translation 
N 	 C 	Protein 
Figure 1.1. General mechanism of gene expression. Genes are firstly transcribed to 
form pre-mRNA, which is spliced to form mature mRNA. The mRNA is 
subsequently exported into the cytoplasm and protein is then translated. 
Different eukaryotic organisms vary tremendously in both the number of introns 
that their pre-mRNAs contain and the length of these introns. For example, 
examination of the genome of Saccharomyces cerevisiae (referred to here as yeast) 
reveals that only approximately 250 of the 6000 genes contain an intron, almost 100 
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of which are genes for ribosomal proteins (Lopez & Séraphin, 1999). Bioinformatic 
and molecular analysis of the yeast genome has led to the further identification of 
intron-containing genes (Spingola et al., 1999), however, further intron-containing 
genes are thought to still be unidentified. The vast majority of intron-containing 
genes only contain one intron. Notable exceptions are the MATaI and the ribosomal 
RPL8A genes, both of which contain two introns. Yeast introns also tend to be 
relatively small, being below 400 nucleotides in length. In contrast, most genes of 
higher eukaryotes contain multiple introns which tend to be much larger (sometimes 
exceeding 200,000 nucleotides in size) than those of yeast. Despite yeast possessing 
only a few intron-containing genes, it has been estimated that these genes give rise to 
over one quarter of all mRNAs produced in the cell (Ares Jr. et at, 1999). 
S. cerevisiae 
Exoni_AGUAUGU 	UACUAAC —YAE Exon2 
5' splice 	 Branch Point 3' splice site 
Mammalian 
Exoni_AGURAGU - YNYRA - (Y) - YA 	Exo 
Figure 1.2. Schematic representation of conserved sequences within the introns of S 
cerevisiae and mammalian introns. The positions of the 5' splice site, branch point 
and the 3' splice site are indicated, where Y represents conserved pyrimidines and R 
represents conserved purine residues. The conserved adenosine residue is underlined. 
Exons are represented by grey boxes. 
Despite the differences in the number and size of introns between yeast and 
higher eukaryotes, the splicing reaction itself is remarkably similar between the two. 
This is demonstrated by three regions of conserved sequence within the otherwise 
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relatively non-conserved sequences of both yeast introns and introns of higher 
eukaryotes. These occur at (1) the junction between the upstream exon and the 5' end 
of the intron, known as the 5' splice site, (2) a region within the intron known as the 
branch point, and (3) the junction between the 3' end of the intron and the 
downstream exon, referred to as the 3' splice site (Figure 1.2). 
The splicing reaction itself is an ATP-dependent process involving two 
transesterification reactions. During the first reaction step, there is a nucleophilic 
attack by the 2' hydroxyl group of the conserved branchpoint adenosine residue upon 
the phosphate at the 5' splice site resulting in the phosphodiester bond being cleaved. 
This forms an intron-exon 2 lariat structure due to a 5'-+2' bond between the 5'-end 
of the intron and the conserved adenosine at the branch point within the intron. 
During the second step, cleavage at the 3' splice site occurs as a result of nucleophilc 
attack by the free 3' hydroxyl of exon 1. This results in the ligation of the two exons 
releasing the intron-lariat structure, which is subsequently degraded (reviewed by 
Kramer, 1996; Green, 1991; Figure 1.3). 
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Figure 1.3. (A) Schematic representation of the two steps of the 
splicing reaction. Step I involves the formation of a 5' to 2' bond 
between the 5' splice site (5'ss) and the conserved adenosine at the 
branch point (BP), releasing exon 1 and forming a lariat-exon2 
intermediate. Step 2 joins exon I to the 3' splice site (3'ss), 
removing the intron-lariat structure. (B) Structure of the branchpoint 
following lariat formation after step 1 of pre-mRNA splicing. The 
bond between the 5' phosphate of the 5' splice site and the 2'-OH 
group of the A nucleotide is shown. Taken from Alberts (1994). 
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1.2 The Spliceosome 
The splicing reaction is dependent on the formation of a large, dynamic 
ribonucleoprotein complex termed the spliceosome, on the pre-mRNA. Despite the 
relative simplicity of the splicing reaction itself, this is not reflected in either the 
composition or the assembly of the spliceosome. It is composed of five small nuclear 
RNAs (U I, U2, U4, US and U6 snRNAs; Guthrie, 1991) packaged with proteins into 
five small nuclear ribonucleoprotein particles (snRNPs), as well as various other non-
snRNP proteins. Approximately 50 proteins involved in pre-mRNA splicing have 
been identified (reviewed in Will & Luhrmann. 1997; Staley & Guthrie. 1998, 
Hastings & Kramer, 2001). The U4 and U6 snRNAs have extensive regions of 
complementarity, allowing their respective snRNPs to associate together to form a 
U4/U6 di-snRNP. The U5 snRNP can further associate with this U4/U6 particle via 
protein-protein interactions to form a tri-snRNP. All the snRNPs are trans-acting 
factors which associate with one another and with the conserved cis-acting elements 
within the pre-mRNA in a highly ordered pathway in order to form an active 
spliceosome (Figure 1.4). 
The first stage in spliceosomal assembly is the creation of the commitment 
complex (CC), so called because formation of this complex commits the pre-mRNA 
to the splicing pathway. This complex is formed by the binding of the U  snRNP to 
the 5' splice site of the pre-mRNA. The specificity of this interaction is due to a 
conserved region of complementarity between the U  snRNA and the conserved 5' 
Figure 1.4. Diagram demonstrating the assembly of the 
spliceosome by the ordered addition of snRNP particles onto the 
pre-mRNA. The Ui snRNP (green) interacts with the 5' splice site 
(S'ss) to form the commitment complex (CC). Following this, the 
U2 snRNP (yellow) associates with the branch point sequence, 
bulging out the branch point adenosine (BP) to form the A complex. 
Next, the U5.U4/U6 tri-snRNP associates with the complex to 
create complex B. Splicing complex C is then produced by dynamic 
rearrangements within the spliceosome, including the dissociation 
of the Ui snRNP and the U4 snRNP (blue) from U6 (red). The 
splicing chemistry then occurs and the splicesome disassembles, 
releasing mature mRNA and the intron-lariat structure. snRNPs are 
then released and recycled back into the splicing pathway while the 
lariat is debranched and degraded. 
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splice site sequence, allowing the two to interact via Watson-Crick base pairing. U  
is also reported to bind to the 3' splice site in S. pombe (Reich et al., 1992), but there 
is no evidence of this occurring in other organisms, including S. cerevisiae (Séraphin 
& Kandels-Lewis, 1993). The next stage in spliceosomal assembly is the binding of 
the U2 snRNP to the branch point sequence, again via Watson-Crick base pairing, 
forming the A complex. Owing to the two sequences not being completely 
complementary, however, the conserved adenosine residue at the branch point is 
unpaired and bulges out of the U2 snRNA-pre-mRNA duplex, allowing it to be 
involved in the first step of splicing. Following this, the U4/LT6.U5 tri-snRNP, as 
well as other non-snRNP factors associate with the complex, forming a spliceosomal 
B complex. 
During the splicing reaction, both the composition and arrangement of the 
spliceosome alters considerably, allowing the two stages of the splicing reaction to 
be efficiently catalysed. One of the most important rearrangements is the 
destabilisation of the base pairing between U4 and U6 snRNAs and the formation of 
RNA-RNA interactions between U2 and U6 (Uman & Guthrie, 1995). Also, UI 
snRNA is displaced from binding to the 5' splice site by US and U6 snRNAs. Both 
the UI and U4 snRNPs are believed to leave the spliceosome following these 
rearrangements, forming the active spliceosome, called the C complex. These 
arrangements are believed to be functionally very important as such RNA 
rearrangements form the catalytic centre of the spliceosome, allowing splicing to 
occur. Following the splicing of the pre-mRNA, the spliceosome disassembles, 
releasing the mature mRNA and the lariat, the latter being subsequently hydrolysed 
and degraded. 
More recently, a novel class of pre-mRNA introns was discovered in 
metazoan genes. These introns have non-canonical consensus sequences and are 
spliced by a novel spliceosome, called the U12 (formally AT-AC) spliceosome 
(reviewed in Tarn & Steitz, 1997). The U12 spliceosome shares components with the 
canonical spliceosome, including the US snRNP (Tam & Steitz, 1996a). All the other 
snRNPs, however, in the U12 spliceosome are specific to this splicesome. The U  I 
and U12 snRNPs appear to functionally replace the UI and U2 snRNPs (Tarn & 
Steitz, 1996a). U12 spliceosomes also require highly diverged forms of U4 and U6 
snRNA, termed U4atac and U6atac respectively (Tam & Steitz, 1996b). It is thought 
that Ull, U12, U4atac and U6atac snRNPs, as well as the U5 snRNP interact with 
one another in a similar way to their more common canonical analogues. The U12 
spliceosome has not been found in yeast. 
1.3 The U snRNP Assembly pathway 
The Ui, U2, U4 and U5 snRNPs all share a common assembly pathway (reviewed 
in Will & Lührmann, 2001). Following the transcription of the respective gene by 
RNA Polymerase II, the resulting snRNA is exported from the nucleus into the cell 
cytoplasm (Figure 1.5). This export pathway shares common components used for 
Sm proteins 
m7G P—~~_ 	m7G 17 
Hypermethylation  
CYTOSOL 	 m727GP 
I mportin ji  
PJIAN r 	 Snurportini 
GTP I m 22 







Figure 1.5. Assembly of the U snRNP in higher eukoryotes. Newly 
transcribed U snRNA acquires a methyl guanosine (m7G) cap in 
the nucleus, to which the cap binding complex (CBC) binds. This 
then associates with phosphorylated (represented by a circled P) 
PHAX which in turn binds to CRMI/Xpol which associates with 
Ran-GTP. This complex is exported to the cytoplasm where the 
complex dissociates, owing to PHAX desphosphorylation and GTP 
hydrolysis by Ran. Sm proteins then assemble around the Sm site of 
the U snRNA, which leads to the hypermethylation of the m7G cap, 
forming an m 2'2 ' 7G cap.This can then be reimported back into the 
nucleus via nuclear membrane proteins importin3 and snurportini. 
Once there, the U snRNA associates with snRNA-specific proteins, 
forming a mature U snRNP particle. 
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the general export of mRNA from the nucleus, including the 7-monomethyl 
guanosine (7mG) cap structure (Hamm & Mattaj, 1990), the cap-binding complex 
(CBC; Izaurralde et al., 1995), the export receptor CRM1/Xpol (Stade et al., 1997, 
Fornerod et al., 1997) and RanGTP (Izaurralde et al., 1997). In addition, a factor, 
named PHAX (phosphorylated adaptor for RNA export) has been identified that is 
specific for the export of U snRNAs from the nucleus (Ohno et al., 2000) and 
functions by mediating the interaction between the CBC/U sriRNA complex and the 
CRMI/RanGTP complex. Dephosphorylation of this complex occurs in the 
cytoplasm causing the complex to disassociate, ensuring the directionality of U 
snRNA export. 
Once there, the snRNA is bound by a common set of seven core proteins, referred 
to as the Sm proteins. Each of the Ui, U2, U4 and U5 snRlNPs contains a complex of 
these Sm proteins, which binds to a specific sequence known as the Sm site, the 
single-stranded structural motif which consists of the sequence RA(U) 46GR, present 
in the UI, U2, U4 and U5 snRNAs (reviewed by Lührmann, 1988). Following the 
binding of the Sm complex to the snRNA (see below), the cap is hypermethylated (to 
tn-methyl guanosine (TMG), the 3' end is processed and shortened, resulting in a 
core snRNP complex which is imported back into the nucleus. Import is dependent 
on the nuclear membrane proteins importin P (Palacios et al., 1997) and snurportin 1, 
which bind to both the nuclear import signals on the Sm proteins and to the 
hypermethylated cap (Singh & Reddy, 1989). Following nuclear import, other 
snRNP-specific proteins associate with the core complex, forming mature snRNPs. 
Immunofluorescence data from Sleeman & Lamond (1999), however, suggest that 
there is a specific pathway for newly assembled snRNPs, as newly assembled GFP -
labelled snRNPs accumulated firstly in nucleoli and subnuclear structures known as 
coiled bodies (reviewed in Lamond & Carmo-Fonseca, 1993), and later in Cajal 
bodies (Huang & Spector, 1992; Gall, 2000). In contrast, mature snRNPs localised to 
speckles immediately after entering the nucleus. The significance of these data is not 
yet understood. 
1.4 Canonical Sm Proteins 
Sm proteins were originally identified by their cross-reactivity with antibodies 
from patients suffering from the autoimmune disease systemic lupus erythematosus 
(Lerner & Steitz, 1979). Anti-Sm antibodies were shown to immunoprecipitate 
snRNPs from a wide variety of organisms including plants, fungi, Drosophila and 
yeast (Séraphin, 1995), demonstrating a high level of evolutionary conservation. In 
total, there have been seven canonical Sm proteins identified in mammalian cells 
(B/B', Dl, D2, D3, E, F and G) and their genes cloned (Hermann et al.. 1995). The B 
and B' proteins were found to differ at their C-termini (van Dam et al., 1989) and are 












snRNP core F 
-T 
B 
Figure 1.6. (A) Schematic representation of the assembly of the Sm 
protein core onto snRNAs in mammalian cells. Firstly, Dl -D2 and E-
F-G complexes are formed, which assemble into a pentameric 
complex in the absence of RNA, before binding to an U snRNA Sm 
site to form the subcore. Finally, a B-133 dimer binds to the subcore, 
forming a proposed ring structure around the Sm site. (B) Structural 
models of the Sm heptameric ring. The left-hand side represents the 
ribbon structure, with each subunit labelled. The surface 
representation (Nicholls et aL, 1991) is shown on the right with 
electrostatic potential (blue, positive; red, negative). The two 
orientations are identical. From Kambach et al., 1999. 
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Sequence comparisons of the Sm proteins from different organisms revealed a 
common motif, the Sm motif, which consists of two domains separated by up to 30 
amino acid residues (Hermann et al., 1995; Séraphin, 1995). Although the primary 
sequence of the Sm domain is not highly conserved, amino acid residues at 
equivalent positions within Sm proteins have similar physicochemical properties. 
This suggests that the three-dimensional fold, rather than the amino acid sequence 
may be more important in their function (Séraphin, 1995). The Sm domain appears to 
be an ancient motif, being identified in archaea (Achsel et al., 2001). These Sm-like 
proteins in archaea also bind to oligo(U) RNA. 
Due to their low abundance, it was not until relatively recently (Fabrizio et al., 
1994) that the biochemical characterisation of Sm proteins in yeast was possible,. 
Other yeast genes encoding Sm proteins were discovered due to their similarity to the 
higher eukaryotic sequences (Rymond, 1993; Roy et al., 1995; Bordonné & 
Tarassov, 1996). The sequencing of the yeast genome reveals that there are seven Sm 
proteins, analogous to the situation in higher eukaryotes (Neubauer et al., 1997). 
The assembly of the Sm proteins onto the Sm site of the Ui, U2, U4 and US 
snRNAs is highly ordered and occurs in the cytosol (Feeney et al., 1989; Figure 
1.6A). Pulse-chase experiments revealed that a protein heterooligomer forms prior to 
association with the snRNA (Fisher etal., 1985; Sauterer etal., 1990). This complex 
contains the Dl, D2, E, F and G proteins and is capable of binding to the Sm site. 
Subsequent studies (Fisher et al., 1985; Sauterer et al., 1990; Raker et al., 1996; 
14 
Plessel et al., 1997; Figure 1.6A) have shown that, firstly, the E, F and 0 proteins 
form a trimeric complex and the Dl and D2 proteins associate to form a heterodimer. 
These two complexes then assemble to form a heteropentameric complex that binds 
to the Sm site of the U snRNA. This then associates with a heterodimer formed by 
the B/B' and D3 proteins to form the complete snRNP core particle. Although the 
snRNP particle binds to the U snRNA, none of the Sm proteins has a recognised 
RNA recognition motif (RRM; reviewed in Birney et al., 1993; Burd & Dreyfuss, 
1994). The RNA binding properties of the Sm proteins probably results from the 
formation of a novel RRM present only when the proteins are bound to each other 
and/or the Sm site of the U snRNA. Crosslinking experiments have demonstrated 
that SmB/B' and SmG can directly contact the Sm-site and therefore have RNA-
binding properties in the presence of the other Sm proteins (Urlaub et al.. 2001). The 
C-terminal tails of SmB and SmD 1 appear to be essential for the nuclear import of 
the yeast Sm complex (Bordonné, 2000) as nuclear fluorescence of GFP-tagged 
versions of these proteins was reduced following deletions or mutations within these 
domains. 
Further evidence has suggested that there are accessory proteins that regulate the 
assembly of Sm proteins onto the U snRNAs. Firstly, Sm proteins form a complex 
with the protein SMN (survival of motor neurons; Liu et a!, 1997), which binds 
preferentially to the dimethylarginine modified arginine and glycine rich (RG-rich) 
domains at the C-tennini of SmDI and SmD3 (Friesen et al., 2001a). SMN is 
associated with SIP1 (SMIN-interacting protein 1; Liu et al., 1997), also known as 
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Gemin2. In Xenopus oocytes, anti-SIPI/Gemin2 antibodies blocked the association 
of Sm proteins with U snRNA whereas anti-SMN antibodies enhanced this 
association. Other members of the Gemin family of proteins are also thought to 
directly interact with the Sm proteins and facilitate Sm complex assembly (Charroux 
et al., 2000; Gubitz et al., 2001). Mutations within components of this SMN protein 
complex in humans can lead to the development of the disease spinal muscular 
atrophy (SMA). In contrast, the protein pICIn has been suggested to inhibit snRNP 
biogenesis by binding to, and sequestering. Sm proteins (Pu et al., 1999). p1Cm 
appears to be located within a multiprotein complex, known as the methylosome 
(Friesen el al., 2001b). a 20S complex consisting of pICIn and a methyltransferase 
JBPI, which produces dimethylarginine.-modified SmDI and SmD3. This may direct 
the Sm proteins to the SMN complex for assembly into snRNP core particles. 
Although it is unknown whether or not any of these proteins has functional 
homologues in yeast, several proteins have been identified that may be involved in 
Sm protein assembly. For example, Brrlp is distantly related to SIP1/Gemin2 and 
may play a role in U snRNA biogenesis (Noble & Guthrie, 1996). The yeast 
homologue of the La protein, Lhplp (see below), as well as associating with newly 
transcribed U6 snRNA (Pannone et al., 1998), has also more recently been 
discovered to interact with Ui, U2, U4 and U5 RNA precursors, assisting in vivo 
snRNP assembly (Xue et al., 2000). 
There has been some controversy about the stoichiometry of each Sm subunit 
within the fully assembled Sm particle. Electron microscopy showed that the EFG 
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complex itself appeared as a ring, which was shown biochemically to contain two 
copies of the E, F and G proteins (Plessel et al., 1997). More recently, however, it 
has become accepted that there is probably only one Sm subunit with the Sm 
complex. Firstly, data suggest that the Sm proteins form a ring structure with seven 
subunits (Kambach et al.. 1999; see below.), consistent with one Sm subunit being 
present in every complex. Secondly, immunoprecipitation experiments have 
indicated that only one copy of each Sm protein is present in each Sm complex in 
yeast (Walke et al., 2001). 
The crystallisation of the Dl-D2 and the B-D3 sub-complexes has also been 
achieved, allowing the structure of these sub-complexes to be solved to atomic 
resolution (Kambach et al., 1999; reviewed by Lamond, 1999). Each Sm monomer 
appears to consist of a highly conserved fold, forming a barrel-type structure 
consisting of an N-terminal cc-helix followed by a strongly bent five-stranded 3-
sheet. This structure allowed the modelling of the complete Sm complex structure, 
which suggested that the Sm proteins associate to form a seven-membered closed 
ring structure with a positively charged central hole (Figure 1.613). This lead to 
speculation that the negatively charged snRNA may pass through this hole, which is 
too narrow for double stranded RNA but would accommodate single stranded RNA, 
such as that at the Sm site. 
More recently, the X-ray structures of several Sm complexes from prokaryotic 
organisms have been solved to atomic resolution (Mura et al., 2000; Collins et al., 
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2001; TOrö et a!, 2001). In each case, the Sm monomer in question had a structure 
very similar to those demonstrated for the human Sm proteins (see above). In the 
crystal structures of the prokaryotic Sm proteins, these monomers were assembled 
into complexes, forming a seven-membered ring with a central positively-charged 
hole at the centre, similar to the model suggested by Kambach et al. (1999). 
Significantly, the crystal structure of the AF-Smi complex from Archaeoglobus 
fungus has been solved whilst bound to a U 5 oligonucleotide (Törö ci' al., 2001). This 
RNA interacts with the central cavity on one side of the heptameric complex. The 
RNA is bound via hydrogen bonding contacts between the bases and residues highly 
conserved in archaeal and eukoryotic Sm proteins. It has yet to be proven whether 
full length U snRNA interacts with eukaryotic Sm proteins in a similar manner, 
although cross-linking experiments suggest that 5mB/B' and SmG do contact the Sm 
site via residues located at the positively charged inner ring (Urlaub ci' al., 2001). 
1.5 U6 snRNP biogenesis 
U6 is dissimilar in many ways to the other snRNAs. Firstly, it is transcribed by 
RNA polymerase III (Reddy et al., 1987; Moenne et al., 1990), and has a y -
monomethyl cap structure (Singh ci' al., 1989). In addition to its templated 
nucleotides, in mammals the 3' end of the RNA is elongated by the addition of non-
templated nucleotides and converted to a 2', 3' cyclic phosphate (Lund & Dahlberg, 
1992; Terns et al., 1992). Unlike the other U snRNAs, both the sequence and 
secondary structure of U6 is highly conserved from yeast to mammals (Brow & 
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Guthrie, 1988), being 75% identical between yeast (112 nucleotides) and human (106 
nucleotides). U6 snRNA in yeast is transcribed from the SNR6 gene (Siliciano et al., 
1987). Following transcription of U6 snRNA, it is bound at its 3' terminus by the La 
protein (Rinke & Steitz, 1985). La is known to interact with the 3' terminal UUUU OH 
of all RNA transcripts produced by RNA polymerase III (Stefano, 1984) and is 
thought to bind to U6 snRNA immediately following transcription, stabilising the 
nascent RNA. The yeast homologue of the La protein is coded by the LHPJ gene 
(Yoo & Wolin. 1994) and interacts with newly transcribed U6 snRNA in vivo. 
In contrast to other U snRNAs, U6 RNA is not thought to leave the nucleus 
(Vankan et al., 1990; Boelens et al., 1995; Pante et al., 1997), although contrary to 
this, U6 snRNA has been detected in the cytosol of mouse fibroblasts (Fury & Zieve. 
1996). Unlike most mRNAs, however, injection experiments in Xenopus oocytes 
suggested that U6 snRINA is selectively retained in the nucleus, rather than actively 
exported (Boelens et al.. 1995). Furthermore, the La protein was implicated in being 
the factor that binds to, and prevents export of U6 snRNA from the nucleus. 
Despite not being exported into the cytoplasm, U6 snRNA appears to have a 
transient phase in the nucleolus (Tycowski et al., 1998; Ganot et al., 1999; Lange & 
Gerbi, 2000). It appears that U6 enters the nucleolus to be pseudouridylated and 
2'-O-methylated at specific residues within its sequence. U6 snRNA seems to require 
its interaction with U4 RNA before it is pseudouridylated (Zerby & Patton, 1996). 
Guide small nucleolar RNAs (snoRNAs) have been identified that are responsible for 
2'-O-methylation in Xenopus oocytes (Tycowski et al., 1998) and HeLa cells (Ganot 
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et al.. 1999), whereas mouse nucleoli contain all the factors that are essential for both 
pseudouridylation and 2'-O-methylation (Ganot et al., 1999). Injection of 
fluorescein-labelled U6 snRNA into Xenopus oocytes has subsequently shown that 
the nucleolar localisation of U6 snRNA is transient (Lange & Gerbi, 2000) 
suggesting that U6 returns to the nucleus following processing. 
As U6 snRNA lacks an Sm site, it does not bind to the core Sm proteins. Instead, 
it appears to interact with seven analogous proteins known as the Lsm (Like Sm) 
proteins (see below). The Lsm complex appears to bind to the 3' terminus of U6, 
which consists of four or more poly(U) residues (Aschel et al., 1999; Vidal et al., 
1999). The 3' end of U6 appears to be necessary and sufficient for LSm binding in 
Hela extracts (Aschel et al., 1999), although the 3' stem loop of U6 snRNA is also 
required in yeast extract (Vidal et al., 1999). As the Lsm proteins bind to the same 
site as Lhplp, the latter is displaced and the Lsm proteins interact with the 3' 
terminus of U6 snRNA. The Lsm proteins are known to be components of the free 
U6 snRNP, the U41U6 di-snRNP and the U5.U41U6 tri-snRNP (Mayes et al., 1999), 
although it is currently unknown whether they stay associated through the splicing 
cycle, or whether they re-associate with U6 snRNA after spliceosome disassembly. 
One splicing factor, Prp24p, is known to be a component of the U6 snRNP in 
yeast (Shannon & Guthrie, 1991; Jandositz & Guthrie, 1995). Prp24p is an essential 
protein in yeast and binds specifically to U6 snRNA with three recognisable RRMs 
(Shannon & Guthrie, 1991). Recently, a 110 kDa homologue of Prp24p has been 
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found in humans (Bell, Schreiner, Reddy & Bindereif, unpublished results) that had 
previously been identified while trying to isolate the human U6 capping enzyme and 
subsequently shown to possess RNA-binding activity (Gu et al., 1998). 
By using a chemical probing method it was found that Prp24p binds to 
nucleotides G39-U57 within U6 (Jandositz & Guthrie, 1995; Ghetti et al., 1995) as 
well as interacting with stem II of the U4/1J6 RNA duplex (Ghetti et al., 1995). 
Prp24p appears to facilitate the formation of U41LJ6 RNA duplexes as recombinant 
Prp24p can anneal U4 and U6 RNA in vitro at high Prp24p concentrations (Ghetti et 
al., 1995). In addition, purified Prp24p can restore duplex formation in yeast extract 
depleted of Prp24p (Raghunathan & Guthrie, 1998). This process, however, is 
inefficient in deproteinised extracts, indicating that other proteins must facilitate 
U4/1J6 RNA duplex formation. It is suggested that Prp24p may act by bringing U4 
and U6 together in close proximity to one another. It is possible, however, that 
Prp24p does not facilitate base-pair formation between the two RNAs, but instead the 
Prp24/U4/U6 complex may be a transient intermediate in the spliceosome cycle 
(Shannon & Guthrie, 1991) and may dissociate to allow complete U4/U6 duplex 
formation (Jandrositz & Guthrie, 1995). More recent data suggest that Prp24p might 
stabilise a structure of free U6 snRNA which antagonises annealing to U4 (Vidaver 
et al., 1999), allowing Prp24p to influence both the association and the dissociation 
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Figure 1.7. Schematic diagram showing the U6 snRNA cycle during 
splicing. Free U6 firstly anneals to U4, forming a U4/U6 RNA 
duplex. During spliceosome assembly, U4 dissociates from U6. 
Instead, U6 base pairs with U2 snRNA and pre-mRNA within the 
spliceosome. Following splicing, the spli cesome disassembles, 
releasing free U6. RNAs interacting with U6 snRNA are shown. 
Proteins that facilitate each RNA arrangement are indicated in ovals. 
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Once annealed, the U41U6 di-snRNP associates with several U411J6-specific 
proteins, including Prp3p (Anthony et al., 1997) and Prp4p in yeast (Bjorn et al., 
1989; Banroques & Abelson, 1989) and proteins of 15.5, 20, 60 and 90 kDa in 
humans (Horowitz et al., 1997, Vidovic et al., 2000). The U4/U6 di-snRNP then 
associates with the U5 snRNP via protein-protein interactions to form the U5.U4/U6 
tri-snRNP (Makarov et al., 2000). It is in this tri-snRNP particle that U6 snRNA 
enters the spliceosome. The main function of the U4 snRNP, by annealing with U6 
snRNA, would appear to be either to mask certain catalytically important residues 
until the U6 snRNA is correctly assembled into the spliceosome. Once the U6 snRNP 
is correctly assembled within the spliceosome, the U4/U6 duplex is unwound. 
allowing U6 RNA to undergo several conformational rearrangements and alterations 
in base-pairing Figure 1.7). The unwinding of the U4/U6 duplex is ATP dependent 
and in yeast requires the DEIH-box helicase Brr2p, a U5 snRNP protein 
(Raghunathan & Guthrie. 1998), and Prp38p (Blanton et al., 1992, Xie et al., 1998), 
a tri-snRNP-specific protein that may function both to stabilise U6 5nRNA and 
recruit or activate components that directly unwind the U41U6 RNA duplex. in 
mammalian systems, the hnRNP C protein appears capable of disrupting U4/U6 
RNA duplexes (Fomé etal., 1995). 
Following the unwinding of U6 from U4 RNA, U6 interacts with the pre-mRNA 
and with U2 snRNA, forming several intermolecular helices (reviewed in Forné et 
al., 1996; Figure 1.7). Firstly, an intermolecular helix (helix II) is formed between 
U6 and U2 snRNAs in both yeast and mammals (Dana & Weiner, 1991; Wu & 
Manley, 1991), the formation of which is facilitated by Sltl lp (Xu & Friesen, 2001). 
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In addition, two short helices (helix la and helix Ib) are formed between these two 
snRNAs as well as an additional helix III being formed in mammalian spliceosomes 
(Sun & Manley, 1995). There is also an interaction between U6 snRNA and the 5' 
splice site of the pre-mRNA that forms an intermolecular helix termed the U6-5'ss 
helix. These helices distort the pre-mRNA in such a way to bring the 5' splice site 
and the branchpoint into close proximity for the first step of splicing. 
Evidence that the actual transesterification reaction is catalysed by U6 snRNA 
itself is growing. This concept originally developed from the idea that pre-mRNA 
splicing in eukaryotes evolved from self-splicing Group II introns (reviewed in 
Newman, 1994). More recently, however, several pieces of evidence have emerged 
supporting a catalytic role for U6 snRNA in the spliceosome. One piece of evidence 
showed that the Schizosaccharomyces pombe U6 gene contains an intron that 
resembles an intron found within pre-mRNA (Tani & Ohshirna, 1989). Moreover, it 
was found that the intron was located between two nucleotides of U6 RNA that 
corresponded to a conserved region of U6 that was essential for the second step of 
splicing in S. cerevisiae (Fabrizio & Abelson, 1990). It was suggested, therefore, 
that this intron may have arisen from an aberrant splicing event in which U6 RNA 
was a catalytic factor, followed by reverse transcription and integration of the cDNA 
into the genome (Reich & Wise, 1990). 
Recently, a protein-free system has been reported where in vitro transcribed U2 
and U6 snRNAs can bind and position a small RNA containing the sequence of the 
intron branch site, and activate the branch adenosine to attack U6, resembling the 
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first step of splicing (Valadkhan & Manley, 2001). It was shown that the branched 
adenosine of the small RNA was covalently cross-linked to A53, which lies within 
the AGC triad, which is a conserved region of U6 essential for splicing (Fabrizio & 
Abelson, 1990; Wolff et al., 1994). This is thought to represent an intermediate 
formed during the first step of splicing. 
Additionally, U6 snRNA has also been shown to co-ordinate a divalent metal ion 
that is critical for splicing activity at nucleotide U80 (Yean et al., 2001). Reducing 
this interaction by substituting the interacting phosphoryl oxygen of U80 with 
sulphur in the presence of Mg" ions still allows spliceosome formation, but prevents 
catalysis. This can be rescued with thiophilic Mn 2 ions, demonstrating that U6 
snRNA co-ordinates divalent metal ions within the catalytic core of the spliceosome 
consistent with its proposed role in RNA catalysis. 
Although the splicing reaction may be catalysed by U6 itself, it is undoubted that 
proteins facilitate this process. One protein that functions at the catalytic core is 
Prp8p (Collins & Guthrie, 2000 and references therein), which is highly conserved 
between all eukaryotic organisms. Prp8p crosslinks near the sites of chemistry for 
both steps of pre-mRNA splicing, in addition to crosslinking to both U5 and U6 
snRNA. In addition, mutations in PRP8 in yeast can suppress a mutation in U4 (U4-
cs 1) that forms additional base-pairs to U6 RNA, preventing the interaction between 
U6 and the 5' splice site (Kuhn ci al, 1999). A PRP8 mutation can also suppress a 
prp28-1 mutation that inhibits the exchange of UI for U6 at the 5' splice site (Staley 
& Guthrie, 1999). Both of these observations suggest that Prp8p has a role at the 
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catalytic centre of the spliceosome. Interestingly, Prp8p interacts with several 
splicing factors including Brr2p (van Nues & Beggs, 2001), suggesting that Prp8p 
may be regulated by Brr2p or visa versa, allowing the unwinding of the U4/U6 RNA 
duplex and the first step of splicing to be co-ordinated. 
1.6 The Lsm Proteins 
The first Lsm-like protein found to interact with U6 was identified in S. 
cerevisiae following a screen to find high copy suppressers of a mutant allele of the 
cell cycle gene DBF2 (Parkes & Johnston, 1992). This gene, named USS1 (U-Six 
snRNA), was shown to be an essential gene necessary for pre-mRNA splicing 
(Cooper et. al, 1995), as Northern analysis of a yeast strain with a regulated USS] 
gene demonstrated an accumulation of RP28 pre-mRNA following USS] shut-off. It 
was further demonstrated that USS] is important for U6 stability, as Ussip depletion 
in vivo resulted in decreased U6 levels and that antiserum raised against Uss I  could 
co-immunoprecipitate U6 snRNA. The sequence of this protein revealed that it 
contained an Sm-like motif. Only the N-terminal half of USS], which contains the 
Sm motif, is required for its function, as deletion of the C-terminal half has no effect 
on cell viability (Cooper et al., 1995). Homologues to USS] (subsequently renamed 
LSM4) have since been found in other organisms (Chun & Goebl, 1996; Hirsch et al., 
2000; Mazzoni & Falcone, 2001). The ability of the first 72 amino acids of the 
Kluyveromyces lactis homologue to restore cell viability in S. cerevisiae cells lacking 
USSJ (Mazzoni & Falcone, 2001) demonstrates that both sequence and function has 
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been evolutionarily conserved. LSM4 is also essential in higher eukaryotes, as a 
LSM4 disruption led to a recessive embryonic lethal phenotype in mice (Hirsch et al., 
2000). 
Comparisons of the consensus Sm sequence with other genes revealed another 
putative Sm-like protein in S. cerevisiae, named SmX4p (Séraphin. 1995) which was 
shown to coimmunoprecipitate U4, U5 and U6, but not UI or U2 snRNA. Further 
analysis of the S. cerevisiae genome database identified other ORFs encoding other 
Sm-Like proteins (Fromont-Racine et. al, 1997). In total, nine Sm-Like proteins were 
identified in yeast and were renamed the Lsm (Like $rn) proteins. SmX4p was 
renamed Lsm3p and Ussip was renamed Lsm4p. When LSMJ-LSM8 where 
investigated, all were essential except for LSM], LSM6 and LSM7, which 
demonstrated a temperature-sensitive phenotype in the knockout strains (Mayes et 
al., 1999). With the exception of Lsm9p, all of the Lsm proteins interacted 
substantially with each other in two-hybrid screens (Fromont-Racine et al., 2000) 
and tagged versions of these proteins could be immunoprecipitated with antisera 
raised against Lsm4p, suggesting that these proteins may form a complex analogous 
to the canonical Sm complex. Inimunoprecipitation experiments demonstrated that 
Lsm2-8p could pull down U4, US and U6 RNAs (Mayes ci al., 1999). This indicated 
that the Lsm proteins are in free U6 snRNPs, as well as in U4/U6 di-snRNPS and 
U5.U4/U6 tri-snRNPs. Lsm2-8p were also identified following the purification of the 
yeast U5.U4/U6 tri-snRNP and subsequent identification of the constituent proteins 
by mass spectrometry (Gottschalk el al., 1999; Stevens & Abelson, 1999; Stevens et 
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al., 2001). In contrast, Lsmlp neither precipitated U4, US or U6 snRNAs, nor was it 
identified as a component of the tri-snRNP (see below). Several of the conditional 
knockouts resulted in a decreased U6 stability, as had been previously observed for 
USS]/LSM4 (Cooper et al., 1995). Therefore, it is believed that Lsm2-8p may form a 
seven-membered complex on U6 snRNA similar to that formed by the canonical Sin 
proteins on Ui. U2, U4 and U5 snRNAs. This complex would also appear essential 
for the splicing reaction to occur, as when the genes are placed under the control of 
the galactose-inducible promoter, a splicing defect is observed when grown in the 
presence of glucose (which represses expression from the galacose-inducible 
promoter) that is not seen in the presence of galactose (Mayes et al., 1999). 
The function of this complex in yeast pre-mRNA splicing has been further 
investigated (Verdone & Beggs, unpublished data). Firstly, native gel electrophoresis 
allowed the separation of the free U6 snRNP, the U4/U6 di-snRNP and the 
U4/U6.U5 tri-snRNP. Such gels demonstrated a decrease in the levels of the free U6 
snRNP in lsm6A and Ism 7A strains as well as an increase in free U4 snRNP, which is 
not seen in wild-type strains. In addition, in vitro splicing experiments were 
performed where wild-type extracts and extracts from lsm6zl or 1sm7A strains were 
incubated in the presence of an unlabelled in vitro transcribed ACT] transcript. 
Following this, radiolabelled ACT] pre-mRNA was added to investigate whether or 
not the extracts could perform multiple rounds of splicing. It was found that the wild-
type extract could effectively splice the radiolabelled ACT] transcript, but the lsm6zl 
and ism 7z1 strains could not. These results have lead to the suggestion that the Lsrn 
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protein complex has a role in recycling the U6 snRNA for further rounds of splicing 
throughout the splicing cycle (Figure 1.7), allowing the U6 snRNA to partake in 
another round of splicing. This may be in the form of facilitating conformational 
rearrangements of U6 snRNA necessary for its (re)incorporation into U4/U6 di-
snRNPs (Fortner et al.. 1994) and/or the correct assembly of U6 snSNP in the 
association/dissociation cycle of spliceosome complexes. An interaction between 
Prp24p (see above) and the Lsm proteins is suggested by two-hybrid data (Fromont-
Racine et al., 2000), so perhaps the Lsm proteins have a role in facilitating U4/U6 
duplex formation. Such a role has been shown to exist in vitro for LSm complexes 
purified from HeLa cells (Achsel et al., 1999). 
Further evidence suggests that the Lsm complex associates with U6 snRNA early 
in U6 snRNP assembly. In an attempt to identify components of the U6 snRNP a 
screen was performed to find mutations in genes that cause yeast cells to require 
LHPJ for growth (Pannone et al., 1998). One gene, LSM8, was identified. Moreover, 
it was subsequently shown that deletions in LSM5, LSM6 or LSM7 also caused LHPJ 
to be required for growth (Pannone et al., 2001). Interestingly, the requirement for 
LHPJ in lsm8-1 cells could be suppressed by overexpression of LSM2 or SNR6 
(Pannone et al., 1998). Another mutation in LSM8 (lsm8-2) which lacks the last 10 
amino acids also required LHPJ (Pannone et al., 2001) was suppressed in cells 
overexpressing LSM4 or SNR6. Like the lsm6A and lsm7A strains, lsm8-1 had 
decreased levels of U6 snRNA, U4/U6 di-snRNP and U4/U6.U5 tri-snRNP complex, 
and accumulated free U4 snRNP (Pannone el al., 1998). This phenotype is rescued 
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by overexpression of LHPJ, with a subsequent increase in U6 bound by Lhplp. The 
Lsm protein complex may, therefore, act redundantly with Lhplp to stabilise U6 
snRNA structure and/or recruit U6-specific proteins to the nascent RNA. Whether 
Lhp I  physically interacts with Lsm8p (or the other Lsm proteins) is unknown. It is 
also unknown whether the Lsm proteins share some of the other reported functions of 
Lhplp, for example, the Xenopus homologue of Lhplp has been implicated in U6 
nuclear retention (Boelens et al., 1995) and it is possible that the Lsm proteins are 
also involved in this function. 
As previously mentioned, LSMJ mutants appear to have no effect on either U6 
snRNA stability or the efficiency of pre-mRNA splicing (Mayes et al., 1999). 
Lsm Ip, however, could efficiently be co-immunoprecipitated with a-Lsm4 antisera 
(Mayes etal., 1999) indicating that Lsmlp was present in a complex with other Lsm 
proteins. This led to the suggestion that, in yeast, there may be more than one Lsm 
complex with distinct subunit compositions and functions (see below). 
Human homologues to the Lsm proteins have also been identified (Fu, 1996; 
Schweinfest et al., 1997; Salgado-Garrido et al., 1999; termed LSm proteins). 
Antisera raised against LSm4 precipitated U4 and U6 snRNAs, and U4 and U6 
snRNAs were co-precipitated with a protein A-tagged LSm3 (Salgado-Garrido et al., 
1999), suggesting that the Lsm complex is, like the canonical Sm complex, 
conserved throughout evolution, both in terms of sequence and function. It has been 
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shown by electron microscopy that the human LSm complex appears to assemble 
into ring-like structures (Aschel et al., 1999). These form in the absence of RNA, 
suggesting that the LSm protein complex is stable in the absence of RNA and may 
assemble before binding to U6. 
The human protein CaSm has been identified by Schweinfest et al. (1997) as the 
human homologue of Lsmlp, with 67% sequence similarity between the two 
proteins. Interestingly, the authors also report that the over-expression of CaSm is, in 
many cases, associated with pancreatic cancer. The biochemical basis of this link has 
not been established. 
1.7 The role of Lsml-7p in mRNA stability 
In yeast, there appears to be a common pathway for mRNA degradation and 
decay (Figure 1.8; reviewed in Caponigro & Parker, 1996). Firstly, the poly(A) tail 
which is at the 3' end of most mRNAs is degraded until it is only 10-12 nucleotides 
in length (Muhlrad et al., 1994). This length is significant as this is the minimum 
length to which poly(A)-jinding protein (PABI) can bind. PAB] is an essential gene 
required for mRNA stability (Hatfield et al., 1996). However, a mutation in LSMI 
can lead to a bypass suppression of a PAB] deletion (Boeck et al., 1998). These 
mutations in LSMJ lead to the accumulation of capped, deadenylated degradation 
intermediates and the stabilisation of mRNA. 
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Figure 1.8. Schematic diagram demonstrating the deadenylation-
dependent 5'—*3' mRNA degradation pathway in yeast. The poly(A) 
tail at the 3' of the mRNA is first degraded, causing the loss of 
Pabip binding. This then causes the removal of the 5' m7G cap from 
the mRNA by Dcplp, Dcp2p. Patip and LsmI. This allows the 5' 
—*3' exonuclease Xrnlp to digest the rnRNA. 
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Following deadenylation, the 5' methyl-guanosine cap is cleaved off. The 
enzyme responsible for this cleavage, Dcplp, was found during a genetic screen for 
yeast strains that accumulate deadenylated, stable, capped mRNA degradation 
intermediates (Hatfield et al., 1996) and was subsequently shown to be the decapping 
enzyme (Beelman et al., 1996). Other genes identified in this screen included MRTJ 
and MRT3. The latter has since been identified as LSM5, and MRTJ has been 
identified as PAT], which encodes a protein which interacts with Lsm proteins in two 
hybrid screens (Fromont-Racine et al., 2000). More recently, another gene has been 
identified which is a high copy suppresser of a conditional allele of DCPJ. This gene, 
PSUI/DCP2, is required for mRNA decapping in vivo and a tagged version of Dcp2p 
can co-immunoprecipitate Dcplp. This is significant, because, like Patip, both of 
these proteins were found to interact extensively with the Lsm proteins in two hybrid 
screens (Fromont-Racine ci al., 2000). Two other related proteins, Edclp and Edc2p, 
have also been found that stimulate decapping, and overexpression of EDC] and 
EDC2 can suppress conditional alleles of dcp] and dcp2 (Dunckley ci al., 2001). 
Following decapping of the mRNA, the exonuclease encoded by XRN] (Hsu & 
Stevens, 1993; Muhlrad et al., 1994), which was also found to interact with the Lsm 
proteins via two hybrid screens, degrades the majority of the mRNA in a 
direction. 
Subsequent biochemical analysis of the genetic interactions discussed above has 
also demonstrated associations between the Lsml-7p and multiple proteins required 
for mRNA degradation (Bonnerot et al., 2000; Bouveret et al., 2000; Tharun ci al., 
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2000). It has since been demonstrated biochemically that Lsm l-7p associates with 
Patip, Dcplp and Xrnlp in an RNA-independent manner (Bonnerot et al., 2000; 
Bouveret et al., 2000; Tharun et al., 2000). Also, work on the lsm2, lsrn5, lsm6 and 
ism 7 mutations shows an inhibition of mRNA decay and decapping in vivo (Tharun 
et al., 2000), consistent with the earlier work on ism] (Boeck et al. * 1998). More 
recent work indicates that the Lsm1-7p complex is recruited to the mRNA following 
deadenylation and loss of Pab 1 p  and the translation factors eIF4E and eIF4G (Tharun 
& Parker, 2001). This recruitment enhances he activities of Dcplp and Dcp2p, 
increasing the rate of decapping. 
It has been shown, however, that Lsm8p does not have a role in cytoplasmic 
mRNA stability or decapping. This has lead to the conclusion that there are (at least) 
two alternative Lsm complexes in yeast; an Lsm8 complex, which associates with U6 
snRNA and is involved in pre-mRNA splicing in the nucleus, and an Lsml-7p 
complex (LsmI), which is involved in cytoplasmic mRNA stability and decapping 
(Figure 1.9; reviewed in He & Parker, 2000). This idea has been supported by 
showing that Lsmlp is predominantly cytoplasmic, whereas Lsm7p is present in both 
the nucleus and cytoplasm (Tharun c/ al., 2000). The LsmI complex may be 
associated with mRNA that is being translated, as it co-fractionates with polysomes 

















Pre-mRNA Splicing 	 mRNA decay 
Figure 1.9. Diagram showing the assembly of alternative Lsm 
complexes in yeast. Lsm2-7p either assemble with Lsm8p (striped) 
or Lsmlp (black), forming the Lsm8 complex or LsmI respectively. 
The Lsm8 complex associates with U6 snRNA and Prp24p to form 
the U6 snRNP and is involved in pre-mRNA splicing in the nucleus 
(shaded grey), whereas LsmI associates with Dcplp, Dcp2p, Patip 
and XmIp and is involved in mRNA decay in the cytoplasm. 
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A small percentage of mRNA is degraded in a 3'->5' direction by the products of 
the SKI2, SKI3, SKI4, SK16, SKI7 and SKI8 genes (Jacobs etal., 1998; van Hoof el 
al., 2000), these genes being synthetic lethal with XRN1. The products of these genes 
assemble into a complex (Brown etal., 2000) and are required for 3'-+5' degradation 
following the deadenylation of the mRNA by the nuclear RNA processing and decay 
complex (Jacobs etal., 1998,van Hoof et al., 2000), termed the exosome (reviewed 
in Decker, 1998; Mitchell & Tollervey, 2000). The LsmI complex may also have a 
second function in stabilising mRNAs at their 3' ends, as mRNAs in !sml-7 mutants 
appear to be shortened, or trimmed at the 3' end by 10-20 nucleotides (He & Parker, 
2001). lsm8 strains do not exhibit this phenotype. The effect is more severe at 
elevated temperature, indicating why !sml and pat] mutants may be temperature-
sensitive. This is not a consequence of inhibiting the decapping pathway, as dcplzl 
strains do not exhibit this effect. As ism ski double mutants show an accumulation of 
these trimmed mRNAs, it appears that exosome function is not necessary for these 
trimmed species to accumulate, but probably play a role in their degradation (He & 
Parker, 2001). 
1.8 Other Roles for Lsm complexes 
The Lsm2-8 complex and the LsmI complex discussed above may also have roles 
other than pre-mRNA splicing and mRNA decay, respectively. Evidence is emerging 
that the Lsm2-8 complex is involved in nuclear exosome function (Kufel & 
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Tollervey, unpublished data). The Lsm proteins appear to interact with several 
snoRNAs, and are required for their correct 3' end processing. In addition, Lsm2-8 
mutants exhibit defects in tRNA processing, suggesting a role in tRNA biogenesis 
As well as these two complexes, there also appear to be several other Lsm-
containing complexes. In yeast there is another Lsm gene, LSM9. Despite being the 
most divergent Lsm gene in yeast, Lsm9p is still believed to be part of an Lsm 
complex, as two-hybrid data indicate interactions with other Lsm proteins (Fomont-
Racine et al., 2000). No function has yet been assigned to this protein, although an 
LSM9 mutant exhibits defects in the structural stability of the L-A family of dsRNA-
containing viral particles (Winzeler etal., 1999). 
Recently, studies of the U7 snRNP, which is an essential cofactor for 3'-end 
processing in metazoan histone pre-mRNAs (Muller & SchUmperli, 1997; Dominski 
& Marzluff, 1999) demonstrated a new Sm-like protein, Lsm 10, to be present in Hela 
cells (Pillai etal., 200 1) and is analogous to SmD1. LsmlO has no yeast homologue, 
and intriguingly associates with five of the canonical Sm proteins to form a complex. 
This raises the possibility that there may be many complexes within the cell 
containing a combination of Sm and Lsm proteins, and suggesting that Lsm proteins 
may have an even wider variety of functions, both in yeast and higher eukaryotes. 
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1.9 This Thesis 
During this thesis, the role of the Lsrn8 complex during U6 cycling has been 
investigated in greater detail. In particular, the ability of the yeast Lsm8 complex to 
facilitate U4/U6 duplex formation in vitro has been investigated. To do this, in vitro 
translated Lsm proteins have been produced and Lsm8p/Prp24p have been purified as 
recombinant His-tagged proteins from E. co/i. Assays to measure the annealing of U4 
and U6 snRNAs in vitro have also been developed and suggest that the Lsm8 
complex is necessary and sufficient for U4/U6 duplex formation. The duplex formed 
by the Lsm8 complex in vitro has an identical melting temperature to U4/U6 RNA 
duplexes in wild-type extracts. Prp24p, however, appears not to be required for 
duplex formation in vitro but is essential for U4/U6 duplex formation using U6 RNA 
lacking the Lsm binding-site at its 3' terminus. In addition, in vivo experiments 
suggest a specific role for Lsm6p in U4/U6 duplex formation in yeast. 
CHAPTER 2 
Materials and Methods 
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Chapter 2: Materials and Methods 
2.1. General Reagents 
2.1.1.1. Chemicals 
Chemicals were purchased from the following sources, except where stated 
otherwise: Amersham, Fischer, Melford Labs, Scotlab, Sigma. 
2.1.1.2. Enzymes 
Restriction enzymes, DNA and RNA polymerases, RNases and other enzymes 
were purchased from the following sources unless otherwise stated; Epicentre 
Technologies, Gibco BRL, New England Biolabs, Pharmacia, Promega, QIAGEN, 
and Roche. 
2.1.1.3. Growth Reagents 
Reagents for all growth media were purchased from the following sources; Beta 
Lab, Difco Laboratories, Gibco BRL, Oxoid and Sigma. 
2.1.1.4. Antibiotics 
Ampicillin and Hygromycin were purchased from Beecham Research and Roche 
respectively. 
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2.1.2. Bacterial and Yeast Growth Media 
2.1.2.1. General Information 
All liquid growth media were autoclaved prior to use, and stored at room 
temperature, being warmed to the appropriate temperature immediately prior to use. 
For solid media, 2% (w/v) agar was added prior to autoclaving. Solid media were 
stored at 4°C. 
2.1.2.2. Bacterial Media 
Table 2.1.1. 
Bacterial Media. 
Medium 	 Components 
Luria-Broth (LB) 	1% (w/v) Bacto-tryptone 
0.5% (w/v) Yeast extract 
0.5% (w/v) sodium chloride 
pH adjusted to 7.2 with sodium hydroxide 
rii 
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2.1.2.3. Yeast Media 
Table 2.1.2. 
Yeast Media. 
Medium 	 Components 
YPDA 	 I % (wlv) Yeast Extract 
2% (w/v) Bacto-peptone 
2% (w/v) Glucose 
0.003% (w/v) Adenine Sulphate 
YPGa1A 	 1% (w/v) Yeast Extract 
2% (w/v) Bacto-peptone 
2% (w/v) Galactose 
0.003% Adenine sulphate 
YMM I 	 0.67% (w/v) Yeast nitrogen Base without amino acids 
2% (w/v) Glucose 
Gly-Lac 	 2% (w/v) Glycerol 
2% (v/v) Lactose, pH 5.4 
1% (w/v) Yeast Extract 
2% (wlv) Bacto-peptone 
0.003% (w/v) Adenine Sulphate 
5-FOA2 	 0.67% (w/v) Yeast nitrogen Base without amino acids 
2% (w/v) Glucose 
0.2% (w/v) -U drop-out powder 
0.005% (w/v) Uracil 
0.1% (w/v) 5-FOA (Toronto Research Chemicals) 
0.5% (w/v) ammonium sulphate 
Gal 5-FOA2 	0.67% (w/v) Yeast nitrogen Base without amino acids 
2% (w/v) Galactose 
0.2% (w/v) -uracil drop-out powder 
0.005% (w/v) Uracil 
0.1 % (w/v) 5-FOA (Toronto Research Chemicals) 
0.5% (w/v) ammonium sulphate 
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'Selective media were supplemented with nutrients from drop-out mix as required. 
Drop-out powder was added prior to autoclaving. 
2  5-FOA powder was dissolved in distilled water and filter-sterilised, then 
subsequently mixed with the other constituents of the medium which had previously 
been autoclaved. 
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2.1.2.4. Antibiotics 
Antibiotics were added to liquid media immediately prior to use, whereas for solid 
media antibiotics were added after autoclaving. Ampicillin was stored at -20°C, and 
hygromycin was stored at 4°C. 
Table 2.1.3. 
Antibiotics. 
Antibiotic 	Abbreviation 	Solvent 	 Final concentration 
(xg/ml) 
Ampicillin Amp Ethanol 100 
Hygromycin Hph PBS 300 
Dissolved in PBS (50 mg/ml) when purchased. 
2.1.2.5. Drop-out Powder 
Drop-out powder was prepared by adding and mixing 2 g of each of hte following 
nutrients; adenine, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic 
acid, glutamine, glycine, histidine, isoleucine, lysine, methionine, phenylalanine, 
proline, serine, threonine, tyrosine, tryptophan, uracil and valine. In addition, 4 g of 
leucine was added to the drop-out powder when required. For a specific drop-out 
powder, the relevant nutrients were omitted. This mix was then ground with a mortar 
and pestle to ensure complete mixing and was added to yeast media to a final 
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concentration of 0.2% (w/v). One pellet of NaOH was added to each 500 ml of media 
containing drop-out powder, in order to adjust the pH. 
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2.1.3. Commonly Used Buffers 
Table 2.1.4. 
Commonly Used Buffers. 
Buffer 	 Components 
1 Ox TAE 	 0.4 M Tris-acetate. pH 7.5 
20 mM EDTA 
lOx TE 	 100 mM Tris-HC1, pH 7.5 
10 m EDTA 
lOx TBE 	 0.9 M Tris-borate, pH 8.3 
20 mM EDTA 
I Ox TBM 	 0.9 M Tris-borate, pH 8.3 
25 mM magnesium chloride 
lOx TBST 	 0.5 M Tris-HC1, pH 7.5 
1.5 MNaC1 
1% (w/v) Tween-20 
20x MOPS 
I Ox Western Buffer 
1MMOPS 
1 M Tris Base 
2% (wlv) SDS 
20 mM EDTA 
200 mM Tris Base 
1.5 M Glycine 
20x SSPE 	 3.6 M NaCl 
0.2 M NaH2PO4 
0.02 M EDTA 
pH adjusted to 7.4 with NaOH 
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2.1.4. Escherichia co/i Strains 
Bacterial strains utilised during this work are listed in table 2.1.4. below. TOP 10 
cells were used for cloning, preservation and transformation of DNA via 
electroporation. XL-1 Blue cells were used for cloning and transformation of DNA 
using chemically competent cells. BL21 (DE3) cells were utilised for the expression 
of recombinant S. cerevisiae proteins in E. coli. 
Table 2.1.5. 
Escherichia co/i Strains 
Strain 	Genotype 	 Source 
TOP 10 	F, mcrA, deoR, recAl, rpsL, A(mrv-hsdRMS- Invitrogen 
mcrBC), 	801acZAM15, AlacX74, araD139, 
A(ara-leu)7697, galU, galK, endAl, nupG 
XLI -Blue 	supE44, hsdR 17, recA I, endA 1, gyrA46, re/A 1 lac, Bullock et al., 
F'proAB, lacP, 1acZAM15, TNIO(tef)] 	 1987 
BL2I (DE3) F, oinpT, hsdS 1 . (ri, MB),  gal. dcm (DE3) 	Novagen 
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2.1.5. S. cerevisiae Strains 
The strains used during the course of this study are listed below in table 2.6. 
Table 2.1.6. 
S. cerevisiae Strains 
Strain 	Genotype 	 Source 
BMA38a 	IviA Ta/a, irpIzil, his3zl200, ura3-1, leu2-3,-112, A.E. Mayes 
ade2-1, canl-100 
BMA64a 	MA Ta/a, trplzll, his3-11,45, ura3-1, leu2-3,-112, A.E. Mayes 
ade2-1, can]-] 00 
MYC4 	MA Ta, ade]-101, his3-1, leu2-3,-112, trpI-289, Cooper et 
ura3-52, LEU2-PGAL]-LSM4, GAL+ 	 al., 1995 
AEMY7 	MA Ta/a, ade2-101, his3zl200, leu2zll, lrplzl99, Mayes 	et 
ura3Ll99, LSM611sm6zi::HIS3 	 al., 1999 
AEMY19 	MATa, ade2-1, his3zl200, leu2-3, -112, rrpl-1, Mayes 	et 
ura3-1, canl-100, lsm6/i:J-11S3 	 al., 1999 
AEMY22 	MATa, ade2-1, his3zi200, leu2-3, -112, trpl-1, Mayes 	et 
ura3-1, can]-100, lsm7zt:HIS3 	 al., 1999 
AEMY28 	MATa, ade2-1, his3-11,-15, leu2-3, -112, lrpIzl, Mayes 	ci 
ura3-1, HA:LSM] 	 al., 1999 
AEMY46 	MATa, ade2-1, his3-11,45, leu2-3, -112, trplzl, Mayes 	ci 
ura3-1, lsm8zl::TRPJ [pAEM76] 	 al., 1999 
AEMY28- 	MATa, ade2-1, his3-I1,45, leu2-3, -112, IrplA, This thesis 
p22myc ura3-1, HA:LSMJ [p22myc] 
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Table 2.1.6. 
S. cerevisiae Strains continued. 
Strain 	Genotype 	 Source 
BSY557 	Mata, ade2, arg4, leu2-3, -112, trpl-289, ura3-52, Luukkonen & 
SNR6:.ADE2 [pBS 1191 	 Séraphin, 
1998 
YGALU6 	Mata, ade2, arg4, ieu2-3,412, trpl-289, ura3-52, This thesis. 
SNR6::ADE2[pBS1181.pBS1184] 
YGALU66 	Mata, ade2, arg4, leu2-3,-112, trpl-289, ura3-52, This thesis 
SNR6::ADE2, lsm6A::URA3 [pBSII81, pBSI 184] 
BMA38-G63A MATa lrpI/i1, his3zl200, ura3-1, leu2-3,-112, This thesis 
ade2-1, canl-100 SNR6-G63A::HPH 
BMA38-C69A 	JvL4Ta, trplzil, his3zl200, ura3-1, leu2-3,-112, This thesis 
ade2-1, can]-IOOSNR6-C69A::J-JPJ-J 
BMA38- 	MATc trplzil, his3ii200, ura3-1, leu2-3,-112, This thesis 
G63AC69A ade2-1, can]-100 SNR6-G63A,-C69A:.HPJ-J 
AEMY19-G63A MATq, trplAl, his3zi200, ura3-1, leu2-3,-112, This thesis 
ade2-1, 	can]-100 	lsm6zl::HIS3, 	SNR6- 
G63A::HPH 
AEMYI9-C69A MATa IrpizU, his3zl200, ura3-1, leu2-3,-112, This thesis 
ade2-1, 	can]-100 	lsm6Lt:HIS3, 	SNR6- 
C69A..HPH 
AEMYI9- 	JvL4Ta trp]zll, his3A200, ura3-1, leu2-3,-112, This thesis 
G63AC69A ade2-1, can]-100 lsm6zt:HIS3, SNR6-G63A,- 
C69A.:HPH 
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Table 2.1.6. 
S. cerevisiae Strains continued. 
Strain 	Genotype 	 Source 
AEMY22- 	MI4Ta, 1rpM], his3A200, ura3-1, leu2-3,-112, This thesis 
G63A 	ade2-1, 	can]-100 	lsm7A::HIS3, 	SNR6- 
G63A.:HPH 
AEMY22- 	MA Ta, 1rpM], his3zt200, ura3-1, leu2-3,-112, This thesis 
C69A 	ade2-1, 	can]-100 	lsm7A:.HIS3, 	SNR6- 
C69A::HPH 
AEMY22- 	MATc 1rpM], his3zi200, ura3-1, leu2-3,-112, This thesis 
G63AC69A ade2-I, can]-100 	lsm7::HIS3, SNR6-G63A- 
C69A :HPH 
MCY4-G63A 	MA Ta. adel-101, his3-1, leu2-3,-112, trpl-289, This thesis 
ura3-52, LEU2 -P GALl  -LSM4, SNR6-G63A : .HPH 
MCY4-C69A 	MA Ta, adel-101, his3-1, leu2-3,-112, trpl-289, This thesis 
ura3-52, LEU2-PGALJ-LSM4, SNR6-C69A::HPLJ 
MCY4- 	MA Ta, adel-101, his3-1, leu2-3,-112, trpl-289, This thesis 
G63AC69A 	ura3-52, LEU2-PGAL j -LSM4, SNR6-C69A HPH 
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2.1.6 Oligonucleotides 
Oligonucleotides that were used in this study are listed below. All 
oligonucleotides were synthesised and purchased from MWG Biotech, Genosys 
Biotechnologies Ltd., or Bioline. 
Table 2.1.7. 
General and Cloning Oligonucleotides 
Name 	Sequence (5-3') 	 Description 
6UF 	CCAACTTGCTCATTCCTACATATTAATCCA Used for ORF 
TTAGAGGAGATAAGTTTTTCTTTCCAATTT deletion of LSM6 
TTTTTTT 	 with URA 3 
6UR 	CTATTATTAAAACATTTTACCCGGGGGCAG Used for ORF 
CTGTTCGTGTACATTCAA 	 deletion of LSM6 
with URA3 
Fl 	 GAATTCATGCCAAATAAGCAACG 	 LSM6 sequence 
F2 	 GGATCCATTAGAGGAGA 	 LSM6 sequence 
3LSM2 	CGGGATCCCGTTATTTTCTTTCAGTCAT 	Used for RT- 
PCR of LSM2 
U6HPH 	AGTACTAATAGCATTCTTACGCACTAAAAT Anneals to HPH 
GAATCACGCGGTCTTGAATTCGAGCTCGTT gene with region 




Chapter 2: Materials and Methods 
Table 2.1.7. 
General and Cloning Oligonucleotides continued. 
Name Sequence (5'-3') Description 
U6G63A ATGATCAGCAATTCCCCTGCA SNR6 	G63A 
mutation 
U6C69A AGCAGTTCCCATGCATAAGGA SNR6 	C69A 
mutation 
U663A69A ATGATCAGCAATTCCCATGCATAAGGAGA SNR6 G63A and 
A C69A mutation 
BAMLSM8F CGGGATCCCGATGGACCAGCAAGCTGCAT LSM8 sequence 
AC 
BAMLSM8R CGGGATCCCGTTATTTTGTCTTTGATTCGT LSM8 sequence 
A 
BAMTJ6F 	CGGGATCCCCTGGCATGAACAGTGGT 	SNR6 sequence 
SMAU6R TCCCCCGGGAACCGATAGCAAAGGCTT 	SNR6 sequence 
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Table 2.1.8. 
Oligonucleotides for snRNAs 
Name 	Sequence (5 '-'3') 	 Description 
G8102 	CACGCCTTCCGCGCCGT 	 U  snRNA probe 
for Northern blot 
and primer 
extension 
G6568 AGGTATTCCAAAAATTCCC U4 	snRNA 
Northern probe 
485A AATATGGCAAGCCC U5 	snRNA 
Northern probe 
W3464 TCTCTGTATTGTTTCAAATTG U6 	snRNA 
Northern probe 
V4528 ATCTCTGTATTGTTTCAAATTGACCAA U6 	snRNA 
knockout probe 
U3exon2 CCAAGTTGGATTCAGTGGCTC U3 	snoRNA 
primer extension 
LORYI CGTAATACGACTCACTATAGGGAGAGTTC Introduces a T7 
GCGAAGTAACCC promoter to the 
5' end of SNR6 
S5761 AAAACGAAATAAATCTCTTTGTAAAAC Anneals to 3' end 
of SNR6 
T7U4F CGTAATACGACTCACTATAGGGAGAATCC Introduces a T7 
TTATGCACGGG promoter to the 
5' end of SNR14 
U4R AAAGGTATTCCAAAAATTCCC Anneals to Tend 
of SNR I 4 
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Table 2.1.9. 
Oligonucleotides for synthesis of template DNA for in vitro transcription/translation 
Name 	Sequence (5'-3') 	 Description 
T7PRP24 	ACGGATCGTAATACGACTCACTATAGGGA Introduces a T7 
GATGGAGTATGGACATCAC 	 promoter to the 
5' end of PRP24 
3PBM125 	ATGCCCCGCGCCCACC 	 3' primer for 
genes cloned into 
pBM 125 
LexRev 	TTTTAAAACCTAAGAGTCAC 	 3' primer for 
genes cloned into 
pBTM1 16 
5'LSM2TNT GGAATTCCACGGATCGTAATACGACTCAC Introduces a T7 
TATAGGGAGATGCTTTTCTTCTCC promoter and 
EcoRI site to the 
5' end of LSM2 
5'LSM3TNT ACGGATCGTAATACGACTCACTATAGGGA Introduces a T7 
GATGGAGACACCTTTG 	 promoter to the 
5' end of LSM3 
5'LSM4TNT ACGGATCGTAATACGACTCACTATAGGGA Introduces a T7 
GATGCTACCTTTATAT 	 promoter to the 
5' end of LSM4 
5'LSM5TNT ACGGATCGTAATACGACTCACTATAGGGA Introduces a T7 
GATGAGTCTACCGGAG 	 promoter to the 
5' end of LSM5 
5'LSM6TNT ACGGATCGTAATACGACTCACTATAGGGA Introduces a T7 
GATGTCCGGAAAAGCTTCT 	 promoter to the 
5' end of LSM6 
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Table 2.1.9. Continued. 
Oligonucleotides for synthesis of template DNA for in vitro transcription/translation 








Introduces a T7 
promoter to the 
5' end of LSM7 
Introduces a T7 
promoter to the 
5! end of LSM8 
3' primer for 
LSM8-2 
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2.1.7. Plasmids 
All oligonucleotide primers used are detailed in Table 2.1.7. 
Table 2.1.10. 
Cloning Vectors. 
Name 	Description 	 Reference 
pBTM 116 	Yeast-E. coil shuttle vector: ADH 1 promoter Vojtek et al., 
sequence; LexA DNA-BD sequence; Am/; 1993. 
TRPJ; 2t 
pRS306 	Yeast-E. coli shuttle vector: URA3, Amp', MCS, Sikorski & 
CEN6, ARS 	 Hieter, 1989. 
pETI 9b 	E. coil expression vector: MCS, T7 promoter Novagen 
sequence, 6x His-tag coding sequence, 
Enterokinase cleavage site sequence, T7 
trtanscription termination sequence, A mpR , 
/acl,colEl on. 
pBM 125 	Yeast-E. coil shuttle vector: P GAL promoter Johnston & 
sequence, CEN4, ARSJ, URA3, tet ' , Amp' 	Davis, 1984 
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Table 2.1.11. 
Modified Vectors. 
p283 	 Modified pGEM1: Contains ACT] template 	O'Keefe el 
under the regulation of the T7 promoter. 	 al.. 1996 
pRG1-l3myc- 	Contains an MCS and a hygromycin-.resistance 	R. Grainger, 
hph 	 cassette (110-1750); Amp'. 	 this lab 
pIP24 	 E. coli expression vector used to produce a 6x 	Vidal et al., 
Histine-tagged Prp24 protein. Expression of 1999 
PRP24 is controlled by the IPTG-inducible lac 
promoter. Multiple cloning site; (His) 6 :PRP24; 
A mpR . 
pAEM76 	Modified pBM125: LSM8 with an N-terminal 	Mayes eta!, 
HA tag was cloned into the MCS of pBMI25, so 1999 
that it was under the control of the PGAL 
promoter. 
pBS 1191 	Contains the SNR6 gene with its wild-type 	Luukkonen 
promoter, URA3 	 et al., 1998 
pBS1181 	Contains the SNR6 gene wits its wild-type 	Luukkonen 
promoter with the Lacl binding site inserted at et al., 1998 
position —2 relative to the start of transcription, 
TRPJ 
pBS1 184 	Contains the LACI template under the control of 	Luukkonen 
the PGAL  promoter, LEU2 	 et al., 1998 
pT7HISLSM8 	Modified pETl9b: LSM8 was amplified by PCR 	This Thesis 
from pAEM76 with primers BAMLSM8F and 
BAMLSM8R and digested with BamHI. This 
was then ligated into a BamHI opened pET19b. 
This was then digested with NcoI, the sticky 
ends being filled in with Klenow and these blunt 
ends re-ligated back together. 
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Table 2.1.11. continued. 
Modified Vectors. 
Name 	Description 	 Reference 
pU6Hph 	Modified pRG1-13myc-hph: SNR6 sequence This Thesis 
including both the coding sequence and promoter 
was amplified by PCR from pBS1I9I using 
primers BAMU6F and SMAU6R. This was then 
digested with BamHI/SmaI before being ligated 
into pRG1-13myc-hph digested with 
BainHlISmaI. 
pU4 	 Plasmid containing the SNR14 template. 	This Lab. 
pT7U6 	Modified pUC9: Contains a T7 promoter with a Peter 
downstream SNR6 gene. The SNR6 gene Hodges, This 
contains a Dral restriction site at its 3' end. 	Lab. 
p22rnyc 	Modified pADI2: consists of 387 nt of 5' 	Pannone et 
flanking sequence, the entire LSM8 coding al., 1998 
sequence, three copies of the c-myc epitope and a 
stop codon cloned into the SmaI-ClaI sites of 
pAD12. 
58 
Chapter 2: Materials and Methods 
Table 2.1.12. 
Plasmids used as templates for in vitro transcription/translation 
Name 	 Description 	 Reference 
pLEX24 	Modified pBTMI 16: contains PRP24 ORF 	This Thesis 
cloned in frame with the LexA binding site 
encoding sequence. PRP24 ORF was 
isolated from BamHI/)G7o1-digested pIP24 
plasmid and cloned in BamHI/XhoI opened 
pBTM 116 vector. 
pT7LSM2 Modified 	pBM 125: 	LSM2 	cDNA 	was This Thesis 
prepared 	from 	total 	yeast 	RNA 	and 
amplified by PCR using primers T7LSM2 
and 3'LSM2. The resulting DNA fragment 
was digested with BamHI/EcoRI and ligated 
into 	a 	BamHI/EcoRI 	opened 	pBM 125 
vector. 
pAEM65 Modified 	pBM 125: 	Contains 	HA:LSM3 Mayes et al., 
under the control of the PGAL  promoter. 1999. 
pGAL-USS1 Modified 	pBM125: 	Contains 	HA:LSM4 Cooper et al., 
under the control of the PGAL  promoter. 1995 
pAEM75 Modified 	pBMI25: 	Contains 	HA:LSM5 Mayes etal., 
under the control of the PGAL  promoter. 1999. 
pAEM34 	Modified pBTM1 16: Contains LSM6 in 	Fromont- 
frame with the LexA DNA binding Racine et al., 
sequence. 	 2000 
pAEM59 	Modified pBTM1 16: Contains LSM7 in 	Fromont- 
frame with the LexA DNA binding Racine et al., 
sequence. 	 2000 
pAEM76 	Modified pBM125: Contains HA:LSM8 	Mayes et al., 
under the control of the PGAL  promoter. 	1999. 
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2.1.8. Antisera 
The antisera used in this study are described in Table 2.1.13. below. 
Table 2.1.13 
Antisera. 
Antibody 	Description 	 Reference 
Anti-HA 	Rabbit polyclonal antibodies raised against the Santa Cruz 
haemagglutinin HA-1 protein epitope of the Biotechnology 
influenza virus. 
1:1,000 dilution for Western blotting. 
5 p1 for immunoprecipitation. 
Anti-c-Myc 	Rabbit polyclonal antibodies raised against the Santa Cruz 
(A- 14) 	carboxy-terminus of human c-Myc. 	 Biotechnology 
1:1,000 dilution for Western blotting. 
2 tl for immunoprecipitation. 
Anti-(His) 5 	Mouse monoclonal antibodies. 	 Qiagen 
1:1000 dilution for Western blotting. 
4 p1 for immunoprecipitation. 
Anti-Rabbit 	Donkey Anti-rabbit IgG covalently linked to Amersham 
IgG-HRP horseradish peroxidase. 
1:5,000 dilution for Western blotting. 
Anti-Mouse 	Sheep Anti-rabbit IgG covalently linked to Amersham 
IgG-HRP horseradish peroxidase. 
1:5,000 dilution for Western blotting. 
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2.2. Microbiological Methods 
2.2.1. Growth of Strains 
2.2.1.1. Growth of Bacteria 
Strains of E. coli were grown in rich LB medium at 37C. To select for or 
maintain the incorporation of a plasmid, the transformed bacteria were grown in rich 
LB medium containing the appropriate antibiotic (Table 2.1.1) 
2.2.1.2. Growth of Yeast 
Unless otherwise stated, yeast strains were grown at 30°C in appropriate media 
(Table 2.1.2). To maintain selection for plasmid DNA and/or for a nutritional 
reporter gene inserted on the genome, cells were grown in YMM (Table 2.1.2) with 
appropriate dropout powder added to the medium. To maintain selection for an 
antibiotic resistance gene inserted into the genome, cells were grown in appropriate 
media with the relevant antibiotic added to the required concentration (Table 2.1.3) 
2.2.2. Preservation of Strains 
2.2.2.1. Preservation of Bacteria 
For storage of E. co/i for time periods up to and including two weeks, bacteria 
were stored on solid medium at 4°C. In order to preserve strains indefinitely, E. coli 
61 
Chapter 2: Materials and Methods 
were grown to stationary phase. 750 p1 of this culture was added to 750 j.il of 30% 
(wlv) glycerol, resulting in the cells being suspended in 15% (wlv) glycerol. This 
was subsequently snap-frozen on dry ice and stored at —70°C. 
2.2.2.2. Preservation of S. cerevisiae 
Yeast strains were preserved on solid medium for up to four weeks at 4°C. In 
order to preserve strains indefinitely, yeast cells were grown to mid-logarithmic 
phase. Seven hundred microlitres of this culture was added to 750 p1 of 30% (wlv) 
glycerol, resulting in the cells being suspended in 15% (w/v) glycerol. This was 
subsequently snap-frozen on dry ice and stored at —70°C. 
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2.2.3. Transformation of E. co/i 
2.2.3.1. Preparation of Electro-competent Cells 
TOP 10 E.coli (Table 2.1.5) were streaked out from a _700  stock and grown 
overnight on solid medium at 37°C. A single colony was then chosen and grown in 
liquid LB (Table 2.1.1) overnight at 37°C. From this culture, 500 ml of liquid LB 
was inoculated to an optical density at 600 nm of 0.1 au and grown at 37°C until an 
0D600 of 0.6 au was reached. Cells where then placed on ice for 15 minutes and then 
sedimented (20 mm, 4200 rpm, 4°C; Beckman 10.500 rotor). Cells were then washed 
twice in 500 ml of pre-chilled sterile distilled water and sedimented as before. Cells 
were then washed twice in 250 ml of pre-chilled 10% (w/v) glycerol and sedimented 
as before. Finally, cells were resuspended in 2 ml of pre-chilled 10% (w/v) glycerol 
and 40 il aliquots were snap frozen in Eppendorf tubes on dry ice. These were stored 
at —70° indefinitely. 
2.2.3.2. Transformation of Electro-competent Cells 
Electro-competent TOP 10 E. co/i cells (Section 2.2.3.1) were thawed on ice and 
100 ng of transforming DNA was added. This mix was then transferred to a pre-
chilled electroporation cuvette (0.2 cm electrode gap; Equibio). The cuvette was 
dried and electroporation was then performed using a Biorad Gene Pulser II using the 
following settings; 200 ohms, 25 j.iF, 2.5 kV. Immediately after electroporation, 1 ml 
of LB (Table 2.1.1) was added. Cells were then transferred to a sterile Eppendorf 
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tube and incubated on a rotating wheel (1 h, 37°C) to let the cells recover. Cells were 
then sedimented (30 s, 14000 rpm) and resuspended in 100 l of LB (Table 2.1.1) 
before being spread by the Copacabana' method (Worthington et al., 2001) on solid 
medium supplemented with an antibiotic (Table 2.1.3) suitable to ensure the 
maintenance of the transformed plasmid within the E. co/i. 
2.2.3.3. Preparation of Chemically-competent Cells 
E. co/i XL1-Blue cells (Table 2.1.5) were taken from a —70°C stock and grown 
overnight on solid medium. The next day, a single colony was taken and 2 ml of rich 
LB medium (Table 2.1 .1) was inoculated and grown to stationary phase. Following 
this, 200 ml of LB medium pre-warmed to 37°C was inoculated with the pre-
prepared 2 ml stationary-phase culture and incubated at 37°C for 3 hours in a shaking 
incubator (New Brunswick Scientific). Cells were then sedirnented (10 mm, 3000 
rpm, 4°C; Beckman 10.500 rotor) and resuspended in 15 ml lx TS buffer (see 
below). Cells were placed on ice for 60 ml, after which time they were transferred in 
200 .i1 aliquots to pre-chilled Eppendorf tubes. Cells were stored until required for 
use at —70°C. 
2.2.3.4. Transformation of Chemically-competent Cells 
For transformation of chemically-competent XL 1-Blue cells (Table 2.1.5), 
aliquots were thawed on ice and either up to 10 p.1 of DNA, or the entire volume of a 
ligation reaction (Section 2.3.2.9) was added to 100 p.1 of competent cells and 
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thoroughly mixed. Cells were then left on ice for 30 min before being transferred to 
37°C for 2 min and subsequently returned to being on ice for a further 2 min to allow 
them to recover. 1 ml of rich LB medium (Table 2.1.1) was then added and the cells 
incubated at 37°C for a further 40 mm. Cells were then pelleted (14000 rpm, RT, 
Eppendorf microfuge) and resuspended in 100 jil of LB medium. The cells were then 
placed by the 'Copacabana' method (Worthington et al., 2001) on solid LB medium 
containing an antibiotic suitable for the selection and maintenance of the plasmid 
within the transformed cells. This was placed at 37°C overnight to give cells 
transformed with the required plasmid time to produce visible colonies on the 
medium. 
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2.2.4. Transformation of S. cerevisiae 
Yeast cells were transformed using the method of Gietz et al. (1992). 
2.2.4.1 Standard Yeast Transformation 
Single colonies of yeast were taken and inoculated into 10 ml of appropriate liquid 
medium (Table 2.1.2). This was incubated overnight at 30°C until the cells had 
entered stationary phase. This culture was used to inoculate 50 ml of fresh medium to 
an 0D600 of approximately 0.1 au. This was then incubated until the 0D 600 of the 
culture was approximately 0.4 au. The cells were then sedimented in a Mistral 1000 
centrifuge (5 mm, 3000 rpm, RT). Cells were then washed in 10 ml of distilled water 
and sedimented as before. Cells were then washed in 10 ml lx TE/LiAc and 
sedimented as before and resuspended in 250 jtI of lx TE/LiAC. Fifty microlitres of 
cell suspension was then mixed with approximately 1 g of transforming DNA and 
50 tg of denatured salmon sperm carrier DNA (Gibco BRL). To this mix, 300 p1 of 
PEG/LiAc solution was added, vortexed briefly to mix and incubated at 30°C for 30 
min on a rotating wheel. Following this, cells were heat-shocked at 42°C for 15 mm, 
then sedimented (14000 rpm, 30 s, Eppendorf microfuge). The pelleted cells were 
then resuspended in 100 p1 lx TE (Table 2.1.4) and plated by the 'Copacabana' 
method (Worthington et al., 2001) onto the appropriate solid medium to select for 
transformants. Plates were incubated at 30°C for 2-3 days. 
1OxTE: 	 See Table 2.1.4. 
lOx LiAc: 	 I M Lithium Acetate 
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PEG/LiAc: 	 40% PEG33501 lx TE, lx LiAc 
2.2.4.2. Transformation and Genomic Integration of DNA 
In order to prepare DNA for transformation and integration into the yeast genome, 
a linear DNA fragment was produced by polymerase chain reaction (PCR; Section 
2.3.2.6). This PCR template was chosen to contain the relevant DNA sequence 
required following the integration. The primers were designed so that the final PCR 
product would be flanked at both ends by approximately 45 bp of sequence identical 
to the DNA immediately 5' and 3' to the coding sequence to be replaced. The PCR 
product was purified (Section 2.3.2.9) and transformed into the relevant (Section 
2.2.4.1) with the additional step of adding 30 tl DMSO immediately prior to the 
42°C incubation. Colonies growing on the appropriate selective medium were re-
streaked onto fresh solid medium and the integration was investigated using PCR 
(section 2.3.2.6) and, where relevant, Western blotting (Section 2.3.4.4). 
2.2.4.3. Growth Curves 
Growth curve analysis was performed on yeast cells which were either 
temperature sensitive or which had carbon-source dependence. Cells were grown in 
liquid media to mid-logarithmic phase under permissive conditions (usually 30°C or 
on a permissive carbon source (Table 2.1.2)). Cells were then harvested, washed in 5 
ml of sterile, distilled water and resuspended in pre-warmed medium (Containing the 
appropriate carbon source) to an 0D 600 of approximately 0.1. Cultures were then 
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incubated at the appropriate temperature with the growth rate measured by recording 
the 0D600 at regular intervals, typically every 2 hours. Cultures were maintained in 
logarithmic growth by diluting with pre-warmed growth medium to ensure that OD wO  
readings were below 0.8. 
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2.3. Nucleic Acid Methods 
Unless otherwise stated, all DNA and RNA manipulations were carried out 
according to Ausubel et al., 1994. 
2.3.1. General Methods 
2.3.1.1. Spectrophotometric Quantification of Nucleic Acids 
The concentration of DNA or RNA was determined by measuring the absorption 
of diluted solutions at 260 urn using a Cecil CE 2040 spectrophotometer, and a 
quartz cuvette. For double-stranded DNA, an 0D2 60 value of 1.0 represents a DNA 
concentration of approximately 50 .tg/ml. For single-stranded RNA an OD 260 value 
of 1.0 represents an RNA concentration of approximately 40 ig/ml (calculations 
were performed online at 
http ://www. geocities.com/CapeCanaverallLab/9965/calculator-dnaconc.html) . The 
purity of the nucleic acid sample was determined by measuring the absorption at both 
260 and 280 run. Pure preparations of DNA and RNA give an 0D 260 :0D280 ratio close 
to 1.8 and 2.0 respectively. 
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2.3.1.2. Phenol/Chloroform Extraction 
Nucleic Acids were purified away from protein in an aqueous solution by adding 
an equal volume of phenol: chloroform: IAA in a 25:24:1 ratio. This was briefly 
vortexed and centrifuged (14000 rpm, 3 mm). The upper, aqueous, phase containing 
nucleic acid was removed into a fresh Eppendorf tube. 
2.3.1.3. Precipitation of Nucleic Acids 
Nucleic Acids were precipitated from aqueous solution by adding 2 volumes of 
ethanol and 0.1 volumes of 3 M sodium acetate, pH 5.2. This was incubated at -70°C 
for at least 60 mm. Nucleic acids were then pelleted by centrifugation (14000 rpm, 
15 mm, 4°C) and the pellet washed in 70% (vlv) ethanol. The pellet was then dried 
under vacuum and resuspended in an appropriate volume of distilled water. 
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2.3.2. DNA Methods 
2.3.2.1. Small Scale Preparation of Plasmid DNA by Spin Column 
Plasmid DNA was prepared using the QlAprep spin miniprep kit (Qiagen), 
following the manufacturer's instructions. DNA was extracted from 3 ml of E. coli 
culture grown to stationary phase, eluted in 50 !.Li of distilled water and stored 
indefinitely at —20°C. DNA prepared by this method was sufficiently absent of 
RNase contamination to allow subsequent protocols involving RNA to be performed 
using the plasmid DNA. 
2.3.2.2. Preparation of Plasmid DNA by Filtration Column 
Plasmid DN was prepared using the QIA filter maxiprep kit (Qiagen), following 
the manufacturer's instructions. DNA was extracted from 100 ml of E. coli culture, 
resuspended in 500 pl of distilled water and stored at —20°C. DNA prepared by this 
method was sufficiently absent of RNase contamination to allow subsequent 
protocols involving RNA to be performed using the plasmid DNA. 
2.3.2.3. Yeast Genomic DNA Preparation/Plasmid Rescue 
Yeast genomic DNA was prepared using the method of Hoffman and Winston, 
1987. Ten millilitres of appropriate medium was inoculated with a single colony of 
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yeast and incubated overnight at 30°C in a shaking incubator (New Brunswick 
Scientific). Cells were then sedimented by centrifugation (3000 rpm, 5 mm, RT; 
MSE Mistral 1000 centrifuge) and washed using 10 ml of sterile, distilled water. 
Cells were then resuspended in 1 ml of sterile, distilled water and transferred to an 
Eppendorf tube and pelleted (14000 rpm, 1 mm, RT). Two hundred microlitres of 
glass beads (150-2 12 p.m in diameter; Biospec Products Inc), 200 p.1 of lysis buffer 
and 200 p.l of phenol: chloroform: isoamyl alcohol (25:24:1) were added. The mixture 
was the vortexed for 5 mm, after which time 200 p.1 of sterile distilled water was 
added. The tube was then centrifuged (14000 rpm, 5 mm, RT). The upper, aqueous 
phase containing nucleic acid was removed and the DNA precipitated and dried 
(Section 2.3.1.3). 
For a yeast genomic DNA preparation, the pellet was resuspended in 100 p.l of 
distilled water and the concentration measured (Section 2.3.1 .1). Typically, a yield of 
0.2 jig/p.1 was obtained. 
For recovery of plasmid DNA, the pellet was resuspended in 20 p.1 of sterile, 
distilled water. Of this, 1 p.1 was used for transformation into electro-competent 
E.coli cells. 
Lysis buffer: 	 2% (vlv) Triton X- 100 
1% (wlv) SDS 
100 m NaCl 
10 mM Tris-HC1, pH 8.0 
1 mM EDTA 
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2.3.2.4. DNA Restriction Digests 
DNA was digested by restriction endonucleases usually in volumes ranging from 
20-50 i.l. These volumes contained the required quantity of DNA to be digested 
(typically 2-5 jig) as well as the appropriate buffer (supplied and recommended by 
the manufacturer) at lx concentration and between 2-5 units of the restriction enzyme 
in question, ensuring that the total enzyme volume did not exceed 10% of the total 
reaction volume. The digest was then incubated at the appropriate temperature, 
typically for 2 hours. When two or more restriction enzymes were required to digest 
the same DNA fragment, this was performed concurrently, providing that both 
enzymes would retain full activity in a suitable buffer, according to manufacturers' 
guidelines. When this was not possible, the DNA fragment was digested with one 
enzyme in the optimal buffer, then ethanol precipitated (Section 2.3.1.3). 
resuspended and digested with the second enzyme in that enzyme's optimal buffer. 
2.3.2.5. Removal of Phosphates from DNA Ends 
Plasmid DNA digested with restriction endonucleases (Section 2.3.2.3) was 
incubated with 5 units of calf Intestinal Alkaline Phosphatase (CIP) per 20 jil 
reaction volume (30 mm, 37 0C). This removed terminal phosphate groups from the 
DNA and therefore prevented recircularisation of the DNA in any subsequent 
ligation reactions (Section 2.3.2.9). 
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2.3.2.6. Amplification of DNA by the Polymerase Chain Reaction 
Specific regions of DNA were amplified using the polymerase chain reaction 
(PCR). Template DNA was either approximately I jig of plasmid DNA or yeast 
genomic DNA (Section 2.3.2.3) using specifically designed primers manufactured 
commercially. A typical PCR reaction using plasmid DNA as template was as 
follows: 
I Ox Polymerase Buffer 	 5 jil 
100 mm MgCl, t 	 I jil 
2.5 mM dNTPs (dATP, dCTP, dGTP, dTTP) 	5 jil 
Oligonucleotide primer 1 (50 pmol/jil) 	 1 jil 
Oligonucleotide primer 2 (50 pmol/jil) 	 I p.1 
Template DNA (10 ng/p.l) 	 1 p.1 
DNA polymerase (2 U/mI) 	 I p.! 
Sterile distilled water 
	
35 p.1 
MgC1 concentrations were adjusted as required to optimise reaction conditions. 
All PCRs were performed in either a PTC- 100 Hot Lid reactor or a DNA Engine 
Gradient Cycler (Genetic Research Instrumentation Ltd) programmed according to 
the length of the desired product and the annealing temperature of the 
oligonucleotide primers being used. A typical programme is listed below, with 30-35 
cycles commonly being used. 
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Table 2.3.1.1. 
Typical PCR Reaction. 
Step 	 Description 	 Temperature 
I 	 Denaturation 	 94°C 
2 	 Primer Annealing 	 40-60°C t 
3 	 Extension 	 72°C 
t calculated for oligonucleotides up to 20 bases in length using the formula: 
Annealing Temperature (°C) = {4(G+C) + 2(A+T)} —5 
2.3.2.7. Agarose Gel Electrophoresis 
DNA fragments produced either by restriction endonuclease digestion (Section 
2.3.2.4) or generated by PCR (Section 2.3.2.6) were analysed in 0.8-1.2% (w/v) 
agarose gels. Gels were prepared by melting agarose in 100 mlix TAE buffer (Table 
2.1.5) and adding ethidium bromide to a final concentration of 0.5 jig/ml. Samples to 
be analysed were added to Ficoll loading buffer and were loaded directly onto the 
gel. Two hundred volts were applied across the gel so that the DNA fragments 
separated with respect to size. The DNA could subsequently be visualised using a 
UV transilluminator. DNA markers of known molecular size were also loaded on the 
gel so that DNA fragments could be easily identified. 
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1 Ox Ficoll Loading Buffer: 	20% (w/v) Ficoll 
l%(w/v) SDS 
0.25% (w/v) Bromophenol blue 
0.25% (w/v) Xylene cyanol 
100 mM EDTA 
2.3.2.8. Purification of DNA from Agarose Gels 
DNA fragments produced by restriction endonuclease digest or generated by PCR 
were purified by firstly separating DNA fragments by agarose gel electrophoresis 
(Section 2.3.2.7) and subsequently isolating the desired DNA band from the agarose 
gel using the QiaQuick Gel Extraction kit (Qiagen) according to manufacturer's 
instructions. The region of agarose containing the desired DNA fragment was 
removed with a clean razor blade and purified. DNA was eluted in 50 Vtl of sterile 
distilled water and stored indefinitely at -20°C. 
2.3.2.9. Ligation of DNA molecules 
A mixture containing 100 ng of vector DNA, approximately 5 times this amount 
(with respect to the number of moles) of insert DNA, lx ligation buffer, 1 mM ATP 
and 2 units of Fast-Link Ligase (Epicentre Technologies) were incubated in a final 
volume of 15 tl (1 h, RT). Reactions were stopped by incubating at 70°C for 15 
minutes. 
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2.3.2.10. End-labelling of Oligonucleotides 
Oligonucleotides were 5'-end radiolabelled with [7- 32P] ATP (-5000 Ci/mol; 
Amersharn) using T4 Polynucleotide Kinase (PNK) and incubated at 37°C for 45 
mm. The reaction mix was as follows, depending on whether the oligonucleotides 
were used for Northern analysis (Section 2.3.3.3) or primer extension (Section 
2.3.3.2): 
Northern Analysis' 	 Primer Extension 
Oligonucleotide 10 prnol Oligonucleotide 10 pmol 
lOx T4 PNK buffer 2 	tl lOx PNK buffer 1.5 1.11 
T4 PNK (10 uljil) 0.5 	tl 100mM DTT 1.5 	tl 
[7- 32P] ATP 2 t1 [7-32P] ATP 2.5 p1 
Sterile, distilled water to 20 p.1 Sterile, distilled water to 15 p.1 
passed through a 2 p.m filter prior to use to remove any particulate material. 
precipitated (Section 2.3.1.3), and resuspended in 100 p.1 sterile, distilled water 
prior to use. 
2.3.2.11. DNA Sequencing 
Plasmid DNA to be sequenced was prepared by using QlAprep spin columns 
(Section 2.3.2.1) and quantified by visualisation on an agarose gel (Section 2.3.2.7). 
Genomic DNA to be sequenced was firstly amplified using PCR (2.3.2.6) with 
suitable primers (Table 2.1.10) and the resulting DNA fragment was visualised on an 
agarose gel (Section 2.3.2.7) and purified using the QiaQuick Gel Extraction kit 
(Section 2.3.2.8). Sequencing reactions were then performed using a dRhodamine 
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terminator cycle sequencing kit (Perkin Elmer). A typical reaction mix was as 
follows: 
Template DNA (0.5 .tg) 	4 il 
Terminator mix 	 4 gl 
Primer (1.5 pmol) 	2 .xl 
The reactions were then placed in a PTC-100 Hot Lid reactor (Genetic Research 
Instrumentation Ltd) and the program listed in Table 2.3.1.2 was run for 25 cycles: 
Table 2.3.1.2. 
Typical PCR Sequencing Reaction. 
Step 	 Description 	Temperature 	Time 
1 	 Denaturation 96°C 30s 
2 	 Annealing 50°C 15 s 
3 	 Extension 60°C 4 mm 
DNA was then precipitated from the reaction mix by addition of 25 tl ethanol, 1 
p.1 of NaOAc, pH 5.2. This was incubated on ice (15 mm) and centrifuged (14000 
rpm, 15 mm, 4°C) The pellet was washed with 250 p.1 of 70% (v/v) ethanol and dried 
under vacuum. Samples were run in an external department on an ABI PRISM 377 
DNA Sequencer and the resulting DNA sequence studied using the Gene Jockey II 
computer program. 
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2.3.3. RNA Methods 
2.3.3.1. Total RNA Preparation from Yeast 
Total yeast RNA was prepared using the method of Schmitt et al., (1990). 
Briefly, 20 ml of suitable growth medium (Table 2.1.3) was inoculated with a 
single colony of the yeast strain under investigation and incubated at a suitable 
temperature. The cells were sedimented by centrifugation (3500 rpm, 3 mm, RT; 
Mistral 1000 centrifuge) and resuspended in 400 .il of AE buffer (50 mM NaOAc pH 
5.2, 10 mM EDTA). If samples were required to be stored at this point, they were re-
centrifuged as before, and the AE buffer removed. Yeast cells were then frozen on - 
20°C for up to 6 months, until they were thawed and resuspended in 400 .t1 AE 
buffer. 
Samples then had 40 p.1 of 10% (w/v) SDS and 500 p.1 of phenol (equilibrated with 
EA buffer) added to them. Samples were then vortexed and incubated (4 mm, 65°C) 
Samples were then snap-frozen on dry-ice, thawed and centrifuged (14000 rpm, 2 
mm, RT). The aqueous layer was removed and extracted (Section 2.3.1.2). The 
resulting aqueous layer was again removed and precipitated (Section 2.3.1.3). The 
precipitated RNA was dried under vacuum, resuspended in 50 41 sterile, distilled 
water and the concentration determined by spectrophotometric analysis (Section 
2.3.1.1). 
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2.3.3.2. Primer Extension of RNA 
Total yeast RNA was prepared (Section 2.3.3.1) and quantified (Section 2.3.1.1), 
and the relevant oligonucleotide was 5' end-labelled (Section 2.3.2.10). The 
following reaction mix was then set up: 
RNA 	 lOug 
5x hybridisation buffer 	2tl 
Labelled oligonucleotide 	2tI 
Sterile, distilled water 	to 10 tl 
This was then incubated for 5 minutes at 95°C, to denature any RNA secondary 
structure. This was immediately followed by incubating for 90 min at 42°C to allow 
the primer to anneal to its complementary sequence within the RNA target. 40 tl of 
pre-warmed 1.25x RT buffer was then added to each sample, as well as 10 u of 
reverse transcriptase and 10 u of RNAsin (Ambion). This was then incubated for a 
further 40 min at 42°C to allow the reverse transcription reaction to proceed. 
Following this, 7 uI of NaOH/EDTA buffer (1 M NaOH, 0.07 M EDTA) was 
added to each sample and incubated for 30 min at 55°C to hydrolyse the RNA in the 
sample. After this time, the pH of the sample was neutralised with 6 ui of 1 M HC1 
and the DNA was precipitated with ethanol (Section 2.3.1.3). The DNA was then 
centrifuged (14000 rpm, 15 mm, 4°C), washed with 100 ul 70% ethanol and dried 
under vacuum. Pellets were dissolved in 10 ui of Sanger loading dye and ran on a 6% 
Chapter 2: Materials and Methods 
polyacrylamide-urea gel as described in Section 2.3.3.3. After electrophoresis, gels 
autoradiography was performed directly on the gel at —70°C. 
5x hybridisation buffer: 
	
1.5 MNaC1 
5c 0 mM Tris-HC1, pH 7.5 
10 m EDTA 
1 .25x RT buffer: 
	
1.25 mM Tris-HC1, pH 8.4 
12.5 mM DTT 
7.5 MM  MgC12 
1.25 mM each dNTP 
Sanger loading dye: 
	
51% (v/v) formamide 
20 mM EDTA 
0.25% (w/v) Xylene cyanol 
0.25% (w/v) Bromophenol blue 
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2.3.3.3. Denaturing Northern Blot Analysis of snRNAs 
Polyacrylamide Gel Electrophoresis of RNA 
Polyacryamide-urea gels (6%) were prepared using 20 ml Sequagel-6 and 5 ml 
Sequagel complete buffer reagent (National Diagnostics), as well as adding 100 tl 
10% (w/v) ammonium persulphate (APS). 10 ig of yeast total RNA (Section 2.3.3.1) 
was mixed with an appropriate volume of Sanger Loading Dye (Section 2.3.3.2) and 
heated to 95°C immediately prior to loading. Gels were run in lx TBE buffer (Table 
2.1.5) at room temperature (25 W, 45 mm). 
Transfer of RNA to Nylon Membrane 
RNA was transferred electrophoretically to Hybond-N nylon membrane 
(Amersham Pharmacia) in 0.5x TBE (Table 2.1.5; 60 V, 60 mm). Following transfer, 
RNA was cross-linked to the membrane using a Stratagene UV Stratalinker using the 
'autocrosslink' function to immobilise the RNA on the filter. The membrane was then 
subject to pre-hybridisation in SES 1 buffer (2 hours, 37'Q. 
Hybridisation of 5' End-labelled Oligonucleotide Probes to RNA 
End-labelled oligonucleotides (Section 2.3.2.10) were passed through a 2jim filter 
in order to remove aggregates and then hybridised to the RNA on the nylon 
membrane in SES1 buffer (0.5 M NaPO 4 pH 7.2, 7% (w/v) SDS, 1 mM EDTA), 
typically at 37°C. Membranes were washed twice for 5 minutes in 6x SSPE buffer 
(Table 2.1.4) followed by two washes for 20 minutes in 6x SSPE pre-warmed to 
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42°C. Following washing, nylon membranes were wrapped in Saran Wrap to prevent 
them drying out and subjected to autoradiography at -70°C. 
Membrane Stripping for Reprobing 
For successful removal of probes, membranes were prevented from becoming too 
dry following hybridisation. To strip, a boiling solution of 0.1% (wlv) SDS was 
poured on the membrane and incubated on a rotating platform for 10 minutes. This 
was repeated 3 times. The membrane was either re-probed with another end-labelled 
oligonucleotide as above or blotted dry and stored for future use. 
2.3.3.4. Non-Denaturing Northern Blot Analysis of snRNAs 
Polyacrylamide Gel Electrophoresis of RNA 
Non-denaturing polyacryamide gels (10%) were prepared according to the 
following protocol: 
30% Bis-acrylamide 	8.3 ml 
lOx TBM buffer 	 2.5 ml 
10%(w/v)APS 	 100 
TEMED 	 10 tl 
Sterile, distilled water 	to 25 ml 
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RNA was mixed with an appropriate volume of non-denaturing RNA loading 
buffer and loaded immediately. Gels were run in pre-chilled lx TBM buffer (Table 
2.1.5) at 4°C (5 W,4 h). 
2x Native RNA loading buffer: 	30% (w/v) glycerol 
80 mM HEPES, pH 7.6 
100 m KC1 
2 mM MgOAc 
Transfer of RNA to Nylon Membrane 
RNA was transferred to Hybond-N nylon membranes as in Section 2.3.5.3. 
Hybridisation of 5' End-labelled Oligonucleotide Probes to RNA 
End-labelled oligonucleotides were hybridised to the nylon membrane according 
to the protocol in Section 2.3.5.3. 
Membrane Stripping for Reprobing 
Membranes were stripped and re-probed according to Section 2.3.5.3. 
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2.3.3.5. In vitro Transcription of Actin pre-mRNA 
Preparation of DNA Template 
Plasmid DNA p283 (Table 2. 1.11) was linearised by restriction digest (Section 
2.3.2.4) with BamHl. Following digestion, 1.il of the template DNA was used 
directly in an in vitro transcription reaction. 
Transcription Reaction 
The reaction mix was as follows and incubated for 30 minutes at 37°C. The 
transcript was stored at —20°C for up to I week. 
Linearised p283 DNA 	 1 tl 
1 Ox T7 buffer 	 1.5 jil 
1OmM ATP, CTP,GTP 	 I jtl 
400 p.M UTPt 	 I 11 
[CC-32P] UTPt 	 I p.! 
Rnasin 	 5 u 
T7 RNA polymerase 	 25 u 
Sterile, distilled water 	 to 20 p.1 
for non-radiolabelled actin, these components were replaced with 1 p.1 of 10 mM 
UTP. 
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2.3.3.6. In vitro splicing 
To investigate the ability of whole yeast cell extracts (Section 2.3.4.2) to splice, in 
vitro splicing was performed using in vitro-transcribed actin pre-mRNA Section 
2.3.3.5) as a substrate. To investigate this, the following reaction was set up: 




Sterile, distilled water 	 1 .t1 
Yeast cell extract 	 5 j.xl 
In vitro actin pre-mRNA (-500 cpm) 	1 p.1 
This reaction was incubated for 30 minutes at 24°C before being stopped on ice. 3 
p.1 of Proteinase K solution was added and incubated for a further 40 minutes at 
37°C. Following this, 200 p.1 of 'splicing cocktail' was added to the reaction before 
being phenol/chloroform extracted (Section 2.3.1.2), ethanol precipitated (Section 
2.3.1.3) and centrifuged (14000 rpm, 15 mm, 4°C). The supernate was then removed 
and the pellet was washed in 70% (v/v) ethanol and dried under vacuum before being 
resuspended in 10 p.1 Sanger Loading Dye (Section 2.3.3.2). Samples were loaded 
onto a 6% denaturing polyacrylamide gel and subjected to electrophoresis (Section 
2.3.3.3) before being directly subjected to autoradiography at —70°C. 
RR 
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5x Splicing buffer: 
	
300 mM potassium phosphate, pH 7.5 
12.5 mM magnesium chloride 
10 mM ATP 
Proteinase K Solution 
	
1 mg ml Proteinase K 
50 mM EDTA 
1% (w/v) SDS 
Splicing Cocktail: 
	
50 mM sodium acetate, pH 5.3 
1 mM EDTA 
0.1% (w/v) SDS 
25 jig/ml tRNA 
2.3.3.7. In vitro Transcription of U4 and U6 RNA 
Preparation of DNA Template 
In vitro transcription of U4 and U6 RNA was performed from a linear DNA 
template synthesised by PCR (Section 2.3.2.6). This template contained the SNR14 
or the SNR6 gene to transcribe U4 RNA or U6 RNA respectively, as well as the T7 
promoter at the 5' end of the gene. To produce the DNA template for in vitro 
transcription of U4 RNA, oligonucleotide primers T7U4F and U4R were used (Table 
2.1.8) with the plasmid template pU4 (Table 2. 1.11) as a template. To produce the 
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DNA template for in vitro transcription of U6 RNA, oligonucleotides LORY1 and 
S5761 were used (Table 2.1.8) with the plasmid template pT7U6 (Table 2.1.11) as a 
template. Alternatively for the U6 template, plasmid pT7U6 was digested (Section 
2.3.2.4) with the endonuclease DraI (for full-length template) or FokI (for a 3'-end 
truncated template) and gel-purified (Section 2.3.2.8). 
Transcription reaction 
The reaction mix was as follows and incubated for 1 hour at 37 0C. 
I Ox T7 polymerase buffer 	10 p.1 
DNA template (-i p.g/p.l) 	10 p.1 
5mMdNTPs 	 10 PI 
RNAsin 	 40 u 
T7 RNA polymerase 	 300 u 
Sterile, distilled water 	 to 100 p.! 
2.3.3.8. Purification of in vitro transcribed RNA 
Polyacrylamide Gel Elect ophoresis and UV shadowing 
Following in vitro transcription of U4 or U6 RNA (Section 2.3.3.6) RNA was 
phenol/chloroform extracted (Section 2.3.1.2), ethanol precipitated (Section 2.3.1.3) 
and centrifuged (14000 rpm, 15 mm, 4°C). Samples were resuspended in 10 p.! of 
Sanger Loading Dye (Section 2.3.3.2) and run on a 8% denaturing polyacryamide- 
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urea gel using the same procedure as in Section 2.3.3.2, with the exception that 
Sequagel-8 (National Diagnostics Ltd) was used instead of Sequal-6. Following this, 
the RNA in the gel matrix was visualised by UV shadowing using a hand-held UV 
illuminator at 254 nm (UVItec Ltd). Areas of the gel containing RNA were excised 
with a clean razor blade. RNA was eluted from gel slices immediately or the gel 
slices were stored at -20°C. 
Elution of RNA from Polyacrylamide Gel Slice 
To elute RNA from the gel slice, the Bio-Trap elution system (Schleicher & 
Schuell) was used according to maufacturer's guidelines. The gel slice containing the 
RNA was immersed in an elution chamber filled with 0.25x TBE (Table 2.1.4). A 
potential difference is applied across the gel and the RNA migrates from the gel and 
through a permeable membrane (BTI; Schleicher & Schuell) into a second chamber. 
The presence of a impermeable second membrane (BT2; Schleicher & Schuell) 
prevents the RNA from moving out of this chamber, thereby "trapping" the RNA in 
this chamber. Elution was typically performed at 200 V for 1 hour, eluting the RNA 
into a final volume of 100 p1 of 0.25x TBE. After elution, the direction of the current 
applied was reversed for approximately 10 seconds to ensure that the RNA was in 
solution rather than sticking to the BT2 membrane. The RNA solution was then 
removed from the chamber and ethanol precipitated (Section 2.3.1.3), centrifuged 
(14000 rpm, 15 mm, 4°C), washed with 70% (v/v) ethanol and resuspended in 50 p1 
of sterile, distilled water. The concentration was determined spectrophotometrically 
(Section 2.3.1.1). Typically, yields of 20-50 ig of RNA were achieved. 
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2.3.3.9. U4/U6 RNA Annealing Assay 
In order to assay the protein components necessary to anneal the U4 and U6 
RNAs in vitro, the following assay was developed. Each protein under investigation 
was produced in a TNT transcription-translation coupled reaction (Section 2.3.4.6) 
and the following reaction was set up and incubated for 20 minutes at 30°C: 
1 Ox RNA annealing buffer 	 5 p.1 
TNT synthesised protein 	 5 p.1 each 
Mock TNT reaction 	 to 40 p.! 
U6 RNA 	 50 n 
Sterile, distilled water 	 to 50 p.1 
This reaction mix was incubated for 30 minutes at 30°C before adding '-'100 ng of 
U4 RNA. This mix was then incubated for a further 60 minutes at 30°C. RNA was 
then ethanol precipitated (Section 2.3.1.3), the pellet was resuspended in 10 p.1 native 
RNA loading buffer (15% (w/v) glycerol, lx RNA annealing buffer) and subjected to 
non-denaturing Northern blot analysis. U6 RNA was probed for using the 
oligonucleotide W3464 (Table 2.1.8) and U4 RNA was probed for using the 
oligonucleotide G6568 (Table 2.1.8). 
I Ox RNA annealing buffer: 	300 mM Tris-HC1, pH 7.5 
IM KC1 
50 MM MgCl2 
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2.3.3.10. Depletion of U6 snRNA from yeast cell extract 
The procedure for depletion of U6 snRNA from yeast cell extract was adapted 
from Fabrizio et al. (1989). The principle involves adding a DNA oligonucleotide 
complementary to the U6 snRNA sequence (positions 28-54). This RNA-DNA 
hybrid is then specifically degraded by endogenous RNase H activity in the extract. 
Whole yeast extract (Section 2.3.4.2) was incubated (35 mm, 30°C) with the 
oligonucleotide V4528 (Table 2.1.8) to a final concentration of 10 .iM. After 
incubation, the extract was placed on ice before being analysed further. 
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2.3.4. Protein Methods 
2.3.4.1. Crude Protein Preparation from Yeast 
Ten millilitres of the appropriate medium was inoculated with a fresh single 
colony of the yeast strain under investigation. This was incubated at 30°C overnight. 
Cells were then sedimented by centrifugation (3500 rpm, 4 mm, RT; Mistral 100 
centrifuge) and resuspended in 200 tl of Ix SDS loading buffer. Fifty microlitres of 
glass beads approximately 500 p.m in diameter (Biospec Products Inc) were added, 
and the tubes were vortexed for 60 seconds. The tubes were then incubated at 96°C 
for 60 seconds before being placed on ice for a further 60 seconds. These incubations 
were repeated a further two times, after which the lysates were cleared by 
centrifugation (14000 rpm, 5 mm, RT). Samples were heated to 96°C for 5 minutes 
immediately prior to loading on SDS-PAGE gels (Section 2.3.4.3). 
2x SDS Loading Buffer: 	100 mM Tris-HC1, pH 6.8 
20% (w/v) glycerol 
200 mM DTTt 
0.2% (wlv) Bromophenol blue 
added immediately prior to use 
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2.3.4.2. Large Scale Yeast Whole Cell Extract Preparation 
Ten millilitres of the appropriate medium was inoculated with a single colony 
of the yeast strain under investigation and incubated overnight at 30°C. This was then 
taken and used to inoculate 2-3 1 of pre-warmed medium to an optical density at 600 
nm of approximately 0.1 au, and incubated until the 0D 600 was approximately 0.8 au. 
Cells were then centrifuged in a JLA 10.500 rotor (5000 rpm, 5 mm, RT) and cells 
were resuspended in 50 ml of AGK buffer. Cells were sedimented (3500 rpm, 5 mm 
RT; Mistral 1000 centrifuge), resuspended in 20 ml AGK buffer and centrifuged as 
above. The supernate was then removed and the resulting yeast pellet was weighed 
(typical weight was between 3 and 5 g). Cells were resuspended in a volume of AGK 
buffer, in millilitres, corresponding to 0.4x the cell pellet weight, in grams. DTT was 
added to a final concentration of 2 mM. The yeast suspension was then frozen by 
adding dropwise to liquid nitrogen. This could be either processed further 
immediately or stored for up to 12 months at -70°C. 
The frozen cell pellet was then added to a mortar containing liquid nitrogen 
and ground to a fine powder with occasional further additions of liquid nitrogen to 
ensure the pellet did not thaw. This frozen powder was transferred to a pre-chilled 
polycarbonate centrifuge tube and thawed on ice. This was centrifuged in a JA25.50 
rotor (17000 rpm, 30 mm, 4°C). The supemate was then transferred to a pre-chilled 
polycarbonate centrifuge tube. The top layer of the supernate containing lipid was 
avoided as much as possible during the transfer. This was then centrifuged in a 70.1 
Ti rotor (40000 rpm, 60 mm, 4°C; Beckman), the resulting supernate being 
transferred to dialysis membrane with a molecular weight cut-off of approximately 
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10 kDa. This was placed in 11 of pre-chilled dialysis buffer and dialysed for 3 hours 
at 4°C, changing the dialysis buffer twice. The supernate was then placed in a pre-
chilled Eppendorf tube and centrifuged (14000 rpm, 10 mm, 4°C). The resulting 
supernate was then aliquoted into pre-chilled Eppendorf tubes and frozen at -70°C 
until use. 
AGK buffer: 	 10 mM HEPES, pH 7.9 
1.5 MM MgCl2 
200 mM KC1 
10% (vlv) Glycerol 
Dialysis buffer: 	 20 mM HEPES, pH 7.9 
50 mM KC1 
0.4 mM DTT 
2.3.4.3. SIDS Polyacrylamide Gel Electrophoresis (SOS-PAGE) 
Samples to be analysed by SDS-PAGE firstly had an equal volume of 2x SDS 
Loading Buffer added before being heated at 95°C for 10 minutes. Samples were 
then, unless otherwise stated, loaded onto a pre-cast 4-12% polyacrylamide gel 
(Novagen), alongside molecular weight markers of known size (Novagen) for 
reference. Gels were subject to electrophoresis in a Novex Mini-cell (Novagen) with 
Ix MOPS (Table 2.1.3) as buffer. Electrophoresis was performed at 200 V until the 
bromophenol blue dye front reached the bottom of the gel. 
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2x SDS Loading Buffer: 	100 mM Tris-HCL, pH 6.8 
200 mM DTF 
4% (w/v) SDS 
0.2% (w/v) bromophenol blue 
20% glycerol 
2.3.4.4. Western Blotting 
Electrophoretic Trasfer of Proteins to PVDF Membrane 
Proteins were transferred electrophorectically from the SDS-polyacrylamide gel to 
PVDF membrane (Amersham) using the Bio-Rad transfer system according to the 
manufacturer's instructions. Electrophoretic transfer was performed in lx Western 
Transfer Buffer at 100 V for 2 hours. Transfer was confirmed by staining of the 
membrane with Ponceau S (Amersham). 
. 1 Ox Western Transfer Buffer: 	1.5 M Glycine 
200 mM Tris-HCI, pH 8.3 
Antibody Binding 
Non-specific protein interactions were blocked by incubating the PVDF 
membrane following transfer (60 mm, RT). Blocking was performed in 100 ml 
TBST-M (lx TBST (Table 2.1.4) and 5% (w/v) dry milk powder (J. S. Sainsbury 
Ltd) with constant shaking. Primary antiserum (Table 2.1.13) was diluted to the 
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appropriate concentration in 10 ml TBST-M, added to the blocked membrane and 
incubated (2 h, RT, or 0/n, 4°C), with constant shaking. The membrane was then 
washed in 100 ml of lx TBST for 15 minutes. This washing was repeated a further 3 
times. Secondary HRP-conjugated secondary antiserum was then diluted in 10 ml of 
lx TBST, applied to the membrane and incubated with constant shaking (60 minutes, 
RT). The membrane was then washed as detailed above. 
Enhanced Chemiluminescence (ECL) 
Three millilitres of developer solution (Amersham) was prepared according to 
manufacturer's instructions, added to the membrane and incubated (60 s, RT). 
Following incubation, the membrane was placed in Saran wrap and exposed to 
photographic film. Exposure times varied depending on the strength of the signal, but 
were typically between 10 and 60 seconds. 
2.3.4.5. Production and purification of His-tagged recombinant 
protein from E.coli 
Protein expression 
Five millilitres of LB medium (Table 2.1 .1) containing the relevant antibiotics 
(Table 2.1.3) were inoculated with a single colony of E. coli containing the 
expression plasmid and grown overnight at 37°C with agitation. This was then used 
to inoculate 2 1 of LB medium with the appropriate antibiotics. This culture was then 
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grown at 23°C tpo an 0D 600 of 0.3-0.4. To induced expression of the desired protein, 
IPTG was added to a final concentration 0.75 mM. The culture was then incubated 
for a further 12 hours at 23°C. Cells were then harvested (5000 rpm, 10 mm, 4°C; 
Beckman JLA 10.500 rotor). 
Preparation ofprotein extract 
Cells were resuspended in 60 ml of Lysis Buffer A. Lysozyme was added to a 
final concentration of 0.2 mg/ml and the extract was stirred on ice for 45 minutes. 
Triton-X- 100 was added to a final concentration of 0.1% (v/v) and the extract stirred 
on ice for a further 5 minutes before being transferred to polypropylene centrifuge 
tubes and centrifuged (17000 rpm, 45 mm, 4°C; Beckman JLA 10.500 rotor).The 
supernate was transferred to a 50 ml polycarbonate tube and stored at -70°C until 
required. 
Ni-NTA affinity purification of the His-tagged protein 
Two millilitres of Ni-NTA agarose (Qiagen) were washed with 10 ml Washing 
Buffer (20 mM Tris-HCI pH 7.5, 0.5 M NaC1) on a rotating wheel (45 mm, 4°C). 
This was then sedimented and subject to centrifugation (3500 rpm, 3 mm, RT; 
Mistral 1000 centrifuge). The supernate was then removed and 35 ml of the thawed 
protein extract was added before being incubated (2 h, 4°C). The Ni- NTA agarose 
was sedimented by centrifugation as before and resuspended in a residual 1 ml of the 
mixture, before being transferred to a small disposable column and subsequently 
handled at 4°C. The column was washed for 60 minutes with 10 ml of BC 100 buffer 
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containing 20 mM imidazole (pH 7.9) with the flow-through being collected. The 
column was then washed in 10 ml of BC 100 buffer containing 55 mM imidazole (pH 
7.9) with the flow through being collected as before. The His-tagged protein was 
finally eluted with 10 ml of BC 100 buffer containing 200 mM imidazole (pH 7.9). 
The eluate was collected in I ml fractions. 
Samples of the washes and the eluted fractions were then analysed by SDS-PAGE 
(Section 2.3.4.3) and Western blotting (Section 2.3.4.4). Fractions of the eluate 
shown to contain the purified protein were placed in dialysis membrane with 
approximately 10 kDa cut-off and dialysed against 2 1 of BCIOO. After dialysis, 
saples were aliquoted into 1 ml fractions and then stored at -80°C. 
. Lysis buffer A: 	 50 mM Tris-HC1, pH 7.5 
250 mM NaCl 
10% (w/v) Sucrose 
. BC 100: 	 20 mM Tris-HCL, p1-I 7.9 
100 m KC1 
20% (wlv) Glycerol 
2.3.4.6. In vitro transcription/translation of proteins 
Preparation of DNA template 
Synthetic oligonucleotide primers were designed (Table 2.1.9) to specifically 
amplify the protein (or protein fragment) of interest from an appropriate template 
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(Table 2.1.12) by PCR (Section 2.3.2.6). These primers were designed in order to 
introduce a consensus T7 promoter sequence upstream of the protein coding 
sequence. Following amplification of the desired sequence, the resulting DNA 
template was subject to agarose gel electrophoresis (Section 2.3.2.7) and gel 
purification (Section 2.3.2.8). 
In vitro coupled transcription-translation (TNT) reaction. 
Ten micrograms of the resulting DNA template was added to the components of 
the Wheat Germ in vitro transcription-translation TNT kit (Sigma) according to 
manufacturer's instructions and incubated (2 h, 30°C). [35 S]-methionine was included 
in the reaction in order to be able to visualise the protein by autoradiography. 
Following incubation, in order to check the efficiency of the reation, 2 l of each 
sample was subject to SDS-PAGE (Section 2.3.4.3). The gel was then placed on 
blotting paper and covered in Saran wrap and dried on a Gel-Vac vacuum gel drier 
(Hybaid) for 2 hours at 80°C. This was then subject to autoradiography with MR film 
(Kodak) at room temperature. 
2.3.4.7. Co-immunoprecipitation of Proteins 
Co-immunoprecipilation of in vitro synt hesised proteins 
Approximately 20 l of recombinant protein purified from E. coli (Section 
2.3.4.5) was added to 5 il of protein produced by the TNT reaction (Section 2.3.4.6). 
In vitro transcribed RNA (Section 2.3.3.7) was added to the necessary concentration 
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if required and the total volume was made up to 50 .il with IP buffer. This was then 
incubated on ice for 10 minutes. Anti-His antiserum (Qiagen; Table 2.1.13) was then 
added before being incubated on ice for 60 minutes. Protein A-Sepharose (PAS) 
beads (10 mg/sample) were swollen in NTN buffer, washed twice in I ml NTN 
buffer and once in IP buffer before being suspended in 200 tl of IP buffer per 
sample. PAS beads were then added to each sample and incubated on a rotating 
wheel (60 mm, 4°C). The suspension was then washed three times with 1 ml IP 
buffer and the pellet finally resuspended in 30 tl of lx SDS buffer (Section 2.3.4.3). 
Samples were then vortexed and subject to SDS-PAGE (Section 2.3.4.3). In order to 
visualise any co-imniunoprecipitated [35S] -Methionine-labelled proteins, the gel was 
then placed on blotting paper and covered in Saran wrap and dried on a Gel-Vac 
vacuum gel drier (Hybaid) for 2 hours at 80°C. This was then subject to 
autoradiography with MR film (Kodak) at room temperature. 
Co-immunoprecipitation ofproteins from yeast extract 
Yeast extracts were prepared (Section 2.3.4.2) and 500 tg of protein (20 tl) was 
made up to 50 tl with IP buffer, mixed with antisera (Table 2.1.13) and incubated on 
ice for 60 minutes. Protein A-Sepharose (PAS) beads (10 mg/sample) were swollen 
in NTN buffer, washed twice in I ml NTN buffer and once in IP buffer before being 
suspended in 200 tl of IP buffer per sample. PAS beads were then added to each 
sample and incubated on a rotating wheel (60 mm, 4°C). The suspension was then 
washed three times with 1 ml IP buffer and the pellet finally resuspended in 30 tl of 
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Ix SDS buffer (Section 2.3.4.3). Samples were then vortexed and subject to SDS-
PAGE (Section 2.3.4.3) and Western blotting (2.3.4.4). 
. NTN Buffer: 	 50 mM Tris-HC1, pH 7.5 
150 m NaCl 
0.1% (v/v) NP-40 
• IP Buffer: 	 6 mM HEPES, pH 7.9 
150 m NaCI 
2.5 MM  MgC12 
0.05% (vlv) NP-40 
2.3.4.8. Glycerol Gradient Sedimentation 
Glycerol gradients were made and run as described in Bordonné et al., (1990). 
Samples were prepared by incubating 200 iI of splicing extract (Section 2.3.4.2) at 
25°C for 15 minutes under I splicing conditions without transcript. Samples were 
then diluted by addition of 400 pd GG buffer and layered onto an 11 ml 10-30% 
glycerol gradient in GG buffer previously poured using a gradient pourer (Anachem). 
Samples were then centrifuged (37000 rpm, 14 h, 4°C) in a SW40 Ti rotor 
(Beckman). Five hundred microlitre fractions were then collected and stored at - 
70°C. 
To analyse the snRNA distribution, 250 il from odd-numbered fractions were 
taken and phenol/chloroform extracted (Section 2.3.1.2) and ethanol precipitated 
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(Section 2.3.1.3) and subjected to electrophoresis on a 6% denaturing polyacrylamide 
gel followed by Northern blotting for U4, U5 and U6 snRNAs. 
To analyse the protein distribution, the total protein content of 250 tl from odd-
numbered fractions was precipitated with an equal volume of 10% TCA and 
incubated (20 mm, RT). Samples were then centrifuged (14000 rpm, 10 mm. RT), 
the pellet resuspended in 2x SDS buffer and subjected to SDS-PAGE (Section 
2.3.4.3) and Western blotting (Section 2.3.4.4). 
GG Buffer: 	 50 mM Tris-HC1, pH 7.5 
25 mM NaCl 
5 MM  MgCl2 
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Investigation of alternative Lsm complexes in yeast 
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3.1. Introduction 
Previous data have suggested that Lsm I  is dissimilar to the other Lsm proteins. For 
example, strains with an Ism] deletion, despite being temperature sensitive, neither have 
a splicing defect nor affect the level of U6 snRNA when grown at the restrictive 
temperature (Mayes et al.. 1999). In addition, an epitope-tagged allele of Lsmlp cannot 
co-immunoprecipitate U4, U5 or U6 snRNA, in contrast to the other Lsm proteins that 
can co-immunoprecipitate these snRNAs (Mayes et al., 1999). Finally, crystallographic 
and modelling studies of the canonical Sm proteins revealed that the Lsm proteins were 
likely to form a seven-membered ring. In combination with other biochemical evidence, 
this suggests that Lsm2-8p may form a seven-membered ring and be involved in pre-
mRNA splicing whereas Lsmlp may have another biochemical function. Therefore, it 
was decided to investigate whether Lsmlp was present in different complexes to the 
other Lsm proteins. 
3.2. Glycerol Gradient Analysis 
To study this initially, it was decided to use glycerol gradient sedimentation analysis 
(Section 2.3.4.8). This involves setting up a glycerol density gradient and, by 
centrifugation, separating protein or protein-RNA complexes in the gradient according 
to their densities (Figure 3.1). This has previously been used to separate U6, U41U6 and 
U5.U4/U6 tri-snRNP particles in mammalian systems (Brown & Beggs, 1992; 
Gottschalk et al., 1999). By analysing the fractionation of HA:Lsmlp on a glycerol 
gradient by Western blotting (Section 2.3.4.4) and comparing it to the fractionation of 
HA:Lsm8p, it could be determined whether or not Lsmlp was present in the same 
fractions as Lsm8p. 
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Figure 3.1. Schematic diagram of glycerol gradient sedimentation. Yeast 
extract is layered onto a 10-30% glycerol gradient and centrifuged 
(Section 2.3.4.10). Complexes of differering mass and density reach an 
equilibrium at differing points in the gradient. U6 snRNP reaches 
equilibrium near the top of the gradient, U4/U6 di-snRNP in the middle of 
the gradient and U5.U4/1J6 tri-snRNP reaches equilibrium towards the 
bottom of the gradient. Gradient fractions can subsequently be analysed 
for the presence of these complexes. 
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In addition, the profile of snRNAs could also be analysed by Northern blotting 
(Section 2.3.3.3) to determine in which U6-containing particles Lsmlp and Lsm8p were 
present. 
Northern blotting of the RNAs present in the resultant fractions clearly demonstrates 
that the U6-containing particles do fractionate on a glycerol gradient owing to their 
differing densities. The least dense of these particles, the U6 snRNP migrates towards 
the top of the gradient in fractions 7-9. The U4/1J6 di-snRNP is more dense than this 
and migrates approximately in fractions 11-13. The most dense particle is the U5 .U4.U6 
tri-snRNP. This migrates towards the bottom of the gradient, approximately in fractions 
19-22 (figure 3.2A). This is typical of the distribution of U6-containing particles 
previously observed (Brown & Beggs, 1992). This distribution of snRNAs was 
independent of the strain of yeast from which the extract analysed was derived. 
Using the yeast strain AEMY46 (Table 2.1.6), which contains a chromosomal 
deletion of LSM8 and the plasmid pAEM76 expressing Lsm8p with an HA epitope 
under control of the PGfLJ promoter allows Lsm8p to be detected by Western blotting. 
Western analysis of the glycerol gradient fractions reveals that Lsm8p is present in the 
same fractions as U6 snRNA figure 3.213). Lsm8p appears to co-fractionate with free 
U6 (fractions 7-9), U4/U6 di-snRNP as well as with U5.U4/U6 tri-snRNP (fractions 19-
23). These data are supported by co-immunoprecipitation data (Mayes et. al, 1999) in 
which U4, U5 and U6 snRNA are co-precipitated with Lsm8p, suggesting the presence 
of Lsm8p in U6 snRNP, U4/U6 di-snRNPs and U5.U41U6 tri-snRNPs. In addition to 
the Lsm8p that co-fractionates with U6-containing particles, there also appears to be a 
large proportion of Lsm8p that is not associated with U6 (figure 3.213, fractions 3-5). 
This probably results from Lsm8p being over-expressed from the PGALJ  promoter. 
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Figure 3.2. Glycerol gradient fractionation (Section 2.3.4.10) of snRNA, 
Lsmlp and Lsm8p. (A) Extract was layered onto a 10-30% glycerol 
gradient and centrifuged. The gradient was then divided into 0.5 ml 
fractions. Odd-numbered fractions were subjected to Northern blotting 
(Section 2.3.3.3) and probed for U4, U5 and U6 snRNA. (B) HA:Lsm8p 
extract was treated as in (A) and the proteins precipitated with TCA in 
the odd-numbered fractions before being subject to SDS-PAGE (Section 
2.3.4.3) and Western blotting (Section 2.3.4.4). Immunodetection was 
with rabbit anti-HA antibodies (Table 2.1.13) and was visualised by 
ECL. (C) HA:Lsm8p yeast extract was treated for 30 min with the U6 
knockout oligonucleotide V4528 (Table 2.1.8) at a concentration of 10 
.tM before being treated as in (B). (D) Yeast extract containing 
HA:Lsm I  was treated as in (B). 
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Whether Lsm8p, when expressed at wild-type levels, is not associated with U6 snRNA 
or other Lsm proteins is not clear. 
To ensure that this fractionation was due to the association of Lsm8p with U6-
containing particles and not particles of a similar density, glycerol gradients were 
performed using yeast extract prepared from AEMY46 that had previously been 
depleted of endogenous U6 snRNA. This was done by incubating the extract with a 
synthetic oligonucleotide complementary to the U6 snRNA sequence, allowing the 
endogenous Rnase H activity of the extract to hydrolyse the U6 RNA (Section 2.3.3.10). 
U6 depletion was verified by Northern blotting (data not shown). Following U6 snRNA 
depletion from the AEMY46 extract, the distribution was considerably altered (figure 
3.2C). Lsm8p co-fractionates with neither the U4/U6 di-snRNP nor the U5.U4/U6 tn-
snRNP demonstrating that the co-fractionation of Lsm8p with those complexes was 
indeed due to its association with U6 snRNA. However, the distribution of Lsm8p has 
not significantly altered for lanes 3-9, which represents free Lsm8p and Lsm8p 
associated in U6 snRNPs. This was surprising, as Lsm8p may have been expected to be 
absent from lanes 7-9 following the ablation of U6 snRNPs. One explanation for this 
could be that, following the depletion of U6 snRNA, the actually mass and density of 
the particles does not significantly change. For this to occur, the protein complex, and in 
particular, the seven-membered ring thought to be formed by Lsm2-8p must be stable in 
the absence of U6 snRNA. This would be in contrast to the canonical Sm proteins that 
require U snRNA to assemble into a heptameric ring. This proposal is investigated 
further in chapter 4. 
To compare the distribution of Lsm8p with Lsm 1 p  in order to determine 
whether or not Lsmlp co-fractionated with Lsm8p, a yeast extract was prepared from 
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AEMY28 (Mayes ci al., 1999) which has Lsm ip HA epitope-tagged upon the genome, 
allowing the fractionation of Lsmlp to be analysed by Western blotting. When a yeast 
extract prepared from AEMY28 cells was fractionated on a glycerol gradient and 
subsequently analysed (figure 3.2D), the protein distribution was markedly different to 
that of Lsm8p in the presence of U6 snRNA. In particular, there appears to be little or 
no Lsmlp co-fractionating with either U4/U6 di-snRNP or U5.U4/U6 tri-snRNP, 
indicating that Lsm Ip is not contained within these complexes. Lsm Ip is, however, 
mainly detected in fractions 7-9, which correspond to fractions containing U6 snRNPs. 
Although it is possible that Lsmlp associates with U6 snRNPs, this is unlikely due to 
the inability of Lsmlp to co-immunoprecipitate U6 snRNA. Lsmlp may thus be in a 
complex of similar density, and therefore fractionating with a similar profile, as Lsm8p 
following U6 snRNA depletion. Given that both Lsmlp and Lsm8p associate with 
Lsm4p (Mayes et. al, 1999), it seems likely that both Lsmlp and Lsm8p are associated 
in separate higher order complexes that contain other Lsm proteins and which are stable 
in the absence of U6 snRNA. 
3.3. Co-immunoprecipitation of Lsmlp and Lsm8p 
To demonstrate that Lsmlp and Lsm8p were not associated in the same complex in 
Figure 3.2C and figure 3.21), their association was investigated by co-
immunoprecipitation (Section 2.3.4.7). To perform the immunoprecipitation with 
epitope tags with a lower molecular weight than protein A, yeast strain AEMY28-
p22myc was constructed by transforming AEMY28 (Table 2.1.6) with plasmid p22myc 
(Table 2.1.11.; Section 2.2.4.1) expressing Lsm8p epitope-tagged at the C-terminus 
with 3 copies of the c-myc epitope. 
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Fig. 3.3. Immunoprecipitation of HA:Lsmlp and c(myc) 3 :Lsm8p. Yeast 
extract was prepared (Section 2.3.4.2) from a strain containing HA-tagged 
Lsmlp and c(my0 3-tagged Lsm8p and were immunoprecipitated (Section 
2.3.4.7) with beads only, anti-HA or anti-c(myc) antisera. The resulting 
supernatants and pellets were separated by SDS-PAGE (Section 2.3.4.3) 
and Western blotted (Section 2.3.4.4). This was then probed with rabbit 
cHA or rabbit ae(myc) antibodies (Table 2.1.13) as indicated, followed 
by HIRP-linked ai'abbit antisera (Table 2.1,13). The resulting 
autoradiograph is shown above. 
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Yeast extract was prepared from AEMY28-p22myc (Section 2.3.4.2) and co-
immunoprecipitations were performed with either a-HA or a-c-myc antibodies (Table 
2.1.13) to immunoprecipitate Lsmlp or Lsm8p respectively. Beads only were added to 
one sample to ensure that any precipitation that occurred was specific. Western blotting 
was performed on the resulting pellet and supernate from each sample (Figure 3.3). 
When cc-HA antibodies were used to precipitate Lsmlp, Lsmlp was efficiently 
precipitated and detected on a Western blot, however, there is no signal corresponding 
to Lsrn8p in the pellet when the blot is probed with a-c-myc antibodies. Conversely, 
when a-c-myc antibodies are used to precipitate Lsm8p, Lsm8p is efficiently 
precipitated and detected on a Western blot, however, there is no signal corresponding 
to Lsmlp in the pellet when the blot is probed with cc-HA antibodies. This demonstrates 
that Lsmlp and Lsm8p do not co-precipitate with each other and that they are present in 
separate complexes. This is interesting as both of these proteins co-immunoprecipitate 
with Lsm4p (Mayes et al., 1999) indicating the existence of two (or more) alternative 
Lsm complexes, one containing Lsmlp and another containing Lsm8p. 
This technique has subsequently been used to suggest that Lsmlp and Lsm8p 
were located in different complexes (Salgado-Garrido et al., 1999). It was not felt, 
however, that these results were reliable due to the proteins being tagged with protein 
A. This tag has a molecular weight of 15 kDa which would significantly increase the 
molecular weights of the Lsm proteins concerned, and may cause these proteins to 
function and/or interact abnormally. This has subsequently been justified by Pannone et 
al. (2001) who have demonstrated that Lsm3p, when tagged with protein A, functions 
differently to an untagged allele of the same protein. 
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3.4. Discussion 
At the time of investigation, little data were available about the function of 
Lsm Ip in the yeast cell, or the composition of any particle in which it is contained. The 
data presented here suggest that Lsmlp and Lsm8p are present in completely separate 
complexes, as they demonstrate different fractionation profiles on glycerol gradients 
(Figure 3.2) and the two proteins do not co-immunoprecipitate together (Figure 3.3). As 
both the Lsm 1 p-containing complex and the Lsm8p-containing complex fractionate 
similarly, and because both Lsmlp and Lsm8p can be co-immunoprecipitated with 
Lsm4p, this strongly suggested that Lsmlp and Lsm8p might be located in alternative 
Lsm complexes. Given that it was thought that the Lsm proteins were present in 
heptameric rings, it could be imagined that Lsmlp was in a complex containing Lsml-
7p, whereas Lsm8p was in a complex containing Lsm2-8p. This was also supported by 
the fact that amongst the Lsm proteins, Lsmlp and Lsm8p display the highest sequence 
similarity to the canonical Sm protein 5mB. It can be envisaged that Lsmlp and Lsm8p 
are the equivalent of SmB in their respective complexes, with Lsm2-7p substituting for 
SmD1, D2, D3, E, F and G. 
Subsequent data have shown that this indeed appears to be the case. Boeck et al. 
(1998) suggested that Lsmlp has a role in mRNA decay in the cytoplasm. Subsequent 
to this, Tharun et al. (2000) have demonstrated that the seven proteins Lsml-7p are all 
involved in mRNA decay in the cytoplasm and that they co-precipitate with other 
cytoplasmic mRNA decay factors, such as Dcplp and Xrnlp. Therefore this must 
represent a completely separate complex to Lsm2-8p, as this latter complex must be 
localised in the nucleus. The existence of two separate complexes was also 
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demonstrated by Tandem Affinity Purification (TAP) and subsequent mass 
spectroscopy of the proteins (Bouveret et al., 2000). 
The role of two separate Lsm complexes raised many issues. For example, are 
there two quite separate pools of Lsm proteins within the cell, one located in the 
nucleus, one in the cytoplasm? Or is it the case that Lsm2-7p can shuttle between the 
two? If the latter were the case, this could have important functional implications, 
perhaps being a direct link between the splicing of a pre-mRNA and the degradation of 
its resulting mature message. Also, how the cell recognises specifically the Lsm2-8p 
complex for import into the nucleus should also be considered. It seems unlikely that 
the individual Lsni proteins are imported separately as they have no recognised nuclear 
localisation sequence (NLS). Perhaps Lsm8p forms a nuclear localisation signal in 
association with the other Lsm proteins. Interestingly, the basic C-termini of the 
canonical Sm. proteins SmB/B' and SmD1 have been proposed to form a putative NLS 
in yeast (Bordonné, 2000). As Lsrn8p is analogous to SmB, its C-terminus may form 
part of an NLS with the C-terminus of other Lsm proteins, possibly Lsm2, as it is this 
protein which is analogous to SmD1. Alternatively, it is possible that another carrier 
protein containing a nuclear localisation sequence interacts with Lsm2-8p before it is 
imported. Whatever the exact mechanism is, Lsmlp and Lsm8p must play key roles in 
distinguishing between the localisation and function of these two complexes as the other 
Lsm2-7p are contained within both complexes, although this role remains unclear. 
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In vitro assembly of the Lsm8 complex 
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4.1 Introduction 
Following the discovery that there are at least two different Lsm complexes 
within budding yeast, it was realised that an in vivo approach was unsuitable for a 
detailed study of the function of the Lsm proteins in pre-mRNA splicing. This was 
because it would be difficult to distinguish between the role of the Lsm8 complex in 
splicing, and the role of the LsmI complex in mRNA decay in an in vivo study. Altering 
the function or equilibrium of one of the complexes might alter the function and 
equilibrium of a related complex. Such a situation was made even more complicated by 
the discovery that the Lsm proteins also have a role in the biogenesis and maturation of 
snoRNAs, indicating that they also function with the exosome (J. Kufel & D. Tollervey, 
unpublished data). Therefore it was decided to investigate the function of the Lsm8 
complex in vitro. Using in vitro techniques it is possible to investigate specific 
individual functions and interactions of the Lsm8 complex whilst minimising 
interference from other activities that may contribute to the overall cellular phenotype. 
In addition, the effects of the Lsm8 complex can be studied in isolation without the 
contributing effects of other proteins, which may be either synergistic or antagonistic to 
the effects of the Lsm8 complex. 
42 Coupled transcription/translation of Lsm2-8p and Prp24p 
In order to study the function of the Lsm proteins in vitro, they were produced in 
a coupled transcription/translation reaction in vitro (Section 2.3.4.6), as was Prp24p. 
Prp24p is also associated with the U6 snRNP (Shannon & Guthrie, 1991): therefore 
Prp24p might modify any activity of the Lsm8 complex. 
Figure 4.1. Production of 35 S-methionine-labelled proteins by in vitro 
transcription and translation (Section 2.3.4.6). (A) Schematic diagram 
showing production of in vitro translated protein. The DNA template 
for transcription was produced by PCR (Section 2.3.2.6), using primers 
P1 and P2 (Table 2.1.9). Primer P1 contained a T7 promoter sequence 
upstream of the complementary sequence, allowing the DNA template 
to be transcribed by T7 RNA polymerase. The DNA template produced 
was incubated with wheatgerm TNT extract (Promega). (B) TNT 
reaction mix (5 il) was fractionated by SDS-PAGE (Section 2.3.4.3) 
in a 4-12% polyacrylamide gel. The gel was then dried and proteins 
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To produce these proteins in vitro, a TNT transcription/translation system was used 
(Promega), placing a linear DNA template of the gene to be expressed under control of 
a T7 promoter upstream of the gene. The DNA templates for the LSM genes and for 
PRP24 were produced by PCR (Section 2.3.2.6) using synthetic oligonucleotides as 
primers (Figure 4.IA). This transcript was then produced using T7 polymerase and 
translated in the presence of [35S]-methionine. This allows the proteins to be visualised 
directly by SDS-PAGE (Section 2.3.4.3) and autoradiography following the translation 
reaction. 
It is important that in this coupled transcription/translation reaction, the DNA 
template does not contain any introns, as these will be transcribed but not spliced. This 
will result in the incorrect polypeptide being produced. Two of the LSM genes. LSM2 
and LSM7, each contains one intron. Fortunately, the cDNA of LSM7 had previously 
been cloned into pBTM1 16 (Table 2.1.10) to construct pAEM59 (A. Mayes, Ph.D. 
Thesis, 1998). LSM2 cDNA, however, had not previously been cloned. To produce 
LSM2 cDNA, RT-PCR was performed on mRNA using yeast total RNA as a template 
(Section 2.3.3.2). The synthetic oligonucleotide 3LSM2 (Table 2.1.7) was designed 
complementary to the 3' end of the LSM2 mRNA. This allows reverse transcriptase 
(Roche) to produce an antisense ssDNA copy of LSM2 that lacks the intron (Figure 4.2). 
This ssDNA was then used as a template in a PCR (Section 2.3.2.6) using as primers the 
oligonucleotides T7LSM2 and 3LSM2 that contain restriction sites at their 5' termini 
which allow the LSM2 cDNA to be cloned into pBMI25 (Table 2.1.10) to produce 
pT7LSM2 (Figure 4.2; Table 2.1.12). This vector could then either be subjected to PCR 
as before or linearised by restriction digest with SphI and used directly as a template for 
the in vitro transcription/translation reaction. 
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Figure 4.2 Cloning of LSM2 cDNA into pBM125. Oligonucleotide 
3LSM2 (Table 2.1.7) was annealed to the 3' end of the open reading 
frame of LSM2 mRNA in an incubation containing yeast total RNA. 
Reverse transcription was then performed (Section 2.3.3.2), creating a 
single stranded DNA (ssDNA) complementary to the LSM2 mRNA. 
RNA was then hydrolysed before the ssDNA was subjected to PCR 
(Section 2.3.2.6) using oligonucleotides T7LSM2 (Table 2.1.9) and 
3LSM2. This generated a LSM2 cDNA with a BamHI restriction site 
and T7 promoter upstream of the gene, and a EcoRl restriction site at 
the 3' end. The DNA fragment was digested (Section 2.3.2.4) with 
BarnHl and EcoRI and ligated (Section 2.3.2.9) into pBMI25 (Table 
2.1.10) that had previously been digested with BamHI and EcoRI, 
treated with alkaline phosphatase (Section 2.3.2.5) and gel purified 
(Section 2.3.2.8). 
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Several different systems are available commercially for the in vitro synthesis of 
proteins. In this study the rabbit reticulocyte system and the wheatgerm system were 
tested. As the Lsm proteins have molecular weights in the range 10-24 kDa, it was 
found that the rabbit reticulocyte expression system was not suitable due to a non-
specific contaminating band migrating at approximately 15 kDa that obscured the Lsm 
protein bands (data not shown). This 15 kDa band corresponds to the globin protein in 
the rabbit reticulocyte lysate which non-specifically interacts with tRNA, including that 
charged with 3 S-methionine. To avoid contamination with this non-specific band, a 
wheatgerm lysate was used, as this does not contain globin. Following the in vitro 
transcription/translation reaction, no contaminating band was seen at 15 kDa. 
When the Lsm proteins and Prp24p were produced in vitro (Figure 4.1) it was 
observed that not all of them resolved as a single band on SDS-PAGE (Section 2.3.4.3). 
In particular, DNA templates of LSM4 and LSM7 produced three polypeptides of 
differing sizes when transcribed and translated, with the LSM8 DNA template 
producing two. In each case, it is the band of highest molecular weight that corresponds 
to the correct size for the Lsm protein. The lower bands may correspond to the incorrect 
ATG initiation codon being used for translation. This is a common artefact using in 
vitro transcription/translation systems, and inspection of the corresponding sequences 
reveals that initiation of translation at downstream ATG triplets would result in the 
translation of polypeptides with the observed molecular weights. 
In addition, in vitro translated Lsm3p migrates with an anomolously high 
molecular weight (approximately 15 kDa compared to 10 kDa). It is not clear why this 
is the case: perhaps the LSM3 stop codon is not efficiently recognised by the wheatgerm 
lysate. Alternatively, Lsm3p may be post-translationally modified by the wheatgerm 
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lysate. The other Lsm proteins, however, migrated according to their predicted 
molecular weights. 
4.3 Expression of recombinant Lsm8p and Prp24p in E. coil 
To investigate further the assembly and function of the Lsm8 complex in vitro, it 
was decided to express recombinant His-tagged Lsm8p and Prp24p in E. co/i. This 
would allow the production of relatively large amounts of epitope-tagged protein for use 
in further experiments. PRP24 had previously been expressed as a recombinant protein 
in E. co/i using pIP24 (Table 2.1.11.; V. Vidal, Ph.D. Thesis, 1998) and produced by A. 
Diment (this lab), and this was used for subsequent experiments using recombinant 
Prp24p. 
It was chosen to produce recombinant epitope-tagged Lsm8p, rather than any 
other Lsm protein, as it is Lsrn8p that is specific to the Lsm8 complex, ensuring that any 
results were relevant for this complex, rather than the LsmI complex. To produce 
Lsm8p, the LSM8 gene was cloned into the suitable E. co/i expression vector pETI 9b 
(Figure 4.3) so that a T7 promoter and a penta-His epitope tag was positioned upstream 
of the gene. Lsm8p was firstly amplified using PCR (Section 2.3.2.6) using synthetic 
oligonucleotides designed to introduce a BamHI restriction site at both the 5' and the 3' 
end of the PCR product, which was subsequently digested. The vector was also digested 
with BamHI and the PCR product ligated into the vector. This resulted in the LSM8 
gene being out of frame with the T7 promoter and the penta-His epitope tag. To correct 
this, the NdeI restriction site was digested, and the resulting DNA overhangs filled in 
using Klenow DNA polymerase (Promega). The consequent blunt ends were ligated 
together to create plasmid pT7HisLSM8 (Table 2.1 .11) containing the T7 promoter and 
His5 epitope-tag in frame with the LSM8 gene. 
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Figure 4.3. Schematic showing the cloning of LSM8 into the MCS of 
pET19b. LSM8 DNA was amplified by PCR (Section 2.3.2.6) from 
pAEM70 (Table 2.1.11), using oligonucleotides BamLSM8F and 
BamLSM8R (Table 2.1.7). The DNA fragment produced was digested 
with BamHl (Section 2.3.2.4). Meanwhile, pETl9b (Table 2.1.10) was 
digested with BamHl, treated with calf intestinal phosphatase (Section 
2.3.2.5) and gel-purified (Section 2.3.2.8). Vector and LSM8 DNA 
were then ligated together (Section 2.3.2.9). The resulting plasmid was 
then digested with Mel, the overhangs filled in with Klenow 
(Promega) and the resulting blunt ends ligated back together. This 
produced pT7HisLSM8 (Table 2.1.11) containing LSM8 in-frame with 
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Figure 4.4. Production of recombinant Lsm8p in E. coil (Section 
2.3.4.5). (A) Schematic diagram showing the production and 
purification of recombinant Lsm8p. Plasmid pT7HISLSM8 (Table 
2. 1.11) was transformed (Section 2.2.3.2) into BL21 (DE3) cells 
(Table 2.1.5). IPTG was added to the medium, inducing His-tagged 
Lsm8p synthesis. The cells were then lysed, and the extract passed 
down a Ni-NTA column and eluted as in (B), resulting in purified 
His-Lsm8p. (B) Total protein extract was loaded onto a Ni-NTA 
column, the flow through (FT.) being collected. The column was 
then washed with 20 mM, then 55 mM imidazole. Finally, protein 
was eluted with 200 mM imidazole and collected in 1 ml fractions. 
Samples (20 j.tl) of flow through, wash fractions and elution 
fractions were subjected to SDS-PAGE (Section 2.3.4.3) and either 
Coomassie stained or subjected to Western blotting (Section 2.3.4.4) 
with anti-His antibodies (Table 2.1.13) and ECL (Section 2.3.4.4). 
The resulting gel (upper panel) and autoradiograph (lower panel) are 
shown. 
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To express this construct, pT7HisLSM8 was transformed (Section 2.2.4.1) into E. 
coli strain BL21 (DE3) (Table 2.1.5), which contains a gene to produce T7 polymerase, 
the expression of which is under the control of the IPTG-inducible iacUV5 promoter. 
Growth in the presence of IPTG leads to the production of T7 polymerase and, thus, the 
production of epitope-tagged Lsm8p (Figure 4.4A). In addition, the strain is deficient 
for both ion and ompT proteases, reducing the degradation of the recombinant protein. 
The expressed recombinant protein was then extracted and purified (Section 2.3.4.5). 
Five microlitres of each fraction was subjected to SDS-PAGE (Section 2.3.4.3), stained 
with Coomassie Blue or Western Blotted (Section 2.3.4.4). Coomassie Blue staining 
(Figure 4.413, top panel) revealed that the Lsm8p preparation was contaminated with a 
small number of other polypeptides: these could be other contaminating proteins or 
degradation products of Lsm8p itself. Western blotting, however, confirms that only 
one of these proteins contains a His-epitope tag (Figure 4.413, bottom panel). Therefore, 
despite a small amount of contamination by other proteins, as none of these contain a 
His-epitope tag and consequently should not affect the results of any immunoassays 
using His-Lsm8p, it was decided that this partially purified protein was suitable for use. 
4.4 Immunoprecipitation of in vitro translated Lsm proteins 
with recombinant epitope-tagged proteins 
Using both recombinant proteins expressed in E. co/i and in vitro translated 
proteins, the interactions between the different protein components of the U6 snRNP 
were investigated. Firstly, it was investigated which of the Lsm proteins, if any, interact 
directly with Prp24p. To do this, immunoprecipitations were performed using His-
tagged recombinant Prp24p and in vitro translated Lsm proteins (Section 2.3.4.6). It can 
be seen in Figure 4.5A (top panel) that Lsm3p, Lsm4p, Lsm5p, Lsm6p and Lsm8p 
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Figure 4.5. Immunoprecipitation (Section 2.3.4.7) of Lsm proteins 
with His-tagged Prp24p. (A) Approximately I .ig  of His-Prp24p was 
added to 10 tl of in vitro synthesised Lsm protein and incubated on ice 
for 10 minutes. Following this, anti-His antibodies (Table 2.1.13) were 
added to the samples where indicated, and incubated for 1 hour at RT. 
Swollen protein A-Sepharose beads were added and re-incubated for 1 
hour. These were then pelleted and the pellets and supernates 
investigated for the presence or absence of Lsm proteins. The resulting 
autoradiographs are shown. (B) Amino acid sequence of Lsm8p. The 
mutation in LSM8-2 is indicated and the deleted amino acids are shown 
in bold. (C) Co-immunoprecipitation of His-tagged Prp24p and Lsm8p 
or Lsm8-2p was performed as in (A). 
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individually co-immunoprecipitate with Prp24p, whereas Lsmlp, Lsm2p and Lsm7p do 
not. As only a subset of the Lsm proteins was precipitated, these interactions must be 
specific and not due to non-specific interactions with the Sm-like motif. In addition, all 
the Lsm proteins were stable and not degraded as they could be visualised in the 
supernates (Figure 4.5A bottom panel). The Lsrn proteins which were co-
immunoprecipitated in vitro may be the Lsm proteins that directly contact Prp24p in the 
in vivo U6 snRNP, although this might not be the case if Lsm-Lsm interactions alter 
their affinity for Prp24p. As only individual Lsm proteins were added in this 
experiment, alterations in the binding specificity of Prp24p due to other Lsm proteins 
being present will not be observed. Interestingly, Prp24p interacts with Lsm8p, but not 
Lsrnlp, in this assay. This might be why Prp24p interacts with the Lsm8 complex but 
not the LsmI complex in vivo. 
We next wondered whether the C-terminus of Lsm8p was required for the 
interaction of Lsm8p with Prp24p. This was because a mutation in LSM8 that results in 
a C-terminal truncation of Lsm8p (named LSM8-2; Figure 4.513) is synthetic lethal with 
lhpl (Pannone et al., 2001). A linear DNA template for the production of Lsm8-2p was 
constructed by using the synthetic oligonucleotides T7LSM8 and 3'LSM8-2 (Table 
2.1.9) in PCR (Section 2.3.2.6) Immunoprecipitations were performed using His-tagged 
Prp24p and in vitro translated Lsm8p and Lsm8-2p (Figure 4.5C). Both Lsrn8p and 
Lsm8-2p are efficiently immunoprecipitated with His-tagged Prp24p. This demonstrates 
that Lsm8p does not interact with Prp24p via its C-terminus. 
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Figure 4.6. Co-immunoprecipitation (Section 2.3.4.7) of Lsm proteins 
with His-tagged Lsm8p. Approximately 1 jig of Es-Prp8p was added 
to 10 j.tl of in vitro synthesised Lsm protein (Section 2.3.4.6) and 
incubated on ice for 10 minutes. Following this, anti-His antibodies 
(Table 2.1.13) were added to the samples where indicated, and 
incubated for 1 hour at RT. Swollen protein A-Sepharose beads were 
added and incubated for 1 hour. These were then pelleted and the 
pellets and supernates subjected to SDS-PAGE (Section 2.3.4.3). The 
resulting autoradiographs are shown 
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It was then investigated by immunoprecipitation (Section 2.3.4.7) which of the in 
vitro translated Lsm proteins associate directly with recombinant Lsm8p (Figure 4.6, 
top panel). Lsm8p specifically co-precipitated Lsm3p, Lsm4p and Lsm7p, but not 
Lsm2p, Lsm5p or Lsm6p (top panel). As previously, however, only individual in vitro 
translated Lsm proteins were added in this experiment, so differences in the binding 
specificity of Lsm8p to Lsm2-7p due to other Lsm proteins will not be seen. Again, the 
failure to precipitate Lsm2p, Lsm5p and Lsm6p was not due to protein degradation, as 
the proteins were present in the supernates (Figure 4.6, bottom panel). 
4.5 Assembly of the proteins into a higher-order complex 
Next it was investigated whether the Lsm proteins could assemble into a higher 
order complex in the absence of any other RNA and protein components. To investigate 
this, His-tagged recombinant Lsm8p was incubated with in vitro translated Lsm2-7p 
inclusively, both in the presence and absence of Prp24p and in vitro transcribed U6 
RNA (Section 2.3.3.7). His-tagged Lsm8p and associated factors were 
immunoprecipitated (Section 2.3.4.7) and subjected to SDS-PAGE (Section 2.3.4.3) and 
autoradiography to detect which of the [35S]-labelled proteins were co-
immunoprecipated. From this it could be inferred which complexes were forming in 
vitro. It was found that all the Lsm proteins were co-precipitated with His-tagged 
Lsm8p in the absence of both U6 RNA and Prp24p (Figure 4.7, Lane 2). As Lsm8p 
failed to co-precipitate all of the Lsm proteins individally (Figure 4.6) this suggests that 
one (or more) Lsm complexes are being precipitated. No greater efficiency of 
precipitation was observed following the addition of U6 RNA (Figure 4.7. Lane 3). This 
suggests that this complex(es) assembles prior to binding to the U6 RNA in vivo. This 
complex(es) also interacts directly with Prp24p in the absence of U6 RNA (Figure 4.7, 
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Figure 4.7. Assembly of a higher-order Lsm complex(es) in vitro. His 
-tagged Lsm8p (1 pg) was incubated in the presence of 5 tl of 355 
radiolabelled in vitro synthesised Lsm2-7p (Section 23.4.6) inclusive 
in the absence (lanes 2 and 4) or presence (lanes 3 and 5) of U6 RNA 
and the absence (lanes 2 and 3) or presence (lanes 3 and 4) of in vitro 
translated Prp24p. Lsm8p was immunoprecipitated (Section 2.3.4.7) 
with anti-His antibodies (Table 2.1.13), samples denatured and 
fractionated by SDS-PAGE (Section 2.3.4.3). The resulting gel was 
dried and proteins visualised by autoradiography. 
128 
Lane 4), indicating that there is a direct protein-protein interaction between this Lsm 
complex and Prp24p in the absence of U6 RNA. This interaction is not enhanced by the 
addition of U6 RNA (Figure 4.7, Lane 5). 
4.6 Interaction of the Lsm complex with U6 RNA 
As U6 RNA did not enhance the interaction of either Lsm8p with the other Lsm 
proteins, or the higher-order Lsm complex with Prp24p, it was investigated whether this 
complex interacted with U6 RNA in vitro. To study this, a gel-shift assay was used 
(Figure 4.8). If Lsm2-8p bind to the U6 RNA, then a band migrating with reduced 
mobility should be visible. If the in vitro translated Lsm proteins form only one that is 
capable of binding to U6 RNA, then a single shifted band will be present. It could be 
clearly seen that, at high Lsm2-8p concentrations (50 ng per protein), there was a single 
band-shift (Figure 4.8A). This may represent the Lsm8 complex bound to U6 RNA. At 
lower concentrations of Lsm2-8p (10, 2 and 0.5 ng per protein) there appeared to be a 
lower proportion of the total U6 RNA shifted, indicating that it was an Lsrn complex 
that was binding to the U6 RNA, rather than other factors present in the wheatgerm 
lysate. A 20-fold excess of unlabelled U6 snRNA competed for this binding as 
following its addition, the radiolabelled U6 RNA was no longer shifted (Figure 4.813). 
In contrast, I g of unlabelled US RNA (R. Grainger, this lab) did not compete with the 
radiolabelled U6 (data not shown). This demonstrates that the Lsm8 complex can bind 
to U6 RNA in vitro, without the need for other factors, implying that other factor(s) 
might not be needed for the binding of the Lsm complex to U6 RNA in vivo. 
The ability of a subset of Lsm proteins to interact with U6 RNA was also studied 
(Figure 4.8C). When any of the Lsm proteins was omitted from the incubation, no gel-
shift of the radiolabelled U6 RNA was observed, showing that all of the Lsm proteins 
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Figure 4.8. Gel shift of U6 RNA with the Lsm proteins. (A) 
Approximately 50 ng of radiolabelled U6 RNA was added to 
between 0.5 and 50 ng each of Lsm2-8p and incubated at 24°C for 
60 minutes Samples without Lsm2-8p were also incubated.. Samples 
were then subjected to electrophoresis on a 6% 0.5x TBE gel and 
subject to autoradiography. (B) Samples were treated as in (A) but 
with the addition of I jig of unlabelled U6 RNA to the reaction. (C) 
Samples were treated as in (A), but one Lsm protein was omitted 
from each reaction, as indicated. 50 ng of each Lsm protein used 
was added. 
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are necessary for binding to U6 RNA in vitro. This indicates that the in vitro translated 
Lsm proteins must form a structure consisting of all seven Lsm proteins, as otherwise 
single Lsm proteins would be able to be omitted without loss of binding to U6 RNA. 
This probably represents the Lsm8 complex found in vivo. 
4.7 Reconstitution of splicing using in vitro translated 
proteins 
Using large-scale yeast extract preparations for studying pre-mRNA splicing in 
vitro (Section 2.3.3.6) is a useful and well established technique (Lin et al., 1985 
Fabrizio et al., 1989). It has previously been shown that yeast extracts derived from 
cells containing either a chromosomal LSM6 deletion (lsm6zl; AEMY 19 (Table 2.1.6)) 
or a chromosomal LSM7 deletion (lsm7zi; AEMY22 (Table 2.1.6)) can splice in vitro-
transcribed ACT] pre-mRNA. Previous data, however, suggested that lsm6A and Ism 7A 
extracts could only support splicing during an initial incubation (L. Verdone & J. D. 
Beggs, unpublished data). To assay for multiple splicing incubations, extracts are first 
pre-incubated with unlabelled ACT] pre-mRNA. This was efficiently spliced in wild 
type, lsmOzl and 1sm7zl extracts. Because the in vitro splicing reaction is allowed to go 
to completion, the majority of the splicing machinery in the extract would be used. The 
extract was then re-incubated under splicing conditions with the addition of [12p]_ 
labelled ACT] pre-mRNA. If this is efficiently spliced then splicing intermediates and 
products can be detected by autoradiography. If not, then just ACT] pre-mRNA will be 
visible (Figure 4.9). 
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Figure 4.9. Schematic diagram showing assay to detect multiple 
rounds of in vitro splicing. Splicing extract was incubated under 
splicing conditions (Section 2.3.3.6) in the presence of unlabelled 
ACT] pre-mRNA (Section 2.3.3.5). Following this initial splicing 
incubation, [32P]-labelled ACT] pre-mRNA (Section 2.3.3.5) was 
added and incubated under in vitro splicing conditions. Products 
were then separated on a 7% polyacrylamide-urea gel and visualised 
by autoradiography. If the radiolabelled transcript was spliced, 
splicing intermediates and mature ACT] mRNA would be observed, 
otherwise only ACT] pre-mRNA would be present. 
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The inability of 1sm6zl and ism 7A extracts to perform multiple rounds of splicing 
could have been due to two factors. Firstly, U6 snRNA might have been too unstable in 
1sm6i.1 and 1sm7zi extracts to support two subsequent rounds of splicing. Alternatively, 
there may be a factor that was not recycled correctly in lsm6zl and 1sm7zl extracts and 
becomes limiting, thus preventing further splicing. 
It was tested whether the in vitro translated Lsm proteins were functional by 
adding back Lsm6p or Lsm7p to 1sni6zl and 1sm7zl extracts respectively. This should 
restore splicing of the labelled ACT] pre-mRNA, allowing splicing intermediates and 
products to be visualised. In addition, this assay can be used to distinguish whether 
lsm6zl and lsm7zl extracts are defective for multiple rounds of splicing due to instability 
of U6 snRNA or due to the inability to recycle an essential splicing factor or co-factor. 
This can be achieved by adding the in vitro translated Lsm protein directly after the first 
incubation with unlabelled pre-mRNA, but before the addition of labelled ACT] pre-
mRNA, and observing whether the Lsm proteins can complement the defect. If so, then 
the inability to splice labelled ACT] transcript in 1sm6zl and lsm7zl extracts cannot be 
due to the instability of U6 snRNA, as if this were the case, the U6 snRNA would have 
been degraded during splicing of the unlabelled ACT] pre-mRNA. Addition of Lsm6 or 
Lsm7 protein to the extract before the second incubation, however, would permit 
recycling of factors in the splicing pathway, restoring the extracts' ability to support 
splicing. 
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Figure 4.10. Lsm6p and Lsm7p can restore the ability of lsm6A and lsm7A extracts respectively to splice during 
multiple incubations. Extract prepared (Section 2.3.42) from either wild-type (BMA64; Table 2.1.6), lsm6z 
(AEMY19; Table 2.1.6) or 1sm7z (AEMY22, Table 2.1.6) strains was incubated under in vitro splicing 
conditions (Section 2.3.3.6.) either in the presence or absence of unlabelled ACT] pre-mRNA (Section 2.3.3.5), 
as indicated for 30 minutes. Two microlitres of in vitro translated Lsm6p or Lsm7p (Section 2.3.4.6), or mock 
reaction, were then added to samples as indicated. Samples were then incubated under splicing conditions with 
[32P]-labelled ACT] pre-mRNA for 30 minutes. RNA was then analysed on a 7% poyacrylamide-urea gel and 
subjected to autoradiography. The resulting autoradiogram is shown. 
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The results from this experiment are shown in Figure 4.10. It can be seen in lanes 1 
and 2 that yeast extract from wild-type cells containing all the Lsm proteins can 
efficiently support splicing through two incubations. It is clear, however, that lsm6zl and 
1sm7A extracts cannot, as pre-incubation of extract with unlabelled ACT] pre-mRNA 
abolishes the extracts' ability to subsequently splice labelled ACT] pre-mRNA (lanes 4 
and 8). Strikingly, however, addition of in vitro expressed Lsm6p or Lsm7p to 1sm6zl or 
lsm7A extracts respectively after the first incubation restored the ability of these extracts 
to perform a second round of splicing (lanes 5 and 10), demonstrating that in vitro 
expressed Lsm6p and Lsm7p are functional. This is highly specific and not due to a 
component of the in vitro transcription/translation mixture as addition of Lsm7p does 
not restore the ability of an lsm6zl extract to splice (lane 6) or visa versa (lane 9). 
Significantly, because the in vitro translated protein was added after the first round of 
splicing in each case, the inability to splice the radiolabelled ACT] pre-mRNA must be 
due to the inability to recycle a specific factor or factors back into the splicing pathway. 
Later chapters will investigate the identity of this factor(s). 
4.8 Discussion 
To study the functions and interactions of the Lsm8 complex more 
systematically, it was decided to look at the interactions in vitro rather than in vivo, 
allowing a more detailed study of Lsm function to be investigated. Two approaches 
were used; in vitro coupled transcription/translation to synthesise 35 S-labelled proteins, 
and the production of recombinant His-tagged Lsm8p and Prp24p in E. coli. These two 
methods have allowed a wide variety of experiments to be performed, as described in 
this chapter and in chapter 5. 
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The use of in vitro translated Lsm proteins as an experimental tool has been 
justified by showing that in vitro translated Lsm6p and Lsm7p are functional. This has 
been demonstrated by reconstituting the ability of 1sm6zl and 1sm7zi extracts to perform 
multiple rounds of splicing (Figure 4.4) with in vitro translated Lsm6p and Lsm7p 
respectively. This experiment also demonstrates that the Lsm8 complex is important for 
recycling a particular factor, or factors, through the splicing cycle. As these proteins 
bind to U6 snRNA, this is a good candidate for such a factor. Interestingly, the other 
factor present in the U6 snRNP, Prp24p, is believed to be involved in recycling U6 
through the splicing cycle by promoting the annealing of U6 snRNA to U4 snRNA, 
facilitating di-snRNP formation. The possibility of the Lsm proteins also being involved 
in this process is investigated in the next chapter. 
The use of these in vitro components has allowed the assembly pathway of the 
Lsm8 complex to be elucidated in some detail. It has been shown that in vitro translated 
Lsm proteins can assemble into at least one higher-order Lsm complex (Figure 4.7). 
Gel-shift experiments have demonstrated that only one Lsm complex is formed that is 
capable of interacting with U6 RNA (Figure 4.8A & 4.813) and, given that all seven of 
the Lsm proteins are essential for this interaction (Figure 4.8C) this strongly suggests 
that the complex formed by Lsm2-8p is the heptameric Lsm8 complex. In addition, this 
complex can assemble in the absence of U6 RNA (Figure 4.7). This is consistent with 
previous data demonstrating that the heptameric ring formed by the Lsm proteins can be 
purified and visualised by electron microscopy in the absence of RNA in HeLa cells 
(Achsel et al., 1999). Significantly though, these results are the first to indicate that the 
Lsm8 complex may assemble in the absence of U6 snRNA. This is in contrast to the 
canonical Sm complex assembly pathway in higher eukaryotes which involves the 
assembly of three sub-complexes; the B/B'Dl dimer, the D2D3 dimer and the EFG 
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trimer, in the absence of U snRNA. Only in the presence of an Sm site can these 
subcomplexes assemble into a heptameric ring. The Lsm8 complex differs from the Sm 
complex, however, as the former binds to the 3' end of the U6 RNA, whereas the latter 
interact with the Sm site, which is located at an internal position within the U snRNA, 
surrounded by secondary structure. Assuming that the RNA passes through the 
positively charged hole at the centre of the heptameric ring, the Sm proteins are required 
to assemble onto the Sm site. A fully assembled ring would not be capable of 
"threading" onto the RNA, as it would be inhibited by the RNA's secondary structure. In 
contrast, the Lsm proteins can assemble into a complex then bind to the 3' end of U6. 
The assembly of the Sm proteins into a functional snRNP is also dependent on 
other proteins, notably SMN1 (Liu et al., 1997), and the Gemin proteins (Fischer et al., 
1997; Chapter 1.4). In contrast, there does not appear to be any other factor that is 
required for the assembly of the yeast Lsm8 complex (Figure 4.7), although it cannot be 
ruled out that other factors present in the wheatgerm lysate may facilitate complex 
assembly. It is not known whether in yeast the Sm complex itself requires any auxiliary 
factors for assembly. The assembly pathway is probably not similar to that in 
mammalian cells, as there does not appear to be a yeast homologue of SMN I. It may be, 
however, that other proteins do not facilitate the assembly pathway of the yeast Sm or 
the Lsm complexes. Alternatively, it may be that other protein factors are needed for the 
assembly of these complexes in vivo. The Sm assembly pathway may be sufficiently 
different from the mammalian pathway that the proteins are not readily identifiable by 
homology searching. In addition, it may be that, in vivo, the Lsm proteins may need 
other factors to assist in complex assembly that are not required in vitro. This could be 
to assist the specificity of complex formation, as there will be other proteins containing 
Sm motifs in vivo. Perhaps other proteins are required to ensure that the mis-
incorporation of other proteins into the complex does not occur. 
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For binding of the Lsm8 complex to U6 RNA to occur, it is shown that all seven 
components of the Lsm8 complex must be present in vitro (Figure 4.8C). This is in 
contrast with the situation in vivo, where 1sm6zl and lsm7zl cells are viable (Mayes et 
al., 1999) suggesting that, in the absence of Lsm6p or Lsm7p, the remaining Lsm 
proteins may still interact with U6. This has been confirmed by co-precipitation of U6 
snRNA with anti-Lsm4p antisera (Vidal et al., 1999). It is possible that in the absence 
of Lsm6p or Lsm7p the remaining Lsm proteins bind to U6 as an incomplete ring. If 
this is the case, then perhaps other factors can facilitate this interaction that are not 
present in the in vitro experiments. Alternatively, it is possible that another protein 
containing an Sm-motif can substitute for Lsm6p or Lsm7p in the ring. This is 
intriguing given that Lsm 10 has been shown to interact with canonical Sm proteins in 
the U7 snRNP in Hela cell extracts (Pillai et al., 2001), indicating that Sm proteins can 
make heterogeneous interactions with multiple partners. As the other Sm proteins are 
not present in vitro, this would explain why all the Lsm proteins are required for U6 
binding. 
In addition, specific interactions between Lsm8p and the other Lsm proteins 
have been investigated in vitro, using His-tagged Lsm8p and 35 S-labelled Lsm2-7p. 
Using this method it appears that Lsm8p specifically interacts with Lsm3p, Lsm4p and 
Lsm7p. This is in contrast to the model suggested by Pannone et al. (2001) which was 
based on the suggested positions of the canonical Sm proteins in the seven-membered 
ring and positions Lsrn2p and Lsm4p adjacent to Lsm8p. This discrepancy can be 
explained in several ways. Firstly, If there is a sequential order of assembly of the Lsm8 
complex, it is possible that Lsm2p needs to interact with another Lsm protein before 
interacting directly with Lsm8p. This would be similar to Sin complex assembly, which 
proceeds by the sequential assembly of sub-complexes before ring formation. 
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Alternatively, the relative positions of the Lsm proteins in the heptameric ring may not 
be identical to the positions of their analogues in the Sm ring. Whatever the case, it 
would appear that Lsm8p interacts with more than the Lsm proteins either side of it in 
the ring, as His-tagged Lsm8p co-immunoprecipitates Lsm3p, Lsm4p and Lsm7p 
(Figure 4.6). At least one of these interactions must require contacts other than those 
due to Sm-like motifs, as otherwise only two Lsm proteins could interact with Lsm8p. 
This additional interaction may be due to interactions with the N-terminus or the C-
terminus of Lsm8p. The latter suggestion is intriguing as it was suggested previously 
that the C-termini of several Lsm proteins, including Lsm8p, might interact to form a 
functional nuclear localisation sequence (Section 3.4). The C-terminus of Lsm8p must 
have some function, as deletion of the last 10 amino acids of Lsm8p (named Lsm8-2p) 
confers a requirement for Lhplp for growth of yeast cells (Pannone et aL, 2001). The 
function would appear not to be to interact with Prp24p, as both Lsm8p and Lsm8-2p 
can co-immunoprecipitate with His-tagged Prp24p with similar efficiency (Figure 
4.5C). Therefore, this function is possibly related to interactions with other Lsm 
proteins and/or nuclear import. 
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The annealing of U4 and U6 RNAs in vitro 
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5.1 Introduction 
Following the discovery in Chapter 4 that the Lsm proteins have a role in 
recycling an essential splicing factor, we wished to identify this factor. Possibly the 
best known candidate for this factor was U6 snRNA as the Lsm8 complex is known 
to interact directly with U6 and the stability of U6 is ism-dependent (Cooper et al., 
1995, Mayes et al., 1999). The U6 snRNP does, however, undergo a complex cycle 
of events through the splicing pathway, being present as free U6 snRNP, a di-snRNP 
with U4 snRNP, a U5.U4/U6 tri-snRNP, as well as forming molecular 
rearrangements and base-pair interactions with U2 snRNA in the spliceosome. 
Little information is available about the cycling of U6 snRNA, with the 
exception of U4/1J6 di-snRNP formation. In particular, Prp24p has been identified as 
a factor required for U4/U6 di-snRNP formation in vivo (Ghetti et al., 1995; 
Raghunathan & Guthrie, 1998, Lygerou et al., 1999). Despite this apparent role of 
Prp24p, further evidence suggested that other protein factors must also be involved in 
U4/U6 di-.snRNP formation. One main piece of evidence was that, despite the ability 
of Prp24p to reconstitute U4/U6 di-snRNP formation in Prp24p-depleted extracts 
(Raghunathan & Guthrie, 1998), the process was less efficient following 
deproteinisation of the extracts. This indicated that other snRNP proteins must 
contribute to this process. Recombinant Prp24p from E. coli has also been shown to 
facilitate U4/U6 RNA duplex formation in vitro (Ghetti et al., 1995). This result, 
however, may not be relevant in vivo as the Prp24p concentration used in these 
experiments was very high (80 nM). It may be that Prp24p moderates the kinetics of 
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di-snRNP formation, rather than directly annealing U4 and U6 snRNA because, in 
the experimental conditions used by Ghetti et al. (1995), U4 and U6 will form an 
RNA duplex, even in the absence of Prp24p, but with slower kinetics. Given that the 
human LSm complex promotes U4/U6 duplex formation in vitro (Achsel et al., 
1999), it was wondered whether the yeast Lsm8 complex was involved in facilitating 
U4/U6 RNA duplex formation. This possibility is investigated in this chapter. 
5.2 Formation of the U4/U6 duplex in the presence of in 
vitro translated Lsm proteins 
To investigate the ability of the Lsm proteins to facilitate U4 and U6 RNA 
duplex formation, it was decided to develop an in vitro system using in vitro 
transcribed U4 and U6 snRNA as well as in vitro translated Lsm proteins (Section 
4.2) rather than using purified Lsm complexes from yeast. This was for several 
reasons. Firstly, in vitro translated proteins were easily produced (Figure 4.1) in the 
absence of other contaminating yeast proteins. Also, they were biochemically 
functional (Figure 4.10), forming complexes (Figure 4.7) that interacted specifically 
with U6 RNA (Figure 4.8). In addition, the effect of individual Lsm proteins could 
be investigated by omitting them from the assay (see below). This would not be 
possible with a purified Lsm complex. In vitro translated Prp24p was also tested for 
its ability to form U4/U6 RNA duplexes. 
An assay system was developed in which the U4 and U6 RNAs were incubated in 
the presence or absence of Lsm proteins and/or Prp24p (Section 2.3.3.9). U4 RNA 
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was added in 10-fold excess (Achsel et al., 1999), as it was thought that this might be 
needed to drive the reaction towards the formation of a U4/U6 duplex in the absence 
of any U4 snRNP proteins. Samples were subsequently deproteinised and the RNA 
was resolved on a non-denaturing gel (Section 2.3.3.4). Following Northern blotting 
(Section 2.3.3.4) the membrane was probed with the radiolabelled oligonucleotide 
probe W3464 (Table 2.1.8), which hybridises specifically to nucleotides 33-53 of U6 
RNA, which are single stranded in both free U6 and U41U6 duplexes, allowing both 
species to be visualised (left-hand panel). 
To ensure that any slower migrating bands were U4/U6 duplexes and not just 
U6 snRNA folded into a different conformation, the membrane was stripped (Section 
2.3.3.3) and reprobed using the oligonucleotide G6568 complementary to U4 RNA 
(right-hand panel). This hybridised to a U4 containing species migrating at the same 
position as the U6-containing band. This was good evidence that this slower 
migrating species was indeed a U4/U6 RNA duplex. 
As expected, when no Lsm proteins or Prp24p was added to the annealing 
assay, only free U6 RNA could be visualised (Figure 5.1, Lanes 1 and 5). 
Surprisingly, however, when in vitro translated Prp24p was added to the assay there 
was still no detectable level of U4/U6 duplex formed (Lanes 2 and 6). This was 
unexpected, as previous data suggested that Prp24p could directly anneal U4 and U6 
RNA in vitro (Raghunathan & Guthrie, 1998; Ghetti et al., 1995). In contrast, U4 and 
U6 RNA form a duplex in the presence of the Lsm8 complex (Lanes 3 and 7). This 
indicates that the Lsm8 complex is necessary and sufficient for the annealing of U4 
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Figure 5.1. The role of the Lsm proteins in annealing U4 and U6 
RNA in vitro. (A) 5 p.1 of lOx RNA annealing buffer (Section 
2.3.3.9) was added to 5 p.1 of each of in vitro translated Lsm2-8p 
with 5 p.1 of in vitro transcribed Prp24p where indicated. 
Approximately 10 ng of U6 RNA and 100 ng of U4 were added and 
the volume made up to 50 p.1. Samples were incubated for 60 
minutes before being treated with 3 p.! of 1 mg/ml proteinase K for 
40 mm. RNA was then phenol/chloroform extracted (Section 
2.3.1.2), precipitated (Section 2.3.1.3) and subject to electrophoresis 
on a 10% non-denaturing polyacrylamide gel. RNA was then 
transferred by Northern blotting (Section 2.3.3.3) to Hybond-N 
membrane (Amersham) before being probed with the 5'-end 
radiolabelled oligonucleotide W3464 (Table 2.1.8). (B) The 
Northern blot from (A) was stripped and reprobed for U4 RNA with 
the 5'-end radiolabelled oligonucleotide G6568 (Table 2.1.8). 
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and U6 RNAs in vitro. U4 and U6 RNAs also form a duplex in the presence of Lsm 
proteins following the addition of Prp24p to the reaction (Lanes 4 and 8). There was 
a small but reproducible increase in the efficiency of annealing in the presence of 
Prp24p (Lanes 3 and 4) suggesting that Prp24p may play a role in facilitating U4/U6 
duplex formation, but this role is not essential for the process to occur. Conversely, 
these data suggest that the Lsm8 complex is both necessary and sufficient for stable 
U4/U6 duplex formation. Although previous data suggested that purified human 
LSm complexes could facilitate U4/U6 duplex formation in vitro (Achsel et al., 
1999), this is the first time that such an activity has been reported in yeast. It is not 
clear, however, at what stage of U4/U6 duplex formation the Lsm proteins may be 
functioning. It is possible that they facilitate U6 unwinding, therefore destabilising 
the free U6 RNA and promoting U4/U6 annealing. Alternatively, they may directly 
facilitate the formation of base-pairs between U4 and U6 RNA. The final possibility 
is that they might bind to the annealed U4/U6 duplex, stabilising it and preventing it 
disassociating into free U4 and U6 RNA. 
Using the in vitro assay for U4/U6 duplex formation, it was then investigated 
which of the Lsm2-8 proteins were essential for this process to occur in vitro, by 
excluding one of the Lsm proteins from the assay (Figure 5.2). This was performed 
for all seven of the Lsm proteins present in the Lsm8 complex, and the RNA was 
analysed as before (Figure 5.2). When the blot was probed for U6 RNA (Table 2.1.8) 
it could be seen that U4/U6 duplex was only formed when all seven Lsm proteins 
were present. When any one of the seven Lsm proteins was omitted, the U4/U6 RNA 
duplex was not observed. This is not because of U6 RNA instability, as free U6 
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Figure 5.2. U4 and U6 RNAs do not anneal in the absence of any one of 
the Lsm2-8 proteins in vitro. Samples were treated as in Figure 5. 1, with 
the exception that, in the lanes missing an Lsm protein, 5 p.i of mock 
transcription/translation mix was added instead. Following Northern 
blotting, samples were probed with the S'end labelled oligonucleotide 
W3464 (Table 2.18).  
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could be observed in the absence of Lsm protein. This result is consistent with the 
previous demonstration that the Lsm proteins cannot bind to U6 RNA when one of 
the Lsm proteins is omitted in vitro (Figure 4.8). Even though lsm6zl and 1sm7zi cells 
contain U4/U6 RNA duplexes in vivo (Mayes et al., 1999), Lsm8 complexes with 
either Lsm6p or Lsm7p omitted do not support this, presumably because the Lsm 
proteins need to bind to U6 to function. Alternatively, the Lsm8 complex may be 
able to function without binding to U6, but other factors may be required that are not 
in the in vitro assay. 
5.3 The U4/U6 duplex has the same melting temperature as 
wild-type U4/U6 RNA 
Although it was shown in Section 5.2 that the Lsm proteins can anneal U4 
and U6 RNA to form a U41U6 particle, it was not certain that the duplex formed was 
identical to wild type U4/U6 duplex, or whether the U4/U6 particle was mis-folded 
or incorrectly annealed. Furthermore, it was possible that (during the experimental 
procedure) the RNA could have folded into its most stable, lowest energy state when 
the samples were deproteinised, i.e. the wild type U4/U6 duplex (D. Brow, personal 
communication). To test this, U4 and U6 RNAs were annealed in vitro (Section 
2.3.3.9) and then incubated at a range of different temperatures for 1 hour prior to 
deproteinisation. This was performed to determine the melting temperature of the 
RNA duplex in the U4/U6 RNP particles. Free U6 RNA and U4/U6 particles could 
then be visualised as before (Figure 5.3A). Below 55°C, the U4/U6 duplex was 
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Figure 5.3. Melting curves of U4/U6 duplexes formed in vitro and 
in vivo. (A) U4 and U6 RNAs were annealed as in Figure 5. 1. 
Samples were then heated for 1 hour at the indicated temperature 
before being treated with 1 p.1 of 1 mg/ml proteinase K and subject 
to electrophoresis on a 10% non-denaturing polyacrylamide gel 
(Section 2.3.3.4). RNA was then transferred by Northern blotting 
(Section 2.3.3.3) to a Hybond-N membrane (Amersham) before 
being probed with the 5'-end radiolabelled oligonucleotide W3464 
(Table 2..1.8). (B) 5 p.1 of BMA64 (Table 2.1.6) whole yeast extract 
(Section 2.3.4.2) was incubated at the indicated temperature for I 
hour. Samples were then treated as in (A). 
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stable. When the complex was heated above 55°C, however, there appeared to be no 
U4/U6 present and a corresponding increase in the levels of free U6 RNA. This 
indicated that the melting temperature of the U41U6 particle formed by the Lsm 
proteins was 55°C. 
To determine the melting temperature for the wild type U4/U6 duplex in 
yeast extract, 5 p l of BMA64 extract prepared from BMA64 cells (Table 2.1.6) was 
heated identically to the in vitro annealed U4/1J6 particles and the U6-containing 
complexes were analysed. Similarly to in vitro annealed U41U6 RNA, the U4/U6 
duplex is stable below 55°C but above this temperature the duplex is not present 
(Figure 5.3B). There is a corresponding increase in free U6 RNA, demonstrating that 
the duplex is unwound, rather than digested by RNases or degraded due to the heat 
treatment. This shows that the melting temperature for wild type U4/U6 RNA is also 
approximately 55°C. This is similar to the melting temperature of 53°C previously 
calculated for the deproteinised U4/1J6 duplex (Brow & Guthrie, 1988). It is possible 
that the Lsm8 complex stabilises the duplex, slightly increasing the melting 
temperature. 
These data indicate that there is very good agreement between the melting 
temperatures of the in vitro annealed U4/U6 particle and the wild-type U4/U6 
duplex. As the two melting temperatures are very similar, it is probable that the 
U4/U6 particle formed in vitro is likely to be a U4/U6 duplex with the same base-
pair interactions as the U4/U6 RNA duplex. 
If the Lsm proteins were responsible for the annealing of U4 and U6 RNA in 
vitro, this may also be the case in vivo. If the base-pairing between the two RNA 
molecules were disrupted in 1sm6ii and 1sm7zl strains, this might result in a decreased 
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melting temperature, which could be investigated in the assay used above. Therefore, 
lsm6d and lsm7i extracts were treated identically to the previously analysed wild-
type BMA64 extract (see above). The U4/U6 duplex in the lsmM extract showed an 
identical melting temperature of 55°C for compared to the wild-type extract (Figure 
5.4A), with a corresponding increase in free U6 RNA above this temperature. 
When the lsm6zi extract was heated between the previously defined 
temperatures, however, there was no signal corresponding to either free U6 snRNA 
or U4/U6 duplex (data not shown). The lack of free U6 in the extract was not 
surprising as it has been shown previously that free U6 snRNA in 1sm6zl cells is very 
unstable and cannot be detected by Northern blotting (Mayes et al., 1999). It was 
considered significant, however, that no U4/U6 RNA duplex could be detected at 
these temperatures. This could be because, in this extract, the U4/U6 duplex may be 
base-paired incorrectly, resulting in a lower melting temperature. To test this, the 
stability of the U4/U6 duplex in the 1sm6zi extract was incubated over a lower range 
of temperatures (Figure 5.413). From this, it was clear that the U4/U6 duplex from 
the lsm6A extract was only stable below 32°C. Above this temperature, the level of 
U4/U6 duplex was greatly reduced, being completely undetectable above 42°C. 
Therefore, it seems that the melting temperature of the U4/U6 RNA duplex in lsm6zl 
extracts is only approximately 35°C, suggesting that the U4/U6 duplex may be 
incorrectly base-paired in lsm6zi cells. This indicates that Lsm6p may have a specific 
role in U4/1J6 RNA duplex formation in vivo. 
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Figure 5.4. Melting curves of U4/U6 duplexes in /sm6z% and 1sm7A 
extracts. (A) 5 tl of Ism7A yeast extract (Section 2.3.4.2) was taken 
for each sample and heated at the indicated temperature for 1 hour 
before being treated with 1 jil of 1 mg/ml proteinase K and subject 
to electrophoresis on a 10% non-denaturing polyacrylamide gel. 
RNA (Section 2.3.3.4) was then transferred by Northern blotting 
(Section 2.3.3.3) to a Hybond-N membrane (Amersham) before 
being probed with the 5'-end radiolabelled oligonucleotide W3464 
(Table 2.1.8). (B) 5 p.1 of lsm6A yeast extract was analysed as in (A) 
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5.4. Annealing of U6A3' RNA and U4 RNA by the Lsm8 
complex 
The principle binding site of the Lsm proteins to U6 snRNA in both yeast and 
higher eukaryotes is to the U-rich sequence at the 3'-terminus of the RNA (Vidal el 
al., 1999. Achsel et al., 1999). This 3'-terminus is necessary and sufficient for 
binding of purified human LSm proteins (Achsel el al., 1999) but this is not the case 
for the yeast Lsm complex, which also requires the 3' stem loop of the U6 snRNA to 
bind in yeast extract (Vidal et al., 1999). It was investigated whether the yeast Lsm 
proteins would be able to anneal to in vitro transcribed U6 RNA lacking the 3' 
terminus (named U6A3' RNA). 
To act as a DNA template for in vitro U6 transcription, the plasmid pT7U6 (Table 
2.1.11) was usually digested with the restriction enzyme DraI. This digests the 
plasmid precisely at the 3' end of SNR6 (Figure 5.5). To produce a template for 
U6A3' RNA. the DNA template for wild type U6 RNA was digested with the 
restriction endonuclease FokI. The wild-type U6 DNA template contains a FokI 
restriction site at position 89 (Figure 5.5A). Therefore, digesting pT7U6 with FokI 
creates a SNR6 DNA template with the last 23 base-pairs deleted. This produces a 3'-
truncated U6 RNA transcript in vitro (Figure 5.513; Section 2.3.3.7) which contains 
the region of interaction with U4 RNA but lacks the 3' Lsm binding site. 
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Figure 5.5. (A) Sequence of the SNR6 gene (shown in bold) and 
downstream nucleotides. The cleavage sites for FokI and Dral are 
indicated by arrows. (B) Schematic diagram showing in vitro 
transcription of U6 and U6z3' RNA. Plasmid pT7U6 (Table 
2.1.11) is digested (Section 2.3.2.4) with either FokI or Dral 
resulting in either the full length SNR6 template or a 3'-truncated 
version. These were then used in an in vitro transcription reaction 
(Section 2.3.3.7), producing either full-length U6 RNA or U6A3' 
RNA respectively. 
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Following in vitro transcription (Section 2.3.3.7) and purification (Section 
2.3.3.8), the U6t\3' RNA was tested for the ability to anneal to U4 RNA to form a 
duplex in vitro, using the assay system already developed (Figure 5.6A). Lane I 
shows full-length U4/U6 duplex formation. As with full-length U6 RNA, Prp24p was 
not sufficient to form a U4/U6i3' duplex (Lane 5). In contrast to the previous result 
using full-length U6 RNA, however (Figure 5.1), the Lsm proteins were not 
sufficient to anneal U4 and U6A3' RNA (Figure 5.6A, Lane 3). Only when both 
Lsm2-8p (the Lsm8 complex) and Prp24p were incubated together with U4 and 
U6A3' RNA did an RNA duplex form (Lane 2). This demonstrates that the 3' 
terminus of U6 RNA is necessary for the Lsm8 complex to be sufficient for duplex 
formation. This requirement is presumably due to the 3' terminal U-rich sequence, to 
which the Lsm8 complex is known to bind (Vidal et al., 1999). Therefore it seems 
that the Lsm8 complex needs to bind to the U6 RNA in order to promote U4/U6 
duplex formation. 
It would also appear that a high proportion of U6A3' RNA is mis-folded. This 
is visible as a band migrating slightly faster than the U4/U6A3' RNA duplex. (Figure 
5.6A, indicated by *). This band is not present when full-length U6 RNA is 
incubated (lane 1), but is present in all lanes in which U6A3' RNA was incubated, 
including when U4 was omitted (lane 2). This demonstrates that this band does not 
correspond to an incorrectly base-paired duplex. Given that the RNA migrates 
similarly to the RNA duplex, it is tempting to speculate that this corresponds to a 
more extended, single-stranded form of U6. It is possible that the 3' end of U6 has an 
important role in stabilising the secondary structure of the RNA. 
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U6A 3' snRNP? 
Figure 5.6. Annealing of U4 and U6i 3' RNA in vitro. (A) U6 3' 
RNA requires both the Lsm8 complex and Prp24p to anneal it to U4 
RNA. Samples were treated as in Figure 5.1A, with the proteins and 
RNAs added to each sample as indicated. (B) Schematic diagram 
demonstrating the proposed structures of the U6 snRNP and the 
U6z 3' snRNP. 
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Although the Lsm8 complex cannot bind to the U6A3' RNA and therefore 
cannot by itself promote duplex formation, a combination of both Prp24p and the 
Lsm8 complex was able to anneal U4 and U6A3' RNA. It was proposed that for 
U6A3' RNA, Prp24p is able to act as a binding site for the Lsm proteins, allowing 
them to facilitate duplex formation. It has already been shown that Prp24p can bind 
to Lsm8p (Figure 4.5), as well as binding to U6 snRNA (Jandrositz & Guthrie, 1995) 
so it may be able to "anchor" the Lsm complex to the U6A3' RNA (Figure 5.613). It 
is interesting that U6 snRNPs reconstituted with U6A3' RNA will function in a 
splicing assay, albeit with reduced efficiency (Fabrizio et al., 1989). As the Lsm 
proteins are essential for pre-mRNA splicing, both in vivo and in vitro (Cooper et al., 
1995, Mayes et al., 1999) it seems possible that another factor, possibly Prp24p, is 
required so that the Lsm8 complex can interact indirectly with U613' RNA. 
5.5. Immunoprecipitation of U6A3' RNA with the Lsm8 
complex and Prp24p 
Immunoprecipitations were performed to investigate whether Prp24p could 
interact with both U6A3' RNA and the Lsm complex in the absence of a direct RNA-
Lsm interaction. His-tagged Prp24p was incubated with in vitro transcribed {32P]-
radiolabelled U6 RNA (Figure 5.7, lane 2). Similarly, His-tagged Lsm8p was 
incubated with in vitro translated Lsm2-7p in the presence or absence of in vitro 
translated Prp24p (lanes 3-4). As expected, both epitope-tagged Prp24p and epitope-
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Figure 5.7. Co-immunoprecipitation of U6 and U6A3'RNA by the Lsm complex and Prp24p. (A) 10 p.g of the indicated 
His-tagged protein was added to 5 p.1 of in vitro synthesised proteins and 10 ng of {32P]-radiolabeiled U6 RNA (Section 
2.3.3.7). Immunoprecipitations (Section 2.3.4.7) were performed by adding 5 p.1 of anti-His antibodies (Table 2.1.13) for 
60 minutes followed by incubation with protein A Sepharose beads for a further 60 minutes. Samples were washed, 
precipitated and 50 p.! of 1 mg/ml proteinase K was added for 30 minutes at 37°C. RNA was then extracted and subjected 
to electrophoresis in an 8% denaturing polyacrylamide gel (Section 2.3.3.3). The resulting autoradiograph is shown. (B) 
Samples were treated as in (A), substituting U6A3'RNA for U6 RNA. 
U6 RNA The ability of the Lsm8 complex to immunoprecipitate U6 RNA was not 
affected by the presence of Prp24p (lanes 2 and 3). As a control to show that the U6 
RNA was not non-specifically precipitating with the His-tag, His-tagged Lsm8p was 
immunoprecipitated in the presence of radiolabelled U6 RNA in the absence of other 
proteins (lane 5). No radiolabelled U6 RNA was co-precipitated. 
Identical immunoprecipitations were performed using [32P]-radiolabelled 
U6A3' RNA (lanes 6-10). His-tagged Prp24p can efficiently precipitate U63' RNA 
(lane 7), however, in contrast to full length U6 RNA (lane 3), the Lsm8 complex 
alone is not sufficient to co-precipitate U6A3' RNA (lane 8). This confirms that the 
3' end of U6 RNA is essential for a direct RNA-Lsm interaction. Upon addition of 
Prp24p, however, U6A3' RNA is efficiently precipitated with the Lsm complex (lane 
9), demonstrating that the Lsm8 complex cannot efficiently associate with U6A3' 
RNA directly, but can bind indirectly by binding to Prp24p. 
5.6. Discussion 
In this chapter it has been shown that the Lsm proteins facilitate Lsm U4/U6 
duplex formation in vi/ro (Figure 5.1) This suggests that U6 snRNA may be the 
component that cannot be recycled in 1sm6zl extracts (Figure 4.10). This process does 
not require Prp24p, a U6 snRNP protein previously suggested to be involved in 
U4/U6 duplex formation. Given the inability of lsm6zl extracts to recycle U6 back 
into U4/U6 RNA duplexes, it is perhaps surprising that 1sm6zl cells are viable 
(Mayes et al.,1999). This is perhaps due to newly-transcribed U6 that has not 
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previously been a spliceosomal component being able to form duplexes with U4 
snRNA. This would suggest alternative U6 snRNP assembly pathways for newly-
transcribed and recycling U6. As only newly-transcribed U6 is bound by Lhplp 
(Pannone et al., 1998) this may suggest a mechanism by which the two pools of U6 
can be separately processed. This possibility is also suggested by the observation that 
newly imported UsnRNPs assemble in different nuclear substructures to recycling 
UsnRNPs (Sleeman & Lamond, 1999; see introduction). 
In addition, previous evidence suggests a role for the Lsm proteins in U4/U6 
duplex formation in vivo (L. Verdone & J.D. Beggs, unpublished). This is also 
suggested by the observation that 1sm6zi extract contains U4/U6 duplexes with a 
decreased melting temperature compared to wild type duplexes (Figure 5.413), 
indicating that a partially annealed species with incorrect base-pairing may be 
formed. Interestingly, both previous data (L. Verdone & J.D. Beggs, unpublished) 
and U4/U6 duplex melting assays do not suggest a direct role for Lsm7p in U4/U6 
di-snRNP formation. Instead, it seems that Lsm7p may be involved in U5.U4/U6 tn -
snRNP formation (L. Verdone & J.D. Beggs, unpublished data). 
Given that the Lsm proteins appear to have a role in duplex formation both in 
vitro and in vivo, and given that Pnp24p does not appear to be essential for this 
process to occur in vitro, one important question to address is the role of Prp24p in 
vivo. One possibility is that the in vitro and in vivo situations differ considerably, and 
that Prp24p is essential for duplex formation in vivo. This is possible as the in vivo 
situation will be considerably more complex, with other protein components 
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involved in U6 cycling, including other protein components of both the U4 and the 
U6 snRNPs. As none of the protein components of the U4 snRNP are included in our 
assays, Prp24p might be required to rearrange the U4 snRNP, thereby allowing the 
RNA to anneal with U6 snRNA. It is likely that the in vivo and vitro requirements for 
annealing are different, as Lsm6p and Lsm7p are required in vitro (Figure 5.2) but 
not in vivo (Mayes et al., 1999). This could be due to other proteins, such as Prp24p, 
being able to compensate for the absence of these proteins in vivo. This seems likely, 
as Prp24p may facilitate an Lsm complex with one component omitted in vivo, as 
well as allowing the Lsm8 complex to interact with U6A3' RNA in vitro. 
Alternatively, Prp24p may be required to stabilise the Lsm-U6 complex in 
vivo. It can be seen in this chapter that Prp24p interacts with both U6A3' RNA and 
the Lsrn8 complex, allowing U4 and U6A3' RNA to be annealed. Perhaps a similar 
interaction is essential for annealing of full length U6 RNA in vivo. This is perhaps 
required to increase the affinity of the Lsm complex for the U6 snRNP, thereby 
preventing other proteins binding to the Lsm binding site at the 3' terminus of U6 
RNA. One such protein is Lhplp, which binds to the Lsm binding site immediately 
following the transcription of U6 (Pannone et al., 1998). It is possible that Lhplp 
remains bound to U6 RNA in the absence of Prp24p, preventing the Lsm proteins 
from binding and therefore inhibiting duplex formation. Lhplp is not present in the 
in vitro assays, so this requirement for Prp24p would not be observed. 
One intriguing suggestion is that Prp24p may influence both association and 
dissociation of U4 and U6 RNA during the splicing cycle (Vidaver et al., 1999). 
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Evidence showing that U6 overexpression can suppress prp24 mutants suggests that 
Prp24p increases the probability of interaction of the RNAs. It is also suggested, 
however, that despite bringing these two RNAs into close proximity, Prp24p actually 
antagonises their base-pairing (Shannon & Guthrie, 1991; Vidaver et al., 1999). It is 
also suggested that Prp24p antagonises RNA duplex formation by stabilising an 
alternative conformation of U6 snRNA which contains a telestem structure. This 
structure is mutually exclusive with the formation of U4/U6 RNA duplexes (Vidaver 
et al., 1999). 
It is possible that the Lsm8 complex functions as an unwindase, facilitating 
the unwinding of this telestem, although no known helicase motifs such as the 
DEAD or DExH box motifs (de la Cruz et al., 1999) are identifiable in the sequence 
of any of the Lsm proteins. Another possibility is that the Lsm proteins are 
responsible for directly forming base-pair interactions between U4 and U6 snRNA. 
This is supported by data presented here suggesting that the U4/1J6 duplex of an 
lsm6Ll extract may be incorrectly base-paired, as discussed earlier (Section 5.3). It 
has recently been proposed that the yeast Sm proteins have a role in stabilising and 
promoting the base-pair interactions between the Ul snRNA and the pre-mRNA 
(Zhang et al., 2001) speculating that this might be a general role for proteins 
containing Sm or Sm-like motifs, and may have evolved to aid weak intermolecular 
nucleic acid interactions of only a few base-pairs. Given the high level of sequence 
similarity between the Sm and the Lsm proteins it is tempting to speculate that the 
Lsm proteins directly promote base-pair interactions between U4 and U6 RNA. 
Despite a total of 22 base-pair interactions between U4 and U6 RNA, these are not 
continuous, the longest continuous region of interaction being 11 nucleotides. 
Therefore, the Lsm proteins, and in particular, Lsm6p, may promote the base-pairing 
of one or more of these discontinuous regions of interaction. It should be noted that 
none of these possible roles for the Lsm complex in duplex formation are mutually 
exclusive, and it is possible that more than one mechanism may occur. 
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The role of Lsrn6p in U4/U6 RNA duplex formation 
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6.1 Introduction 
Following the establishment that the Lsm8 complex has a role in annealing U4 
and U6 RNA, it was wondered whether any of the individual Lsm proteins had 
specific functions in this process. Previous data suggested that Lsm6p has a specific 
function in U4/1J6 RNA duplex formation, as lsm6A cells contain less U4/U6 di-
snRNP than wild-type or !sm7A cells (Figure 5.4; L. Verdone & J.D. Beggs, 
unpublished data). In addition, the melting temperature for lsm6/1 U4/1J6 duplexes 
has been shown to be approximately 35°C (Figure 5.4), approximately 20°C lower 
than that for either wild-type (Figure 5.3) or 1sm7A cells (Figure 5.4). This indicates 
that Lsm6p, but not Lsm7p, may have a specific non-redundant function during U6 
snRNA recycling and U4/U6 RNA duplex formation. This function was investigated 
further and the results presented in this chapter. 
6.2 The effect of an LSM6 deletion in SNR6 transcriptionally 
inactive cells 
As previously discussed. Lsm6p is involved in recycling U6 snRNA back into the 
splicing pathway, but as 1sm6A cells are viable, there might exist a separate pathway 
for the incorporation of newly-transcribed U6 snRNA into U4/U6 di-snRNPs. It was 
reasoned that a yeast strain that could not transcribe U6 snRNA should show a 
growth defect at a later time point than a strain that could neither transcribe nor 
recycle U6 snRNA. Therefore, the time of induction of a growth defect in a strain 
containing a repressible SNR6 gene could be compared to that of a strain containing a 
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SNR6 gene and an LSM6 deletion. If Lsm6p is involved in recycling U6 snRNA by 
forming U4/U6 duplexes in viva, then the latter should show a growth defect and 
start accumulating pre-mRNA at an earlier time point than the former. 
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Figure 6.1. (A) Schematic diagram of the two DNA elements required for Lad 
repression of SIVR6 transcription. One consists of the P(; j / promoter (yellow) and the 
E. co/i LACI gene (blue). The other consists of the SNR6 gene (green) with its own 
promoter (yellow) with the Lacl binding site (LBS; black) inserted between the two. 
(B) In the absence of galactose. the LACI gene is not expressed and U6 can be 
transcribed from SNR6. In the presence of galactose. LACJ is expressed producing 
Lacl protein (orange) that binds to the LBS upstream of the SNR6 gene. This blocks 
RNA polymerase III causing U6 transcription to be switched off. Colours are as in 
(A). 
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To switch off U6 production, a system based on the Escherichia coil lac-repressor 
(Lad) was used (Luukkonen & Séraphin, 1998). Strain BSY557 (Table 2.1.6) 
contains both a disrupted chromosomal copy of the SNR6 gene and pBSI 191 (Table 
2.1.11). This was co-transformed with plasmids pBS 1181 and pBS 1184. These 
contain an SNR6 gene with the Lacl binding site (LBS) inserted immediately 
upstream of the transcriptional start-site and a LACI gene controlled by a galactose-
inducible promoter respectively. As 5-fluoroorotic acid (5-FOA) selects for uracil 
auxotrophs (Kondo et ai., 1991), transformants were grown on 5-FOA to counter-
select pBS 1191, creating strain yGALU6 (Table 2.1.6). 
In the absence of galactose, the LACI gene is not expressed and U6 transcription 
can occur. In the presence of galactose, however, LACI is expressed. This then binds 
to the LBS immediately upstream of SNR6, preventing the transcription of U6 
snRNA (Figure 6.1). Previous analysis of this system (Luukkonen & Séraphin, 1998) 
demonstrated that this strain showed an impaired rate of growth after 12.5 hours. 
After this time, cellular U6 RNA levels were reduced to approximately 25% of wild-
type levels. 
To construct a strain with both an inducible SNR6 gene and an LSM6 deletion, the 
method of Lafontaine & Tollervey (1996) was used (Figure 6.2A). A linear DNA 
cassette was amplified by PCR (Section 2.3.2.6) using the URA3-containing plasmid 
pRS306 (Table 2.1.10) and the synthetic oligonucleotides 6UF and 6UR (Table 
2.1.7) that contain regions of complementarity to URA3 at their 3' ends and regions 
of homology to the DNA regions flanking chromosomal LSM6 at their 5' ends. The 
resulting DNA fragment was gel purified (Section 2.3.2.8) and 10 .ig was 
166 
Figure 6.2. Gene knockout of LSM6 in yGALU6. (A) The URA3 
gene from plasmid pRS306 (Table 2.1.10) was amplified by PCR 
(Section 2.3.2.6) using primers 6UF and 6LJR (Table 2. 1.7) to create 
a linear DNA fragment with 5' and 3' termini homologous to DNA 
regions flanking the LSM6 gene. This DNA fragment was 
transformed (Section 2.2.5.2) into yGALU66 (Table 2.1.6) where the 
DNA homologously recombined into the genome. Transformants 
were selected on -ura solid medium. (B) Colonies were checked for 
correct integration by yeast colony PCR (Section 2.3.2.6) using 
primers Fl and F2 (Table 2.1.7) to check for the presence of LSM6 
and primers 6UF and F2 (Table 2.1.7) to check for the integration of 
URA3. Samples were subjected to electrophoresis on a 1% agarose 
gel and visualised by ethidium bromide staining( Section 2.3.2.7). 























transformed into yGALU6 allowing homologous recombination to occur, creating 
strain yGALU66 (Table 2.1.6). 
To test whether yGALU66 has an earlier growth defect than yGALU6, cells were 
initially grown in liquid Gly-Lac medium (Table 2.1.2.) that lacks galactose. To 
induce Lacl expression and to switch off transcription from the SNR6 gene, galactose 
was added to a final concentration of 2% (w/v). Cell density was measured and total 
RNA was prepared from samples every 2 hours (Section 2.3.3.1). The graph showing 
cell growth shows that, in the presence of galactose, yGALU6 shows a greatly 
reduced growth rate after approximately 12 hours (Figure 63A), in agreement with 
previous data (Luukkonen & Séraphin. 1998). When, however, yGALU66 was 
grown in the presence of galactose, a growth defect is noticed after only 6 hours 
(Figure 6.3A). Both strains continued to grow, albeit at much reduced rates, 
presumably because the Lacl system does not completely suppress the transcription 
of SNR6. 
To examine if this correlated with a splicing defect within the cells, total RNA 
from the strains was subjected to primer extension analysis to detect pre-U3 RNA 
(Figure 6.313). It can be seen that, after 6 hours, yGALU6 had accumulated pre-U3 
RNA (top-left panel), indicative of a splicing defect. Strain yGALU66, however, 
demonstrated a splicing defect after only 2 hours (top-right panel). This 
accumulation of unspliced U3 RNA occurred prior to the growth defects seen in 
Figure 6.3A, compatible with a splicing defect being the cause of the growth 
problem. No change in Ui snRNA levels was seen in either yGALU6 (Figure 6.313, 
bottom-left panel) or yGALU66 (Figure 6.3B, bottom-right panel). 
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Figure 6.3. Effects on growth, pre-mRNA splicing and U6 snRNA 
of repressing U6 snRNA production in isni6z cells. (A) Yeast strains 
yGALU6 and yGALU66 (Table 2.1.6) were grown in selective 
medium containing 2% glycerol, 2% lactate, 0.05% glucose. At t=0, 
galactose was added to applicable samples to a final concentration of 
2%. The turbidity at 600 nm was measured every 2h, diluting the 
cells as appropriate to maintain log-phase growth. (B) Total RNA 
was isolated (Section 2.3.3.1) at the time points indicated and primer 
extension analysis (Section 2.3.3.2) was performed using synthetic 
oligonucleotide U3exon2 (Table 2.1.8) to detect U3 pre-mRNA and 
G8102 (Table 2.1.8) to detect UI snRNA. (C) Northern analysis 
(Section 2.3.3.3) was performed to monitor levels of U6 snRNA and 
U! snRNA, using probed W3464 and G8102 respectively (Table 
2.1.8). 
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U6 snRNA levels in these strains were also measured (Figure 6.3C) using 
Northern blot analysis (Section 2.3.3.3). In the presence of galactose, U6 levels in 
yGALU6 decreased steadily. In yGALU66 cells, however, there was a much faster 
decrease in U6 levels, until, after 12 hours, U6 RNA is almost undetectable. Ui 
snRNA levels remained unchanged in both cases, indicating that this phenomenon 
was specific for U6 snRNA and not as a general activation of RNA degradation. 
Interestingly, U6 RNA levels remain virtually unchanged between 4 and 6 hours 
growth in galactose-containing medium, despite this being the time point where the 
growth rate of yGALU66 was greatly reduced (Figure 6.3A) and a splicing defect 
was observed (Figure 6.313). This is consistent with the splicing defect being caused 
by U6 snRNA not being able to recycle back into U4/U6 di-snRNPs, rather than U6 
snRNA being degraded. This must be due to the LSM6 deletion, as yGALU6 cells do 
not exhibit such an early decrease in growth rate or accumulation of pre-mRNA. 
6.3 Suppression of the Ism6A phenotype with an snr6-C69A 
mutation 
Since Lsm6p appears to have a specific role in the recycling of U6 snRNA into 
U4/1J6 duplexes in vitro and in vivo, we wondered if it was possible to suppress the 
growth phenotype of lsm6zi cells by promoting U4/U6 di-snRNP formation in vivo. 
To do this, positions within the SNR6 gene were searched for where mutations would 
be expected to destabilise the 3' helix in free U6 without affecting the stability of the 
U4/U6 RNA duplex. Two such sites were identified; G63 and C69 (Figure 6.4). Both 
these residues are predicted to form Watson-Crick base-pair interactions in the free 
U6 structure but not in the U4/1J6 RNA duplex. 
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Figure 6.4. Secondary structure models of the yeast U6 RNA and U4/U6 RNA duplex. (A) Yeast U6 RNA (Brow & 
Guthrie, 1988; Fortner et al., 1994). Watson-crick interactions are shown with a straight line; non-Watson-Crick 
interactions are shown with a •. Mutated residues are circled. (B) Yeast U4/U6 RNA duplex (Brow & Guthrie, 1988). 
Labelling is as in (A). 
Figure 6.5. Diagram representing the strategy for cloning and site-
directed mutagenesis of SNR6. The SNR6 gene was subject to PCR 
(Section 2.3.2.6) using pnmersBamU6F and SmaU6R Table 2.1.7), 
which introduced BamHl and Smal restriction sites at the 5' and 3' 
termini respectively. The DNA fragment was then digested (Section 
2.3.2.4) with BamHI and SrnaI. This was then ligated (Section 
2.3.2.9) into pRG1-13myc-hph (Table 2.1.11) which had previously 
been digested with Smal and BamHI, creating vector pU6Hph (Table 
2.1 1 1). This plasmid was then subject to PCR (Section 2.3.2.6) 
using primer U614ph (Table 2.1.7.) and another primer containing a 
single base match at either position 63 or 69. This introduced an A 
residue at the appropriate position instead of the wild-type residue. 
This was then transformed into yeast (Section 2.2.4.2), where it 
underwent homologous recombination with the SNR6 locus in the 
genome. 
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To mutate these residues, the SNR6 gene and promoter elements, including the 
downstream B box (Brow & Guthrie, 1990) were firstly cloned into the MCS 
upstream of the hygromcin-resi stance gene (HPH) in pRG1-13myc-hph (Table 
2. 1.11) to produce plasmid pU6Hph (Figure 6.5). Synthetic oligonucleotide primers 
were then designed to amplify a region of SNR6, including the B box, and the HPH 
cassette. The primer that annealed within SNR6 was designed with a mismatch at 
position 63 (G to A) or 69 (C to A) so that the resulting DNA cassette would be 
specifically mutated at this position (marked with an asterisk in Figure 6.5). The 
other primer had a 5' region homologous to the DNA sequence downstream of the B 
box in the yeast genorne. This allowed the DNA cassette to be recombined into the 
yeast genome by homologous recombination and selected on solid media containing 
hygromycin, resulting in a yeast strain with a chromosomal SNR6 gene containing 
the point mutation of interest (Figure 6.5). BMA64a cells containing either snr6-
G63A, -C69A or both mutations grew identically to cells containing wild-type SNR6, 
showing that these point mutations do not inhibit cell viability at either 30°C (Figure 
6.6A) or 37°C (Figure 6.613). 
AEMY1 9 (1sm6zl) cells were also transformed so that they contained snr6-G63A, 
-C69A or both mutations. After the insertion was verified by PCR (Section 2.3.2.6) 
and DNA sequencing (Section 2.3.2.11; data not shown) the strains were tested for 
the temperature-sensitive phenotype and/or the slow growth rate exhibited by 1sm6zl 
cells (Mayes et al., 1999). When grown at 30°C, the G63A mutation did not rescue 
the slow growth phenotype (Figure 6.6C). In contrast, 1sm6zl cells that contained 
snr6-C69A or the double mutation grew similarly to wild-type cells, the slow growth 
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Figure 6.6. Analysis of the growth of lsmM strains containing U6 snRNA point-mutations. (A) Strain BMA38n (LSM6: 
Table 2.1.6) was transformed and homologously recombined with DNA containing mutations in SNR6 at positions 063, 
C69 or both. A colony of this strain was then suspended in 100 p1 of distilled water and were diluted 10-fold, 100-fold 
and 1000-fold. These were then spotted onto solid YPDA medium (Table 2.1.2) and incubated at 30°C for three days. 
(B) samples were treated as in (A), but incubated at 37 T. (C) Strain AEMYI9 (ls,n6/t; Table 2.1.6) were transformed 
and homologously recombined with DNA containing mutations in SNR6 at positions 063, C69 or both. These strains 
were then diluted in 100 .tI of distilled water and were diluted 10-fold, 100-fold and 1000-fold. These were then 
spotted onto solid YPDA medium and incubated at 30°C for three days. (D) samples were treated as in (C), but 
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phenotype having been rescued. Similarly, the C69A, but not the G63A mutation 
rescued the temperature-sensitivity of lsm61 cells at 37°C (Figure 6.61)). 
6.4 The effect of the snr6-C69A mutation on cell growth is 
specific to Ism6zl cells 
To see whether this effect of the snr6-C69A mutation was specific for 1sm6zl 
strains, the same mutations were made in the 1sm7zl strain AEMY22 (Table 2.1.6). 
Like AEMY19, AEMY22 has a reduced growth rate at 30°C and is inviable at 37°C 
(Mayes et al., 1999). In contrast to the lsrn6zl strain, however, neither a G63A nor a 
C69A point mutation within SNR6 restored growth at 30°C to wild-type levels or 
allowed growth of 1sm7A cells at 37°C (Figure 6.7A). 
The mutations were also tested for their ability to suppress the growth defect of 
Lsm4p-depleted cells. As LSM4 is essential (Cooper et al., 1995), this was performed 
in MCY4 cells (Table 2.1.6), which contain an LSM4 gene under the control of the 
galactose-inducible GAL] promoter (Cooper etal., 1995). This results in MCY4 cells 
being viable on media with galactose as the carbon source, but not on media with 
glucose as the carbon source, as glucose represses the GAL] promoter. SNR6 was 
therefore mutagenised as previously described in MCY4 cells and the ability of the 
transformed strains to grow on galactose and glucose-containing solid media was 
tested (Figure 6.713). All of the snr6 mutant strains tested were able to grow when 
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Figure 6.7. Analysis of the growth of conditional ism strains 
containing U6 snRNA point-mutations. (A) Strain AEMY22 
(1sm7z; Table 2.1.6) was transformed with DNA containing 
mutations in SNR6 at positions G63, C69 or both. A colony was 
then suspended in 100 tl of distilled water and were diluted 10-
fold, 100-fold and 1000-fold. These were then spotted onto solid 
YPDA medium (Table 2.1.2) and incubated at 30°C or 37 °C for 
three days. (B) MCY4 cells (Table 2.1.6) containing P 1 -LSM4 
was transformed with DNA containing mutations in SNR6 at 
positions G63, C69 or both. These strains were then diluted as in 
(A) and spotted onto solid YPDA or '{PGa1A medium (Table 2.1.2) 
and incubated at 30°C for three days. 
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whereas neither MCY4, nor any of the strains containing point mutations within 
SNR6 was able to grow on glucose-containing medium (Figure 6.713; right-hand 
panel). This indicates that the loss of Lsm4p cannot be compensated for by 
production of U6-C69A snRNA. 
It would appear therefore that the snr6-C69A mutation can suppress the growth 
defect of lsm6zl cells but not the growth phenotypes of other ism mutants. As this 
mutation is predicted to destabilise the 3' stem/loop of U6, it is possible that Lsm6p 
also has a specific role in destabilising U6 snRNA secondary structure. This might 
explain why the melting temperature of the U4/U6 RNA duplex is decreased in 
1sm6A cells: the inability to destabilise the 3' stem loop of U6 could limit the extent 
of the interactions between U4 and U6 snRNAs, resulting in a decreased melting 
temperature for the complex. 
6.5 The snr6-C69A mutation can partially restore the heat 
stability of the U4/U6 RNA duplex in Ism6zl cells 
It was seen previously that the melting temperature of the RNA duplex in the 
U4/U6 snRNP is approximately 35°C in 1sm6zi extracts. It was therefore wondered 
whether the snr6-C69A mutation would also restore the stability of the duplex to the 
wild-type level with a melting temperature of 55°C. To test this, yeast extracts were 
prepared from AEMY19-C69A cells (Section 2.3.4.2) and 10 j.tl aliquots were 
incubated at a range of temperatures between 44°C and 60°C for one hour. Samples 
were then deproteinised, the RNA extracted with phenol/chloroform (Section 2.3.1.2) 
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Figure 6.8. Melting curve of the U4/U6 duplex in snr6-C69A 
extracts (Table 2.1.6). Whole yeast extract was incubated for 1 hour 
at the indicated temperature before being treated with I tl of I 
mg/ml proteinase K and subjected to electrophoresis in a 10% non-
denaturing polyacrylamide gel (Section 2.3.3.4). RNA was then 
transferred by Northern blotting (Section 2.3.3.3) to a Hybond-N 
membrane (Amersham) before being probed with the 5'-end 
radiolabelled oligonucleotide W3464 (Table 2.1.8). 
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and precipitated with ethanol (Section 2.3.1.3) before being separated in a non-
denaturing polyacrylamide gel (Section 2.3.3.4), Northern blotted (Section 2.3.3.3) 
and probed for U6 snRNA with oligonucleotide W3464 (Table 2.1.8). 
When the melting temperature for the U4/U6 RNA duplex was investigated in 
cells containing LSM6 but snr6-C69A (Figure 6.8A) it was shown that the melting 
temperature of the duplex was approximately 55°C, similar to that of extracts 
containing wild-type U6 snRNA. This confirms that the C69A mutation within U6 
snRNA does not affect the stability of the U4/U6 duplex. 
Interestingly, The melting temperature of the U4/U6 duplex in lsm6zl cells 
containing the snr6-C69A mutation appears to be approximately 48°C (Figure 6.813). 
This is greater than the melting temperature of the U4/1J6 duplex in SNR6 1sm6zl 
cells (Figure 5.4) but less than that for wild-type SNR6, LSM6 cells (Figure 5.3). 
Therefore, the C69A mutation did not completely suppress the lsm6zl phenotype at 
the RNA level, despite being able to suppress the growth defect. By destabilising the 
3' stem helix, this may permit this double-stranded structure to unwind more easily 
and allow greater regions of interaction to form between U4 and U6 in the RNA 
duplex, therefore raising the melting temperature. 
There are several possibilities why the melting temperature in a lsm6zl, snr6-C69A 
strain is not restored to 55°C. One is that the U6 snRNA requires Lsm6p to 
completely anneal to U6 snRNA, even when the 3' stem-loop is destabilised. This 
may be due to a requirement for Lsm6p to either destabilise other regions of the free 
U6 structure such as the central stem-loop, which also must be unwound for U4/U6 
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RNA duplex formation, or to directly facilitate the annealing of U4 and U6 snRNAs. 
Alternatively, it could be that Lsm6p prevents another factor, such as a helicase, 
from destabilising the U4/U6 RNA duplex once it is annealed. 
In addition, this gel shows that U6-C69A RNA has several different 
conformations, each migrating at a different position in the native gel (Figure 6.8; 
marked with *). This is presumably due to the decreased stability of the wild-type U6 
snRNA secondary or tertiary structure leading to the formation of alternative 
(presumably less compact) conformations. It is notable that the most abundant 
conformation of U6-C69A RNA was also less heat-stable, shown by a decrease in its 
levels and an increase in one of the alternative conformations at 58 and 60°C. Such a 
pattern is not seen when extract containing wild-type U6 snRNA was heated (Figure 
5.3). 
In contrast to free U6 in 1sm6zl extract (Figure 5.4), free U6 snRNA in AEMY19-
C69A extract appears to be more resistant to degradation, as it can be detected by 
Northern blotting. This indicates that the loss of U6 snRNA in 1sm6zl extracts may be 
due to the inability of the U6 snRNA to form stable U41U6 RNA duplexes rather 
than Lsm6p binding to and stabilising free U6 snRNA. 
180 
unapwr o: me role oj Lsmop in VIVO 
6.6 U6-C69A RNA can anneal to U4 RNA in the absence of 
Lsm proteins 
As the C69A mutation in SNR6 was designed to destabilise free U6 RNA 
structure without affecting the stability of the U41U6 RNA duplex, it was reasoned 
that U6-C69A RNA should anneal to U4 RNA more efficiently than wild-type U6. 
To test this, genomic DNA was prepared (Section 2.3.2.3) from AEMY19-C69A 
cells (Table 2.1.6) and used as a template for amplification by PCR (Section 2.3.2.6) 
using oligonucleotide primers LORY1 and S5761 (Table 2.1.8). This resulted in a 
linear DNA product with the T7 promoter fused upstream of the snr6-C69A gene. 
The same procedure was performed with AEMY I 9-G63A cells, producing a DNA to 
act as a template for U6-G63A RNA production. The mutant and wild-type RNAs 
were transcribed in vitro (Section 2.3.3.7) and purified (Section 2.3.3.8). These 
RNAs were then incubated with in vitro transcribed U4 RNA in the presence or 
absence of in vitro translated Lsm proteins (Section 2.3.4.6) in an RNA annealing 
assay (Section 2.3.3.9). As has been shown earlier (Figure 5. 1), wild-type U6 RNA 
annealed to U4 RNA in the presence but not the absence of Lsrn2-8 proteins (Figure 
6.9; Lanes 1-3), as was observed with U6-G63A (Lanes 4-6). When U6-C69A RNA 
was used in the assay, a low amount of U4/U6 duplex production was observed in 
the absence of the Lsm8 complex (Lane 8). This level of annealing, however, was 
increased in the presence of the Lsm8 complex (Lane 9). This shows that U6-C69A 
RNA is destabilised sufficiently to allow U4/U6 RNA duplex formation, although 
the Lsm8 complex still increases the efficiency of this process. Presumably, the 
ability of U6-C69A RNA to form U4/U6 duplexes in vitro is also applicable in vivo. 
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This would explain why lsm6zl cells demonstrate wild-type growth when 
combined with a C69A mutation in SNR6. 
6.7 Discussion 
The C69A mutation within SNR6 appears to specifically suppress the growth 
defect of 1sm6zl cells and did not suppress the growth defect of the other conditional 
ism strains tested. Therefore, either Lsm6p must play a specific role in splicing that is 
functionally non-redundant with either Lsm4p or Lsm7p, or Lsm4p and Lsm7p have 
an additional function that is not suppressed by the U6-C69A mutation. Given that 
the other Lsm proteins not tested are essential whereas Lsm6p is non-essential it 
seems unlikely that other Lsm proteins may have exactly the same function as Lsm6p 
in vivo. One function appears to be to destabilise the 3' stem loop in U6 snRNA, as a 
C69A mutation that is predicted to destabilise this structure promotes U4/U6 RNA 
duplex formation and suppresses the temperature-sensitive slow growth phenotype 
seen in 1sm6zl cells. 
Interestingly, a G63A mutation that might also be expected to destabilise the 3' 
stem loop in U6 does not promote U4/1J6 RNA duplex formation. This can be 
explained in several ways. Firstly, although the G63 residue is not involved in 
Watson-Crick interactions in the U4/1J6 duplex, it is predicted to form non-covalent 
interactions with the A18 residue of U4 RNA (Figure 6.4). Therefore, the U41U6 
RNA duplex may also be destabilised, leading to no overall increase in U4/1J6 levels. 
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Alternatively, the interactions of the nucleotides surrounding the mutated residues 
may influence the stability of the helix. The C69-G77 base-pair has Watson-Crick 
base-paired nucleotides adjacent to it on either side (Figure 6.4). The stacking 
interactions between these base-pairs are likely to contribute to the stability of the 
helix. In contrast, the G63-C84 base pair is adjacent to only one Watson-Crick base-
pair so stacking interactions between G63-C84 and its neighbouring nucleotides are 
not likely to contribute as much to the stability of the 3' stem/loop. Thus, the C69A 
mutation is likely to decrease the stability of the 3'/stem/loop by a greater amount 
than the G63A mutation. 
Data presented here also suggest that Lsm6p may have more than one function, as 
a U6-C69A mutation can increase the melting-temperature of the resulting U4/U6 
RNA duplex, but not to wild-type levels (Figure 6.8). This function may be to 
destabilise the central stem loop within free U6 snRNA, also allowing it to base pair 
with U4 snRNA. Alternatively, as suggested in chapter 5, Lsm6p may facilitate the 
formation of base-pair interactions between U4 and U6 snRNAs. This is in 
agreement with Zhang et a! (2001) who suggested that the Sm proteins might be 
involved in promoting base-pair interactions between UI snRNA and pre-mRNA. 
Given that the decreased melting temperature of the U4/U6 RNA duplex is 7°C 
lower in AEMY 1 9-C69A cells than in wild-type cells, this still seems to be an 
intriguing possibility. 
Another possibility is that Lsm6p inhibits another factor from destabilising the 
U4/1J6 RNA duplex. Therefore, in the absence of Lsm6p the duplex is destabilised 
by this unknown factor. This could be tested by using U6-C69A RNA in an in vitro 
annealing assay and analysing the melting-temperature of the duplex formed in the 
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absence of Lsm6p. If the annealing temperature was similar to wild-type (55°C) then 
another factor present in yeast extract but not present in the in vitro assay must be 
responsible for the decreased melting-temperature seen in Figure 6.813. If, however, 
the melting-temperature of the duplex was 48°C then this must be directly caused by 
the absence of Lsm6p in the annealing assay. 
Throughout this discussion it has been assumed that the effects of the snr6-C69A 
mutation result directly from the destabilisation of the 3' stem/loop of U6 RNA. 
There are, however, other possibilities. One of these is that C69 may form part of a 
binding site on U6 RNA for unknown proteins that influence its conformation. 
Alternatively, tertiary interactions are doubtless important in the cycling of U6 
snRNA through the splicing pathway and these too could be affected by this C69A 
mutation. Lastly, another possibility is that covalent modification (i.e. methylation or 
pseudouridylation) of U6 snRNA is important and that C69 may either be directly 
modified or influence the modification of other residues that are important in the 
structure and/or recycling of U6 through the splicing pathway. 
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7.1 Introduction 
The Lsm2-8 complex has previously been identified as being associated with U6 
snRNA, as well as being essential for efficient pre-mRNA splicing. This thesis has 
characterised further the function of this complex in pre-mRNA splicing and, in 
particular, the role it plays in annealing U4 and U6 snRNAs to form a U411J6 RNA 
duplex. Data presented here suggest that the Lsm8 complex is directly involved in 
forming this duplex in vitro. Furthermore, all seven Lsm proteins are required for this 
process to occur in vitro. The Prp24 protein, which has previously been reported as 
being necessary for U4/U6 duplex formation was shown to be dispensable for 
annealing full-length U6 RNA to U4 RNA, but essential when the Lsm binding site 
was removed from the U6 RNA. 
Additional data support a model where Lsm6p (and possibly other Lsm proteins) 
is involved in U4/1J6 RNA duplex formation in vivo. In particular, a C69A mutation 
within the SNR6 gene, which is predicted to destabilise the secondary structure of U6 
snRNA, can suppress the growth defect of a lsm6A strain. U6-C69A RNA can more 
easily form U4/U6 RNA duplexes in vitro and this is presumably the mechanism for 
the suppression in vivo. 
7.2 The Lsm8 complex may be an unwindase 
One question not directly addressed in this thesis is the actual mechanism by 
which the Lsm complex facilitates annealing of the U4 and U6 RNAs. Data suggest 
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that this mechanism may involve the destabilisation of U6 snRNA, as mutations 
within the SNR6 gene that are predicted to destabilise the free U6 structure, but not 
the U4/1J6 RNA duplex can suppress the impaired growth phenotype of 1sm6A cells. 
In addition, RNA helices that are greater than 9 bp can be extremely stable, with 
half-lives in the order of hours (Xia et al., 1998) and require RNA helicases to 
disrupt them. Given this, it is possible that the Lsm8 complex functions as a helicase 
to unwind the secondary structure of the U6 snRNA, in particular the 3' stem/loop. 
The existence of ring-structures functioning as helicases is not unprecedented. 
One such example is that of the RuvABC helicase complex in E. coil (reviewed in 
West, 1997). This complex is involved in resolving DNA Holliday junctions at sites 
of genetic recombination. The RuvB protein forms two hexameric ring structures that 
bind to two diametrically opposed arms of the Holliday junction. The double-
stranded DNA passes through the centre of each ring, reminiscent of the single-
stranded RNA passing through the ring structure formed by the canonical Sm 
proteins in the model suggested by Kamback et al. (1998). Efficient branch 
migration of the Holliday junction is thought to occur by the helicase activity of the 
RuvB hexamers, exerting equal and opposite forces on the DNA. 
To test whether the Lsm8 complex possessed unwindase activity, a standard 
helicase assay could be used that has been well established (Rozen et al., 1990; 
Wang et al., 1998). This consists of annealing together two complementary RNA 
molecules (one of which is radiolabelled) with either 3' or 5' overhangs, as many 
helicases require single-stranded overhangs for efficient activity. Following 
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incubation with the putative helicase the radiolabelled RNA can be separated to 
determine whether it is still annealed to its complement. This method, however, has 
been questioned by the demonstration that the E. coli RNA DEAD/H box helicase 
DbpA has neither ATPase (Fuller-Pace el al., 1993) nor helicase activity (Diges & 
Uhienbeck, 2001) with non-specific substrates. When, however, DbpA is incubated 
with a substrate that contains the DbpA binding sequence of the loop of hairpin 92 of 
23S rRNA at a specific distance from the substrate helix, then both ATPase and 
helicase activity can be recorded (Fuller-Pace et al., 1993; Diges & Uhienbeck, 
2001). This highlights the difficulty in detecting the helicase activity of proteins: 
many DEAD/H box proteins previously shown not to possess non-specific helicase 
activity may in fact be helicases only with very specific substrates. Given, however 
that the substrate of any helicase activity of the Lsm8 complex is likely to be U6 
snRNA, once unwinding activity has been demonstrated, deletion experiments can be 
performed to identify the precise region of U6 that is both necessary and sufficient 
for such an activity. 
It has previously been discussed that the Lsm8 complex might be functioning to 
promote the annealing of the U4 and U6 snRNAs (Chapters 5 and 6). The model 
proposed by Zhang et al. (2001) supports this, as they suggest that the yeast 
canonical Sm proteins stabilise the base pairing between the Ui snRNA and the 5' 
splice site of the pre-mRNA. Furthermore, it is proposed that this role may be 
general and may be a general mechanism for aiding weak intermolecular nucleic acid 
interactions of only a few base pairs. This suggestion appears to be supported by the 
recent discovery that the E. coli protein Hfq is required for the annealing of both 
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Spot42 sRNA (Moller et al., 2002) and OxyS sRNA (Zhang et al., 2002) to their 
respective RNA substrates. Investigation of the the sequence of Hfq revealed an Sm-
like motif indicating that such a role for Sm-like proteins may be ancient and highly 
conserved. 
This suggestion may not, however, conflict with the suggestion that the Lsm8 
complex could be an unwindase. Recently it has been shown that two highly 
conserved DEAD-box helicases p68 and p72 both possess RNA annealing activity 
(Rössler et al., 2001). It is proposed that, by coupling these two functions, the 
enzymes can catalyse rearrangements of RNA secondary structures that otherwise 
are too stable to be resolved by a helicase activity alone. It can be imagined that such 
a situation could apply to the secondary structure of U6 snRNA and the Lsm8 
complex. 
7.3 The Lsm8 Complex may require ATP to facilitate U4/U6 
RNA duplex formation 
Helicases require the energy provided by ATP hydrolysis to unwind energetically 
favourable RNA helices. It would therefore be interesting to test whether the Lsm8 
complex requires ATP to anneal U4 and U6 RNAs in vitro, by performing in vitro 
annealing assays in the absence of ATP. This may be complicated by the presence of 
ATP in the wheatgerm lysate in which the Lsm proteins are translated. Endogenous 
ATP would have to be depleted prior to the assay being performed. Alternatively, 
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recombinant Lsm2-Lsm7p could be produced in E. coli in a similar way to Lsm8p 
(See chapter 4) and purified in the absence of ATP. 
An alternative to depletion experiments would be to add a non-hydrolysable 
structural analogue of ATP, such as ATPyS (Shuman et al., 1980). This has 
previously been used to demonstrate that ATP hydrolysis is necessary for Prpl6p 
function (Schwer & Guthrie, 1992; Wang el al., 1998). When added in excess to the 
incubation ATPyS binds to any ATP-binding sites of proteins but as it is not 
hydrolysable, this inhibits the energy-dependent step of the reaction. If the Lsm8 
complex does require ATP hydrolysis to facilitate U4/U6 duplex formation then the 
process will be blocked in the presence of ATPyS. 
Any detectable ATPase activity of the Lsrn8 complex may not be due to a helicase 
activity but resulting from another function for the complex. For example the Lsm8 
complex might have a similar function to the RecA/Rad5 I complex, which forms 
hexameric ring structures in solution (Yu & Egelman, 1997). RecA!Rad5l is 
responsible for catalysing homologous recombination and recombinatorial DNA 
repair in an ATP-dependent manner (Cox, 2000). Intriguingly, the A. fulgidus 
homologue binds to single-stranded but not double-stranded DNA (Mcllwraith et al., 
2001) suggesting it may have a polynucleotide binding-site of a similar size to the 
Sm and Lsm protein complexes. The Lsm8 complex could also possess an ATPase 
activity in relation to its other reported function in snoRNA biogenesis and exosome 
function (J. Kufel & D. Tollervey, unpublished data) 
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The crystallisation of both the 13-133 and the Dl-D2 Sm subcomplexes was 
performed in the absence of ATP (Kambach et al., 1998), and no recognisable ATP 
binding-site was observed. It is possible that the Sin and the Lsm proteins have 
diverged sufficiently from each other so that the Sin proteins no longer bind to ATP 
or require it for their function. Alternatively, the Sin proteins may require ATP but 
the binding may occur in subunits of the heptamer that were not crystallised or at the 
interface between specific subunits. 
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7.4 The relationship between the Lsm8 complex and Lsml 
Previous reports (Bouveret et al., 2000; Tharun et al., 2000; He & Parker, 2000), 
as well as this thesis, have shown that Lsm2-7p exist in at least two different 
complexes: one with Lsm8p in the nucleus, and the other with Lsmlp (LSMI) that is 
involved in mRNA decay in the cytoplasm. What is currently not known is how these 
two complexes relate to one another and how this affects their respective functions. 
One question that would be interesting to answer would be whether individual Lsm2-
7 proteins shuttle between the nucleus and the cytoplasm and are involved in both the 
Lsm8 and LsmI complexes, or whether there are two separate pools of Lsm2-7p. To 
investigate this, nuclear import and export mutants could be used, such as nup49-313 
(Lee et al., 1996) and xpol-1 (Stade et al., 1997) respectively. By epitope-tagging 
Lsm proteins in these strains it could be seen by immunofluorescence (Tharun et al., 
2000) whether they accumulated in the cytoplasm (in the case of the import mutant) 
or the nucleus (in the case of the export mutant). If so, then the proteins must shuttle 
between between the two compartments. 
If it were found that Lsm2-7p did shuttle between the two compartments it could 
have significant implications for the regulation of both pre-mRNA splicing and 
mRNA decay. For example, if the rate of export of the Lsm proteins was increased, 
then U4/U6 RNA annealing (and hence pre-mRNA splicing) might be decreased and 
the rate of mRNA decay could be increased. This could be a mechanism for 
regulating the levels of pre-mRNA processing and mRNA decay. 
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If, however, the proteins do not shuttle, this raises a separate set of questions. For 
example, how is only a subset of Lsm2-7p imported into the nucleus, while a subset 
remains in the cytoplasm? If this is regulated by assembling into their respective 
complexes in the cytoplasm, then how is this assembly regulated, and are Lsmlp and 
Lsm8p the sole determinants of these differences in localisation and function? It is 
obvious that there must be an elaborate relationship between these two Lsm 
complexes that requires further investigation. 
Given that the Lsm protein complexes probably form very similar structures and 
share most of their components, it is surprising that they are involved in many 
different functions such as pre-mRNA splicing, mRNA decay and snoRNA 
processing (J. Kufel & D. Tollervey, unpublished results). It will be interesting to 
discover what structural motif(s) of the Lsm complexes make them suitable for a 
such a wide range of functions and how this relates to their function and evolution in 
higher eukaryotes. What is certain is that further study the Lsm proteins in both yeast 
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